https://investor.regeneron.com/ 2026-01-30T07:10:47-05:00 daily 1.0 https://investor.regeneron.com/committee-details/audit-committee 2023-09-11T12:42:45-04:00 0.5 https://investor.regeneron.com/committee-details/compensation-committee 2025-09-15T10:05:40-04:00 0.5 https://investor.regeneron.com/committee-details/technology-committee 2023-09-11T13:02:55-04:00 0.5 https://investor.regeneron.com/committee-details/corporate-governance-and-compliance-committee 2026-09-21T09:18:26-04:00 0.5 https://investor.regeneron.com/committee-details/digital-technology-committee 2026-09-21T09:20:22-04:00 0.5 https://investor.regeneron.com/events/event-details/asrs-2018 2018-08-27T19:38:19-04:00 0.5 https://investor.regeneron.com/events/event-details/ash-2018 2018-12-01T12:15:02-05:00 0.5 https://investor.regeneron.com/events/event-details/37th-annual-jp-morgan-healthcare-conference 2019-02-19T19:47:44-05:00 0.5 https://investor.regeneron.com/events/event-details/regeneron-pharmaceuticals-q4-2018-earnings-conference-call 2019-02-19T19:52:21-05:00 0.5 https://investor.regeneron.com/events/event-details/angiogenesis-exudation-and-degeneration-2019 2019-02-09T16:29:57-05:00 0.5 https://investor.regeneron.com/events/event-details/cowen-39th-annual-healthcare-conference 2019-03-11T09:01:02-04:00 0.5 https://investor.regeneron.com/events/event-details/2019-aaaai-annual-meeting 2019-02-25T12:45:02-05:00 0.5 https://investor.regeneron.com/events/event-details/asco-sitc-2019 2019-03-01T09:58:21-05:00 0.5 https://investor.regeneron.com/events/event-details/jp-morgan-2019-spring-biotech-conference-call-series 2019-03-11T17:25:36-04:00 0.5 https://investor.regeneron.com/events/event-details/annual-shareholder-meeting 2019-06-14T13:56:57-04:00 0.5 https://investor.regeneron.com/events/event-details/regeneron-pharmaceuticals-q1-2019-earnings-conference-call 2019-04-08T16:30:54-04:00 0.5 https://investor.regeneron.com/events/event-details/bank-america-merrill-lynch-healthcare-conference 2019-04-30T13:54:54-04:00 0.5 https://investor.regeneron.com/events/event-details/barclays-biopharmaceuticals-ceocfo-conference-call-series 2019-05-09T16:10:48-04:00 0.5 https://investor.regeneron.com/events/event-details/ubs-global-healthcare-conference 2019-04-30T13:58:27-04:00 0.5 https://investor.regeneron.com/events/event-details/goldman-sachs-global-healthcare-conference 2019-06-11T10:29:59-04:00 0.5 https://investor.regeneron.com/events/event-details/american-society-clinical-oncology-asco-2019-annual-meeting 2019-06-01T14:17:00-04:00 0.5 https://investor.regeneron.com/events/event-details/european-hematology-association-eha-2019-annual-meeting 2019-06-15T10:45:02-04:00 0.5 https://investor.regeneron.com/events/event-details/regeneron-pharmaceuticals-q2-2019-earnings-conference-call 2019-07-08T09:54:36-04:00 0.5 https://investor.regeneron.com/events/event-details/morgan-stanley-17th-annual-global-healthcare-conference 2019-09-06T16:04:52-04:00 0.5 https://investor.regeneron.com/events/event-details/pegs-boston-summit-presentation-april-2019 2019-09-26T17:00:28-04:00 0.5 https://investor.regeneron.com/events/event-details/european-society-medical-oncology-esmo-congress-2019 2019-09-30T12:17:46-04:00 0.5 https://investor.regeneron.com/events/event-details/regeneron-pharmaceuticals-q3-2019-earnings-conference-call 2019-10-18T11:49:02-04:00 0.5 https://investor.regeneron.com/events/event-details/credit-suisse-28th-annual-healthcare-conference 2019-10-28T12:33:43-04:00 0.5 https://investor.regeneron.com/events/event-details/jefferies-2019-london-healthcare-conference 2019-11-18T11:13:33-05:00 0.5 https://investor.regeneron.com/events/event-details/regeneron-oncology-strategy 2019-11-07T16:40:47-05:00 0.5 https://investor.regeneron.com/events/event-details/guggenheim-healthcare-talks-idea-forum-neuroimmunology-day 2019-11-14T14:50:34-05:00 0.5 https://investor.regeneron.com/events/event-details/piper-jaffray-31st-annual-healthcare-conference 2019-11-22T10:36:22-05:00 0.5 https://investor.regeneron.com/events/event-details/american-society-hematology-ash-2019-annual-meeting 2019-12-09T16:46:56-05:00 0.5 https://investor.regeneron.com/events/event-details/overview-sanofi-ownership-regeneron-common-stock 2019-12-11T17:12:10-05:00 0.5 https://investor.regeneron.com/events/event-details/38th-annual-jp-morgan-healthcare-conference 2020-01-13T03:55:36-05:00 0.5 https://investor.regeneron.com/events/event-details/38th-annual-jp-morgan-healthcare-conference-breakout-session 2019-12-20T16:31:04-05:00 0.5 https://investor.regeneron.com/events/event-details/regeneron-pharmaceuticals-q4-2019-earnings-conference-call 2020-01-14T05:23:21-05:00 0.5 https://investor.regeneron.com/events/event-details/angiogenesis-exudation-and-degeneration-2020 2020-02-09T14:14:51-05:00 0.5 https://investor.regeneron.com/events/event-details/svb-leerink-9th-annual-global-healthcare-conference 2020-02-12T20:36:22-05:00 0.5 https://investor.regeneron.com/events/event-details/cowen-40th-annual-healthcare-conference 2020-03-02T10:59:18-05:00 0.5 https://investor.regeneron.com/events/event-details/barclays-global-healthcare-conference 2020-03-09T14:23:23-04:00 0.5 https://investor.regeneron.com/events/event-details/corporate-presentation-feb-2020 2020-02-20T10:27:49-05:00 0.5 https://investor.regeneron.com/events/event-details/jp-morgan-2020-biotech-conference-call-series 2020-03-03T18:59:02-05:00 0.5 https://investor.regeneron.com/events/event-details/oppenheimer-30th-annual-healthcare-conference 2020-03-09T14:31:52-04:00 0.5 https://investor.regeneron.com/events/event-details/acc20 2020-03-30T16:40:47-04:00 0.5 https://investor.regeneron.com/events/event-details/2020-annual-meeting-shareholders 2020-06-12T12:34:47-04:00 0.5 https://investor.regeneron.com/events/event-details/updates-regeneron-accounting 2020-04-06T17:05:55-04:00 0.5 https://investor.regeneron.com/events/event-details/regeneron-pharmaceuticals-q1-2020-earnings-conference-call 2020-05-05T06:41:38-04:00 0.5 https://investor.regeneron.com/events/event-details/bank-america-securities-virtual-health-care-conference 2020-05-04T15:18:37-04:00 0.5 https://investor.regeneron.com/events/event-details/rbc-capital-markets-virtual-global-healthcare-conference 2020-05-12T08:44:12-04:00 0.5 https://investor.regeneron.com/events/event-details/bernsteins-36th-annual-strategic-decisions-conference 2020-05-20T12:07:59-04:00 0.5 https://investor.regeneron.com/events/event-details/regeneron-oncology-investor-event-asco-2020 2022-06-02T14:25:01-04:00 0.5 https://investor.regeneron.com/events/event-details/goldman-sachs-41st-annual-global-healthcare-conference 2020-06-08T23:27:12-04:00 0.5 https://investor.regeneron.com/events/event-details/credit-suisse-biotech-management-board-call-series 2020-06-17T13:57:00-04:00 0.5 https://investor.regeneron.com/events/event-details/bmo-2020-prescriptions-success-healthcare-conference 2020-06-17T14:04:55-04:00 0.5 https://investor.regeneron.com/events/event-details/european-hematology-association-eha-2020 2020-06-12T13:01:04-04:00 0.5 https://investor.regeneron.com/events/event-details/regeneron-pharmaceuticals-q2-2020-earnings-conference-call 2020-07-08T16:33:59-04:00 0.5 https://investor.regeneron.com/events/event-details/regeneron-corporate-presentation-2 2020-08-12T16:04:55-04:00 0.5 https://investor.regeneron.com/events/event-details/citis-15th-annual-biopharma-virtual-conference 2020-09-03T15:03:15-04:00 0.5 https://investor.regeneron.com/events/event-details/morgan-stanley-18th-annual-global-healthcare-conference 2020-09-03T16:44:32-04:00 0.5 https://investor.regeneron.com/events/event-details/cantor-fitzgerald-virtual-global-healthcare-conference 2020-09-03T15:20:54-04:00 0.5 https://investor.regeneron.com/events/event-details/european-respiratory-society-ers-2020-virtual-congress 2020-09-08T19:00:56-04:00 0.5 https://investor.regeneron.com/events/event-details/regeneron-covid-19-program-update 2020-09-29T18:11:23-04:00 0.5 https://investor.regeneron.com/events/event-details/regeneron-pharmaceuticals-q3-2020-earnings-conference-call 2020-10-07T07:54:40-04:00 0.5 https://investor.regeneron.com/events/event-details/credit-suisse-29th-annual-virtual-healthcare-conference 2020-11-04T10:35:55-05:00 0.5 https://investor.regeneron.com/events/event-details/cowen-virtual-presentation-series-2020-io-next-summit 2020-11-04T10:37:36-05:00 0.5 https://investor.regeneron.com/events/event-details/jefferies-virtual-london-healthcare-conference 2020-11-04T10:41:40-05:00 0.5 https://investor.regeneron.com/events/event-details/focis-federation-clinical-immunology-societies-2020-annual-meeting 2020-10-31T11:23:44-04:00 0.5 https://investor.regeneron.com/events/event-details/regeneron-corporate-presentation-3 2020-11-06T11:30:12-05:00 0.5 https://investor.regeneron.com/events/event-details/piper-sandler-32nd-annual-virtual-healthcare-conference 2020-11-23T17:55:59-05:00 0.5 https://investor.regeneron.com/events/event-details/evercore-isi-3rd-annual-healthconx-conference-0 2020-11-20T09:44:04-05:00 0.5 https://investor.regeneron.com/events/event-details/regeneron-oncology-investor-event-ash-2020 2020-12-07T16:42:55-05:00 0.5 https://investor.regeneron.com/events/event-details/regeneron-pharmaceuticals-q4-2020-earnings-conference-call 2021-03-15T09:33:35-04:00 0.5 https://investor.regeneron.com/events/event-details/39th-annual-jp-morgan-healthcare-conference 2021-01-11T08:24:04-05:00 0.5 https://investor.regeneron.com/events/event-details/svb-leerink-10th-annual-global-healthcare-conference 2021-03-15T09:15:11-04:00 0.5 https://investor.regeneron.com/events/event-details/cowen-41st-annual-health-care-conference 2021-03-15T09:16:08-04:00 0.5 https://investor.regeneron.com/events/event-details/barclays-global-healthcare-conference-0 2021-03-15T09:17:01-04:00 0.5 https://investor.regeneron.com/events/event-details/oppenheimer-31st-annual-healthcare-conference 2021-03-16T08:58:05-04:00 0.5 https://investor.regeneron.com/events/event-details/regeneron-pharmaceuticals-q1-2021-earnings-conference-call 2021-05-05T23:21:31-04:00 0.5 https://investor.regeneron.com/events/event-details/2021-annual-meeting-shareholders 2021-06-11T12:51:47-04:00 0.5 https://investor.regeneron.com/events/event-details/regen-covtm-data-non-hospitalized-covid-19-patients 2021-04-14T07:40:44-04:00 0.5 https://investor.regeneron.com/events/event-details/bank-america-securities-virtual-health-care-conferenc 2021-05-07T15:50:28-04:00 0.5 https://investor.regeneron.com/events/event-details/rbc-capital-markets-virtual-global-healthcare-conference-0 2021-05-13T17:35:22-04:00 0.5 https://investor.regeneron.com/events/event-details/2021-american-society-clinical-oncology-asco-annual-meeting 2022-05-26T10:14:52-04:00 0.5 https://investor.regeneron.com/events/event-details/bernsteins-37th-annual-strategic-decisions-conference 2022-05-26T10:14:12-04:00 0.5 https://investor.regeneron.com/events/event-details/goldman-sachs-42nd-annual-global-healthcare-conference 2022-05-26T10:15:30-04:00 0.5 https://investor.regeneron.com/events/event-details/bmo-biopharma-day 2022-05-26T10:16:30-04:00 0.5 https://investor.regeneron.com/events/event-details/baird-sustainability-conference 2021-06-17T08:30:00-04:00 0.5 https://investor.regeneron.com/events/event-details/guggenheim-biopharma-strategy-series-biopharmas-next-decade-views-top-global 2022-05-26T10:17:24-04:00 0.5 https://investor.regeneron.com/events/event-details/regeneron-pharmaceuticals-q2-2021-earnings-conference-call 2022-05-26T10:17:58-04:00 0.5 https://investor.regeneron.com/events/event-details/morgan-stanley-19th-annual-global-healthcare-conference 2022-05-26T10:18:27-04:00 0.5 https://investor.regeneron.com/events/event-details/cantor-fitzgerald-virtual-global-healthcare-conference-0 2022-05-26T10:24:22-04:00 0.5 https://investor.regeneron.com/events/event-details/regeneron-oncology-investor-event-esmo-2021 2022-05-26T10:19:10-04:00 0.5 https://investor.regeneron.com/events/event-details/regeneron-pharmaceuticals-q3-2021-earnings-conference-call 2022-05-26T10:24:50-04:00 0.5 https://investor.regeneron.com/events/event-details/regeneron-investor-event-ash-2021 2022-05-26T10:28:07-04:00 0.5 https://investor.regeneron.com/events/event-details/evercore-isi-4th-annual-healthconx-conference 2022-05-26T10:25:21-04:00 0.5 https://investor.regeneron.com/events/event-details/piper-sandler-33rd-annual-healthcare-conference 2022-05-26T10:26:57-04:00 0.5 https://investor.regeneron.com/events/event-details/hc-wainwright-co-unlocking-full-potential-rnai-world-class-novel-target 2022-05-26T10:27:32-04:00 0.5 https://investor.regeneron.com/events/event-details/regeneron-pharmaceuticals-q4-2021-earnings-conference-call 2022-05-26T10:31:22-04:00 0.5 https://investor.regeneron.com/events/event-details/40th-annual-jp-morgan-healthcare-conference 2022-05-26T10:30:42-04:00 0.5 https://investor.regeneron.com/events/event-details/angiogenesis-exudation-and-degeneration-2022 2022-04-25T03:42:18-04:00 0.5 https://investor.regeneron.com/events/event-details/cowen-42nd-annual-health-care-conference 2022-05-26T10:32:01-04:00 0.5 https://investor.regeneron.com/events/event-details/oppenheimer-32nd-annual-healthcare-conference 2022-05-26T10:33:06-04:00 0.5 https://investor.regeneron.com/events/event-details/barclays-global-healthcare-conference-1 2022-05-26T10:33:34-04:00 0.5 https://investor.regeneron.com/events/event-details/regeneron-pharmaceuticals-q1-2022-earnings-conference-call 2022-05-26T10:34:03-04:00 0.5 https://investor.regeneron.com/events/event-details/2022-annual-meeting-shareholders 2022-10-24T10:57:03-04:00 0.5 https://investor.regeneron.com/events/event-details/bofa-securities-healthcare-conference 2022-05-26T10:34:28-04:00 0.5 https://investor.regeneron.com/events/event-details/goldman-sachs-43rd-annual-global-healthcare-conference 2022-06-06T16:52:18-04:00 0.5 https://investor.regeneron.com/events/event-details/regeneron-purchase-sanofis-stake-libtayo-investor-call 2022-06-02T08:14:05-04:00 0.5 https://investor.regeneron.com/events/event-details/regeneron-pharmaceuticals-q2-2022-earnings-conference-call 2022-08-02T23:28:43-04:00 0.5 https://investor.regeneron.com/events/event-details/esmo-2022 2023-05-12T16:24:47-04:00 0.5 https://investor.regeneron.com/events/event-details/2022-wells-fargo-healthcare-conference 2022-08-29T17:36:38-04:00 0.5 https://investor.regeneron.com/events/event-details/morgan-stanley-20th-annual-global-healthcare-conference 2022-08-29T17:35:44-04:00 0.5 https://investor.regeneron.com/events/event-details/regeneron-pharmaceuticals-q3-2022-earnings-conference-call 2022-11-03T00:16:42-04:00 0.5 https://investor.regeneron.com/events/event-details/american-academy-ophthalmology-2022-annual-meeting 2022-09-30T16:27:19-04:00 0.5 https://investor.regeneron.com/events/event-details/regeneron-investor-event-ash-2022 2022-12-13T17:19:09-05:00 0.5 https://investor.regeneron.com/events/event-details/retina-society-55th-annual-scientific-meeting 2022-11-04T13:46:33-04:00 0.5 https://investor.regeneron.com/events/event-details/jefferies-london-healthcare-conference 2022-11-09T12:46:35-05:00 0.5 https://investor.regeneron.com/events/event-details/5th-annual-evercore-isi-healthconx-conference 2022-12-19T09:57:13-05:00 0.5 https://investor.regeneron.com/events/event-details/piper-sandler-34th-annual-healthcare-conference 2022-11-09T15:44:21-05:00 0.5 https://investor.regeneron.com/events/event-details/regeneron-pharmaceuticals-q4-2022-earnings-conference-call 2023-02-07T18:42:29-05:00 0.5 https://investor.regeneron.com/events/event-details/41st-annual-jp-morgan-healthcare-conference 2023-01-13T08:40:31-05:00 0.5 https://investor.regeneron.com/events/event-details/svb-securities-global-biopharma-conference 2023-02-15T16:35:34-05:00 0.5 https://investor.regeneron.com/events/event-details/cowen-43rd-annual-health-care-conference 2023-03-08T12:43:30-05:00 0.5 https://investor.regeneron.com/events/event-details/oppenheimer-33rd-annual-healthcare-conference 2023-03-21T17:12:01-04:00 0.5 https://investor.regeneron.com/events/event-details/barclays-global-healthcare-conference-2 2023-03-21T17:12:43-04:00 0.5 https://investor.regeneron.com/events/event-details/regeneron-pharmaceuticals-q1-2023-earnings-conference-call 2023-06-09T09:45:55-04:00 0.5 https://investor.regeneron.com/events/event-details/2023-annual-meeting-shareholders 2023-06-09T10:43:33-04:00 0.5 https://investor.regeneron.com/events/event-details/bofa-securities-2023-health-care-conference 2023-06-09T13:40:59-04:00 0.5 https://investor.regeneron.com/events/event-details/2023-rbc-capital-markets-global-healthcare-conference 2023-06-09T15:19:15-04:00 0.5 https://investor.regeneron.com/events/event-details/td-cowen-4th-annual-oncology-innovation-summit 2023-06-09T17:10:49-04:00 0.5 https://investor.regeneron.com/events/event-details/jefferies-healthcare-conference 2023-06-09T17:55:29-04:00 0.5 https://investor.regeneron.com/events/event-details/goldman-sachs-44th-annual-global-healthcare-conference 2023-08-11T10:10:12-04:00 0.5 https://investor.regeneron.com/events/event-details/regeneron-pharmaceuticals-q2-2023-earnings-conference-call 2023-08-11T14:06:21-04:00 0.5 https://investor.regeneron.com/events/event-details/american-society-retina-specialists-annual-meeting-2-year-96-week-data-phase 2023-07-28T14:31:53-04:00 0.5 https://investor.regeneron.com/events/event-details/2023-wells-fargo-healthcare-conference 2023-09-07T14:37:01-04:00 0.5 https://investor.regeneron.com/events/event-details/morgan-stanley-21st-annual-global-healthcare-conference 2023-09-15T12:20:10-04:00 0.5 https://investor.regeneron.com/events/event-details/regeneron-pharmaceuticals-q3-2023-earnings-conference-call 2023-11-06T16:10:35-05:00 0.5 https://investor.regeneron.com/events/event-details/23rd-european-society-retina-specialists-euretina-congress-60-week-and-2-year 2023-10-03T09:19:59-04:00 0.5 https://investor.regeneron.com/events/event-details/truist-securities-biopharma-symposium 2023-11-14T16:28:54-05:00 0.5 https://investor.regeneron.com/events/event-details/ubs-biopharma-conference 2023-11-14T10:30:47-05:00 0.5 https://investor.regeneron.com/events/event-details/jefferies-london-healthcare-conference-0 2024-01-22T10:15:30-05:00 0.5 https://investor.regeneron.com/events/event-details/regeneron-investor-event-ash-2023 2024-01-18T14:28:41-05:00 0.5 https://investor.regeneron.com/events/event-details/piper-sandler-35th-annual-healthcare-conference 2024-01-18T14:27:42-05:00 0.5 https://investor.regeneron.com/events/event-details/42nd-annual-jp-morgan-healthcare-conference 2024-01-18T14:26:53-05:00 0.5 https://investor.regeneron.com/events/event-details/regeneron-pharmaceuticals-q4-2023-earnings-conference-call 2025-02-05T10:18:53-05:00 0.5 https://investor.regeneron.com/events/event-details/oppenheimer-34th-annual-healthcare-life-sciences-conference 2024-02-22T14:24:03-05:00 0.5 https://investor.regeneron.com/events/event-details/td-cowen-44th-annual-health-care-conference 2024-03-14T17:14:53-04:00 0.5 https://investor.regeneron.com/events/event-details/barclays-26th-annual-global-healthcare-conference 2024-03-29T11:04:57-04:00 0.5 https://investor.regeneron.com/events/event-details/leerink-partners-global-biopharma-conference 2024-03-21T13:48:02-04:00 0.5 https://investor.regeneron.com/events/event-details/regeneron-pharmaceuticals-q1-2024-earnings-conference-call 2024-06-07T15:08:54-04:00 0.5 https://investor.regeneron.com/events/event-details/2024-annual-meeting-shareholders 2024-10-29T23:28:34-04:00 0.5 https://investor.regeneron.com/events/event-details/rbc-capital-markets-global-healthcare-conference 2024-06-07T15:17:29-04:00 0.5 https://investor.regeneron.com/events/event-details/jefferies-global-healthcare-conference 2024-06-07T15:06:41-04:00 0.5 https://investor.regeneron.com/events/event-details/goldman-sachs-45th-annual-global-healthcare-conference 2024-06-13T13:48:24-04:00 0.5 https://investor.regeneron.com/events/event-details/regeneron-pharmaceuticals-q2-2024-earnings-conference-call 2024-08-05T18:08:20-04:00 0.5 https://investor.regeneron.com/events/event-details/morgan-stanley-22nd-annual-global-healthcare-conference 2024-09-17T12:49:37-04:00 0.5 https://investor.regeneron.com/events/event-details/2024-wells-fargo-healthcare-conference 2024-09-17T10:36:37-04:00 0.5 https://investor.regeneron.com/events/event-details/regeneron-investor-event-esmo-2024 2024-09-17T12:23:27-04:00 0.5 https://investor.regeneron.com/events/event-details/regeneron-pharmaceuticals-q3-2024-earnings-conference-call 2024-11-05T15:35:06-05:00 0.5 https://investor.regeneron.com/events/event-details/jefferies-london-healthcare-conference-1 2025-01-03T09:37:42-05:00 0.5 https://investor.regeneron.com/events/event-details/piper-sandler-36th-annual-healthcare-conference 2025-01-03T09:36:49-05:00 0.5 https://investor.regeneron.com/events/event-details/43rd-annual-jp-morgan-healthcare-conference 2025-02-06T11:37:27-05:00 0.5 https://investor.regeneron.com/events/event-details/regeneron-pharmaceuticals-q4-2024-earnings-conference-call 2025-02-06T10:33:07-05:00 0.5 https://investor.regeneron.com/events/event-details/td-cowen-45th-annual-health-care-conference 2025-03-10T11:56:20-04:00 0.5 https://investor.regeneron.com/events/event-details/leerink-partners-2025-global-healthcare-conference 2025-03-12T13:54:53-04:00 0.5 https://investor.regeneron.com/events/event-details/regeneron-pharmaceuticals-q1-2025-earnings-conference-call 2025-05-01T16:05:28-04:00 0.5 https://investor.regeneron.com/events/event-details/2025-annual-meeting-shareholders 2025-04-01T09:02:58-04:00 0.5 https://investor.regeneron.com/events/event-details/bofa-securities-2025-health-care-conference 2025-05-19T15:47:53-04:00 0.5 https://investor.regeneron.com/events/event-details/2025-rbc-capital-markets-global-healthcare-conference 2025-05-22T13:38:47-04:00 0.5 https://investor.regeneron.com/events/event-details/46th-annual-goldman-sachs-global-healthcare-conference 2025-06-09T17:10:37-04:00 0.5 https://investor.regeneron.com/events/event-details/regeneron-pharmaceuticals-q2-2025-earnings-conference-call 2025-08-08T14:16:16-04:00 0.5 https://investor.regeneron.com/events/event-details/cantor-global-healthcare-conference-2025 2025-09-08T13:31:34-04:00 0.5 https://investor.regeneron.com/events/event-details/2025-wells-fargo-healthcare-conference 2025-09-08T13:38:20-04:00 0.5 https://investor.regeneron.com/events/event-details/morgan-stanley-23rd-annual-global-healthcare-conference 2025-09-08T16:36:14-04:00 0.5 https://investor.regeneron.com/events/event-details/bernstein-insights-healthcare-leaders-and-disruptors-2nd-annual-healthcare 2025-09-29T16:56:41-04:00 0.5 https://investor.regeneron.com/events/event-details/regeneron-pharmaceuticals-q3-2025-earnings-conference-call 2025-10-30T17:27:05-04:00 0.5 https://investor.regeneron.com/events/event-details/regeneron-roundtable-factor-xi 2026-05-12T10:20:38-04:00 0.5 https://investor.regeneron.com/events/event-details/regeneron-roundtable-lynozyfic 2026-05-07T14:54:20-04:00 0.5 https://investor.regeneron.com/events/event-details/jefferies-london-healthcare-conference-2 2026-02-04T10:23:07-05:00 0.5 https://investor.regeneron.com/events/event-details/7th-annual-wolfe-research-healthcare-conference 2025-11-21T14:38:44-05:00 0.5 https://investor.regeneron.com/events/event-details/8th-annual-evercore-healthcare-conference 2026-02-04T14:04:01-05:00 0.5 https://investor.regeneron.com/events/event-details/citi-2025-global-healthcare-conference 2026-02-04T11:04:21-05:00 0.5 https://investor.regeneron.com/events/event-details/regeneron-pharmaceuticals-q4-2025-earnings-conference-call 2026-02-04T13:27:54-05:00 0.5 https://investor.regeneron.com/events/event-details/44th-annual-jp-morgan-healthcare-conference 2026-02-04T14:03:42-05:00 0.5 https://investor.regeneron.com/events/event-details/leerink-partners-2026-global-healthcare-conference 2026-05-08T15:12:17-04:00 0.5 https://investor.regeneron.com/events/event-details/td-cowen-46th-annual-health-care-conference 2026-03-10T10:57:43-04:00 0.5 https://investor.regeneron.com/events/event-details/barclays-28th-annual-global-healthcare-conference 2026-03-10T14:06:33-04:00 0.5 https://investor.regeneron.com/events/event-details/regeneron-pharmaceuticals-q1-2026-earnings-conference-call 2026-05-01T15:15:36-04:00 0.5 https://investor.regeneron.com/events/event-details/regeneron-roundtable-c5-complement-program 2026-05-12T10:20:07-04:00 0.5 https://investor.regeneron.com/events/event-details/2026-annual-meeting-shareholders 2026-06-12T11:45:15-04:00 0.5 https://investor.regeneron.com/events/event-details/bofa-securities-health-care-conference-2026 2026-05-21T16:05:59-04:00 0.5 https://investor.regeneron.com/events/event-details/goldman-sachs-47th-annual-global-healthcare-conference 2026-06-15T15:00:36-04:00 0.5 https://investor.regeneron.com/events/event-details/regeneron-pharmaceuticals-q2-2026-earnings-conference-call 2026-08-06T14:37:51-04:00 0.5 https://investor.regeneron.com/events/event-details/2026-wells-fargo-healthcare-conference 2026-09-17T15:01:11-04:00 0.5 https://investor.regeneron.com/events/event-details/morgan-stanley-24th-annual-global-healthcare-conference 2026-09-24T12:03:19-04:00 0.5 https://investor.regeneron.com/events/event-details/bernstein-insights-healthcare-leaders-and-disruptors-3rd-annual-healthcare 2026-08-28T11:07:08-04:00 0.5 https://investor.regeneron.com/events/event-details/regeneron-pharmaceuticals-q3-2026-earnings-conference-call 2026-09-25T09:02:41-04:00 0.5 https://investor.regeneron.com/events/event-details/regeneron-sanofi-investor-event 2026-10-01T01:03:24-04:00 0.5 https://investor.regeneron.com/investor-relations 2026-01-30T07:10:47-05:00 0.8 https://investor.regeneron.com/news/press-releases 2024-12-04T14:59:16-05:00 0.8 https://investor.regeneron.com/events-and-presentations/events-and-recent 2026-02-04T16:50:48-05:00 0.8 https://investor.regeneron.com/governance/governance-documents 2026-05-06T16:26:39-04:00 0.8 https://investor.regeneron.com/governance/committee-composition 2024-12-04T18:26:56-05:00 0.8 https://investor.regeneron.com/governance/contact-the-board 2024-12-04T18:36:17-05:00 0.8 https://investor.regeneron.com/financials/overview 2024-12-06T14:54:40-05:00 0.8 https://investor.regeneron.com/financials/sec-filings 2024-12-06T14:55:02-05:00 0.8 https://investor.regeneron.com/financials/annual-reports-and-proxy-statements 2024-12-06T14:55:28-05:00 0.8 https://investor.regeneron.com/stock-information/ownership-profile 2024-12-04T16:25:50-05:00 0.8 https://investor.regeneron.com/stock-information 2024-12-04T16:13:05-05:00 0.8 https://investor.regeneron.com/stock-information/historic-stock-lookup 2024-12-04T16:15:23-05:00 0.8 https://investor.regeneron.com/stock-information/investment-calculator 2024-12-04T16:19:34-05:00 0.8 https://investor.regeneron.com/resources/investor-faqs 2024-12-04T18:40:59-05:00 0.8 https://investor.regeneron.com/email-alerts 2018-06-13T07:11:10-04:00 0.8 https://investor.regeneron.com/financials/quarterly-results 2024-12-06T14:55:51-05:00 0.8 https://investor.regeneron.com/governance/insider-transactions 2024-12-04T18:38:41-05:00 0.8 https://investor.regeneron.com/email-alerts-subscription 2018-06-13T07:05:43-04:00 0.8 https://investor.regeneron.com/news/media-statements 2025-02-03T16:15:34-05:00 0.8 https://investor.regeneron.com/events-and-presentations/archive 2024-12-09T19:45:21-05:00 0.8 https://investor.regeneron.com/sitemap 2025-02-25T17:15:38-05:00 0.8 https://investor.regeneron.com/yearinreview 2026-08-19T17:26:39-04:00 0.8 https://investor.regeneron.com/events-and-presentations/roundtable 2026-05-12T10:19:29-04:00 0.8 https://investor.regeneron.com/news-releases/news-release-details/sanofi-aventis-and-regeneron-announce-results-phase-2-study 2009-07-02T14:58:12-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-converts-interleukin-1-antibody-opt-rights-royalty 2009-07-02T14:59:51-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-8th-annual-needham-life 2009-07-02T15:00:48-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-leerink-swann-novel-cancer 2009-07-02T15:01:29-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-deutsche-bank-34th-annual 2009-07-02T15:02:07-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-first-quarter-2009-financial-and-operating 2009-07-02T15:04:53-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/bayer-and-regeneron-extend-development-program-vegf-trap-eye 2009-07-02T15:10:14-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-university-texas-southwestern-medical-center 2009-07-02T15:11:20-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-university-texas-southwestern-medical-center-0 2009-07-02T15:14:06-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-initiation-phase-3-gout-program-arcalystr 2009-07-02T15:15:56-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-cowen-and-company-29th-annual 2009-07-02T15:16:45-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-barclays-capital-global 2009-07-02T15:17:25-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-participation-panel-discussion-rbc-capital 2009-07-02T15:24:46-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-20th-annual-piper-jaffray 2009-07-02T15:25:34-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-credit-suisse-2008-healthcare 2009-07-02T15:26:11-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/vegf-trap-eye-final-phase-2-results-age-related-macular 2009-07-02T15:27:40-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-ubs-global-life-sciences 2009-07-02T15:28:44-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-columbia-university-enter-strategic-velocimmuner 2009-07-02T15:29:44-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-morgan-stanley-global 2009-07-06T07:17:28-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regenerons-arcalystr-rilonacept-reduced-incidence-gout-flares-81 2009-07-06T07:19:01-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-webcast-presentation-results-phase-2-study 2009-07-06T07:20:34-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-bayer-healthcare-announce-vegf-trap-eye-achieved 2009-07-06T07:21:39-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/key-studies-published-supporting-fda-approval-regenerons 2009-07-06T07:22:59-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-28th-annual-canaccord-adams 2009-07-06T07:23:39-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-velocigener-agreement-sanofi-aventis 2009-07-06T07:24:38-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-bmo-capital-markets-2008-focus 2009-07-06T07:25:34-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-jefferies-2nd-annual-healthcare 2009-07-06T07:26:48-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-needham-seventh-annual 2009-07-06T07:27:46-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/sanofi-aventis-and-regeneron-update-aflibercept-vegf-trap 2009-07-06T07:28:56-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-citi-investment-research-global 2009-07-06T07:29:40-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/bayer-and-regeneron-dose-first-patient-second-phase-3-study-vegf 2009-07-06T07:30:42-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-bayer-healthcare-announce-encouraging-32-week 2009-07-06T07:32:15-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-morgan-stanley-global-0 2009-07-06T07:33:05-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/arcalysttm-rilonacept-first-and-only-fda-approved-treatment 2009-07-06T07:34:09-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-lehman-brothers-global 2009-07-06T07:35:13-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/fda-approves-regenerons-arcalysttm-rilonacept-treatment 2009-07-06T07:36:22-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-merrill-lynch-global 2009-07-06T07:37:14-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-jp-morgan-healthcare-conference 2009-07-06T07:37:55-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-closes-312-million-common-stock-sale-connection-sanofi 2009-07-06T07:38:57-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-participation-panel-discussion-rbc-capital-0 2009-07-06T07:42:07-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-initiates-major-global-collaboration-sanofi-aventis 2009-07-06T07:43:05-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-credit-suisse-healthcare 2009-07-06T07:43:58-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/pdufa-date-rilonacept-il-1-trap-extended-three-months-fda 2009-07-06T07:45:19-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-positive-primary-endpoint-results-phase-2 2009-07-06T07:46:47-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-ubs-global-life-sciences-0 2009-07-06T07:47:35-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-positive-results-exploratory-proof-concept 2009-07-06T07:48:32-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-webcast-presentations-two-investor-conferences 2009-07-06T07:49:14-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/phase-3-oncology-program-aflibercept-vegf-trap-initiated 2009-07-06T07:50:10-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-receives-20-million-milestone-payment-initiation-phase 2009-07-06T07:50:54-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/rilonacept-il-1-trap-granted-fda-priority-review-treatment-caps 2009-07-06T07:51:51-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-bayer-healthcare-initiate-phase-3-global 2009-07-06T08:25:26-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-submits-biologics-license-application-us-fda-il-1-trap 2009-07-06T08:30:58-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-webcast-presentations-two-investor-conferences-0 2009-07-06T08:33:31-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/results-vegf-trap-aflibercept-highlighted-asco-2007-annual 2009-07-06T08:34:32-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/vegf-trap-eye-phase-2-wet-amd-results-reported-arvo-annual 2009-07-06T08:35:35-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-morgan-stanley-global-1 2009-07-06T08:36:50-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/astellas-licenses-regenerons-velocimmuner-technology-discovering 2009-07-06T08:37:34-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/positive-interim-phase-2-data-reported-vegf-trap-eye-age-related 2009-07-06T08:40:13-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-present-lehman-brothers-10th-annual-global-healthcare 2009-07-06T08:44:11-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-expands-commercial-and-clinical-capabilities-through 2009-07-06T08:45:18-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-vegf-trap-clinical-update 2009-07-06T08:46:15-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/astrazeneca-licenses-regenerons-velocimmuner-technology 2009-07-06T08:47:09-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-25th-annual-jpmorgan-healthcare 2009-07-06T08:48:19-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-full-year-and-fourth-quarter-2008-financial 2009-07-16T10:16:38-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-third-quarter-2008-financial-and-operating 2009-07-16T10:18:45-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-second-quarter-2008-financial-and-operating 2009-07-16T10:20:01-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-first-quarter-2008-financial-and-operating 2009-07-16T10:21:04-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-fourth-quarter-and-full-year-2007-financial 2009-07-16T10:22:40-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-third-quarter-financial-and-operating-results 2009-07-16T10:24:04-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-second-quarter-financial-and-operating-results 2009-07-16T10:26:40-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-first-quarter-financial-and-operating-results 2009-07-16T10:27:40-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-fourth-quarter-and-full-year-2006-financial 2009-07-16T10:30:40-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/sanofi-aventis-and-regeneron-announce-results-phase-2-study-0 2009-08-12T09:07:32-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/first-patient-enrolled-regeneron-and-bayer-healthcare-vegf-trap 2009-08-12T09:08:49-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-receives-european-medicines-agency-positive-opinion 2009-08-12T09:09:42-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-second-quarter-2009-financial-and-operating 2009-08-12T09:10:52-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-29th-annual-canaccord-adams 2009-08-12T09:51:54-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-september-2009-investment-conference 2009-09-10T12:34:04-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/phase-3-trial-aflibercept-metastatic-pancreatic-cancer 2009-09-11T12:07:03-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/enrollment-completed-regeneron-and-bayer-healthcare-phase-3 2009-09-14T03:01:15-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-pharmaceuticals-and-biomed-realty-trust-host-ribbon 2009-10-06T13:11:58-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-18th-annual-credit-suisse 2009-10-27T05:31:13-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regenerons-rilonacept-granted-european-marketing-authorization 2009-10-27T12:31:18-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-third-quarter-2009-financial-and-operating 2009-11-03T02:04:21-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-conference-call-discuss-expanded-antibody 2009-11-10T11:37:05-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/sanofi-aventis-and-regeneron-expand-strategic-antibody 2009-11-12T06:40:48-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-21st-annual-piper-jaffray 2009-11-24T04:34:15-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-deutsche-bank-2009-biotech 2009-12-10T04:31:11-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-28th-annual-jp-morgan 2010-01-07T04:34:07-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/vegf-trap-eye-shows-positive-results-phase-2-study-patients 2010-02-18T02:04:32-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-full-year-and-fourth-quarter-2009-financial 2010-02-18T03:34:19-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-participation-panel-discussion-rbc-capital-1 2010-02-25T04:31:12-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-cowen-and-company-30th-annual 2010-03-04T04:31:37-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-barclays-capital-global-2010 2010-03-18T05:34:09-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-appointment-michael-aberman-md-vice 2010-03-22T12:31:07-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-first-quarter-2010-financial-and-operating 2010-04-29T03:05:23-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-bank-america-merrill-lynch-2010 2010-05-07T05:31:05-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-participation-j-p-morgan-biotech-ceocfo 2010-05-11T12:34:05-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-provides-initial-data-two-antibody-product-candidates 2010-05-12T04:55:31-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-2010-citi-investment-research 2010-05-20T05:31:23-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-9th-annual-needham-healthcare 2010-06-04T05:31:08-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-schedules-june-9-2010-teleconference-and-webcast 2010-06-08T13:22:05-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/arcalystr-rilonacept-meets-primary-and-all-secondary-endpoints 2010-06-09T02:58:02-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-goldman-sachs-31st-annual 2010-06-11T05:31:06-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-webcast-investor-day-july-15-2010 2010-07-13T04:49:08-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-second-quarter-2010-financial-and-operating 2010-07-27T23:01:08-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/astellas-pay-295-million-extend-license-regenerons-velocimmuner 2010-07-27T23:01:08-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-bank-america-merrill-lynch-0 2010-08-05T05:31:09-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-morgan-stanley-global-2 2010-09-03T05:31:06-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/phase-3-trial-aflibercept-second-line-metastatic-colorectal 2010-09-08T12:01:12-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-ubs-global-life-sciences-1 2010-09-13T05:31:10-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-panel-discussion-citis-5th-annual-biotech 2010-09-28T05:37:09-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-pharmaceuticals-inc-announces-sale-4500000-shares 2010-10-06T12:22:12-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-increases-size-public-offering-common-stock 2010-10-08T04:04:11-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-exercise-over-allotment-option-and-closing 2010-10-13T05:37:04-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-17th-annual-newsmakers-biotech 2010-10-15T05:31:07-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-third-quarter-2010-financial-results-and 2010-10-28T03:13:38-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-2010-credit-suisse-annual 2010-11-02T05:43:20-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/christine-poon-elected-regeneron-board-directors 2010-11-15T04:04:07-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-schedules-november-22-2010-teleconference-and-webcast 2010-11-19T11:33:10-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/bayer-and-regeneron-report-positive-top-line-results-two-phase-3 2010-11-22T02:46:12-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-22nd-annual-piper-jaffray 2010-11-23T04:33:15-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-2010-deutsche-bank-biofest 2010-12-06T04:33:22-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-schedules-december-20-2010-teleconference-and-webcast 2010-12-19T20:12:08-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-29th-annual-jp-morgan 2011-01-03T04:35:45-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-bayer-start-phase-3-trial-extend-ophthalmology 2011-01-17T21:03:13-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-isi-annual-conference 2011-02-08T04:33:17-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-bayer-report-positive-results-vegf-trap-eye-phase 2011-02-08T10:43:05-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-webcast-investor-briefing-vegf-trap-eye-clinical 2011-02-09T04:04:11-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-full-year-and-fourth-quarter-2010-financial 2011-02-17T02:03:53-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-submits-biologics-license-application-fda-vegf-trap 2011-02-22T03:04:53-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-march-2011-investor-conference-presentations 2011-02-23T04:33:21-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/arcalystr-rilonacept-meets-primary-and-all-secondary-endpoints-0 2011-02-28T02:33:27-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/sanofi-aventis-and-regeneron-report-top-line-results-phase-iii 2011-03-10T11:06:40-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-10th-annual-needham-healthcare 2011-03-30T05:33:14-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-bayer-announce-start-phase-3-clinical-program 2011-04-08T05:00:39-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/fda-grants-priority-review-vegf-trap-eye-treatment-wet-age 2011-04-18T03:34:37-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/sanofi-aventis-and-regeneron-report-positive-phase-iii-results 2011-04-26T12:07:27-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-bayer-report-positive-results-vegf-trap-eye-second 2011-04-27T12:15:03-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-bank-america-merrill-lynch-2011 2011-05-02T05:33:23-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-first-quarter-2011-financial-and-operating 2011-05-03T03:04:44-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/fda-schedules-advisory-committee-meeting-discuss-bla-vegf-trap 2011-05-23T08:15:16-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/zaltraptm-aflibercept-significantly-improved-survival-previously 2011-06-05T21:03:10-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/vegf-trap-eye-submitted-eu-marketing-authorization-treatment-wet 2011-06-06T22:33:09-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-president-and-ceo-leonard-s-schleifer-named-ernst 2011-06-13T12:45:46-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/trading-regeneron-common-stock-halted 2011-06-17T03:06:08-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-eyleatm-aflibercept-ophthalmic-solution 2011-06-17T10:06:10-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/eyleatm-aflibercept-injection-submitted-japan-marketing 2011-06-28T19:03:07-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-pharmaceuticals-inc-announces-r-unit-program-help 2011-06-30T06:48:53-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/phase-3-trial-zaltraptm-aflibercept-advanced-prostate-cancer 2011-07-07T03:03:39-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/sanofi-and-regeneron-report-positive-phase-2b-trial-results 2011-07-12T12:06:22-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-second-quarter-2011-financial-and-operating 2011-07-28T03:06:35-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-review-biologics-license-application-eyleatm 2011-08-16T13:12:17-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-clinical-presentations-asrs-2011-annual 2011-08-17T12:06:21-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-september-2011-investor-conference 2011-08-31T05:33:15-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-appointment-joseph-j-larosa-senior-vice 2011-09-06T03:03:50-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-ranked-science-magazine-2-employer-global 2011-09-15T12:03:21-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-zaltrapr-clinical-presentation-european 2011-09-23T03:03:25-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-pharmaceuticals-announces-proposed-offering 2011-10-17T12:09:08-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-pharmaceuticals-announces-pricing-offering-convertible 2011-10-18T06:03:28-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-third-quarter-2011-financial-and-operating 2011-10-27T03:06:45-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/positive-phase-2b-results-sarilumab-rheumatoid-arthritis-be 2011-10-27T04:04:52-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-2011-credit-suisse-annual 2011-11-07T04:33:18-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/sanofi-and-regeneron-report-positive-preliminary-phase-2-program 2011-11-10T01:24:08-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/rockefeller-university-president-marc-tessier-lavigne-elected 2011-11-21T04:04:20-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-fda-approval-eylea153-aflibercept-injection 2011-11-21T16:03:37-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-fda-acceptance-arcalystr-rilonacept 2011-11-22T04:36:15-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-upcoming-investor-conference-presentations 2011-11-23T04:33:15-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-bayer-initiate-phase-3-clinical-program-treatment 2011-11-27T21:03:28-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-time-change-2011-deutsche-bank 2011-12-01T06:03:22-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/two-year-results-phase-3-studies-eyleatm-aflibercept-injection 2011-12-05T04:47:46-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-host-conference-call-january-3-830-am-eastern-time 2012-01-02T12:21:07-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-settlement-patent-litigation-genentech-us 2012-01-03T02:03:28-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-30th-annual-j-p-morgan 2012-01-03T04:33:14-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-report-full-year-2011-financial-and-operating-results 2012-01-26T11:03:57-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-february-13-2012-date-full-year-2011 2012-02-10T11:06:10-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-fourth-quarter-and-full-year-2011-financial 2012-02-13T02:03:41-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-leerink-swann-2012-global 2012-02-13T11:06:31-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-february-2012-investor-conference 2012-02-21T11:07:31-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-march-2012-investor-conference-presentations 2012-02-28T11:07:00-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-bayer-announce-approval-eylear-aflibercept 2012-03-07T23:03:15-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-change-date-presentation-barclays-capital 2012-03-09T04:33:10-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-data-publication-and-presentations-potential 2012-03-21T13:03:14-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/sanofi-and-regeneron-report-phase-2-data-potential-first-class 2012-03-26T08:53:27-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/sanofi-and-regeneron-announce-regulatory-and-clinical-update 2012-04-04T21:03:15-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-report-first-quarter-2012-financial-and-operating 2012-04-12T12:06:21-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-first-quarter-2012-financial-and-operating 2012-04-26T02:33:35-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-bayer-announce-co-promotion-agreement-santen 2012-05-07T22:03:26-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-provides-update-fda-advisory-committee-discussion 2012-05-08T13:06:10-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-participation-j-p-morgan-biotech-ceocfo-0 2012-05-09T05:33:31-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-bank-america-merrill-lynch-2012 2012-05-10T05:33:32-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/sanofi-and-regeneron-announce-publication-positive-phase-2 2012-05-29T13:18:34-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-june-2012-investor-conference-presentations 2012-05-30T05:33:34-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-report-second-quarter-2012-financial-and-operating 2012-07-11T05:33:16-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/sanofi-and-regeneron-launch-comprehensive-phase-3-clinical 2012-07-20T04:46:32-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-second-quarter-2012-financial-and-operating 2012-07-25T02:33:47-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-receives-complete-response-letter-fda-arcalystr 2012-07-30T15:27:07-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/us-fda-approves-zaltrapr-ziv-aflibercept-after-priority-review 2012-08-03T11:24:43-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-september-2012-investor-conference 2012-08-29T05:33:11-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/eylear-aflibercept-injection-recommended-approval-treatment-wet 2012-09-21T05:24:09-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-named-worlds-1-biopharmaceutical-employer-science 2012-09-21T08:15:09-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-fda-approval-eylear-aflibercept-injection 2012-09-21T10:09:09-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/eylear-aflibercept-injection-approved-treatment-wet-age-related 2012-09-28T00:12:09-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-report-third-quarter-2012-financial-and-operating 2012-10-10T05:33:16-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-publication-eylear-aflibercept-injection 2012-10-18T12:13:53-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-third-quarter-2012-financial-and-operating 2012-10-24T02:33:23-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/sanofi-and-regeneron-announce-publication-phase-2-results-ldl 2012-10-31T13:03:44-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/sanofi-and-regeneron-announce-patient-enrollment-cardiovascular 2012-11-05T03:07:31-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-november-2012-investor-conference 2012-11-06T11:33:31-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/zaltrapr-ziv-aflibercept-receives-chmp-positive-opinion-european 2012-11-16T02:48:10-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/eylear-aflibercept-injection-approved-treatment-wet-age-0 2012-11-26T21:18:07-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-deutsche-bank-2012-dbaccess 2012-11-27T04:33:24-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-named-biotechnology-company-year 2012-11-29T09:18:11-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/eylear-aflibercept-submitted-eu-marketing-authorization 2012-12-05T21:03:08-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-january-2013-investor-conference 2012-12-20T04:33:13-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-recommends-rejection-mini-tender-offer-trc-capital 2013-01-04T11:42:07-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-report-fourth-quarter-and-full-year-2012-financial-and 2013-01-28T11:08:29-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/zaltrapr-ziv-aflibercept-approved-eu-patients-previously-treated 2013-02-05T09:06:01-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-receipt-hart-scott-rodino-notice 2013-02-11T04:36:13-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-fourth-quarter-and-full-year-2012-financial 2013-02-14T01:33:29-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-bayer-initiate-phase-3-trial-eylear-aflibercept 2013-02-18T21:33:08-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-upcoming-2013-investor-conference 2013-02-19T04:33:40-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/sanofi-and-regeneron-report-positive-proof-concept-data 2013-03-02T04:00:12-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-potential-additional-royalty-stream-related 2013-03-04T04:04:43-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-pharmaceuticals-announces-expansion-new-yorks-hudson 2013-04-04T05:18:19-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-report-first-quarter-2013-financial-and-operating 2013-04-11T12:06:47-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-upcoming-2013-investor-conference-0 2013-04-18T05:33:25-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-acquires-full-rights-two-novel-ophthalmology 2013-05-03T02:33:22-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-first-quarter-2013-financial-and-operating 2013-05-03T02:33:25-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-upcoming-2013-investor-conference-1 2013-05-08T05:33:32-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/sanofi-and-regeneron-announce-patient-enrollment-two-phase-3 2013-05-14T21:03:09-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/sanofi-and-regeneron-announce-publication-positive-phase-2a 2013-05-21T04:18:13-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-bayer-report-positive-phase-3-results-eylear 2013-06-05T22:33:07-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-first-recipients-annual-regeneron-prize 2013-06-27T12:33:13-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-report-second-quarter-2013-financial-and-operating 2013-07-02T12:06:33-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/eylear-aflibercept-injection-recommended-approval-treatment 2013-07-26T05:04:02-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-second-quarter-2013-financial-and-operating 2013-08-05T22:33:15-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-bayer-report-positive-one-year-results-two-phase-3 2013-08-05T22:33:18-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-granted-fundamental-patents-covering-mouse-antibody 2013-08-07T12:22:23-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-upcoming-2013-investor-conference-2 2013-08-27T06:09:23-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/eylear-aflibercept-injection-approved-europe-treatment-visual 2013-08-28T22:30:13-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-appointment-robert-e-landry-senior-vice 2013-09-10T04:05:14-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-present-phase-3-data-eylear-aflibercept-injection 2013-09-17T12:06:28-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-report-third-quarter-2013-financial-and-operating 2013-10-10T12:07:57-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/sanofi-and-regeneron-report-positive-top-line-results-alirocumab 2013-10-15T21:03:18-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-positive-phase-3-data-eylear-aflibercept 2013-10-21T03:04:43-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-named-top-employer-global-biopharmaceutical-industry 2013-10-24T12:03:58-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-upcoming-2013-investor-conference-3 2013-11-01T05:30:38-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-third-quarter-2013-financial-and-operating 2013-11-05T01:33:30-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/eylear-aflibercept-injection-submitted-eu-marketing 2013-11-07T01:05:02-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-highlights-eylear-aflibercept-injection-data-be 2013-11-12T11:07:47-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/sanofi-and-regeneron-report-positive-results-sarilumab-first 2013-11-21T20:03:09-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/eylear-aflibercept-injection-approved-treatment-macular-edema 2013-11-21T21:03:16-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regenerons-chief-executive-officer-and-chief-scientific-officer 2013-11-25T02:04:17-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/sanofi-and-regenerons-dupilumab-named-clinical-advance-year 2013-11-25T02:04:19-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-upcoming-2013-investor-conference-4 2013-12-04T04:30:47-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-32nd-annual-j-p-morgan 2013-12-17T04:30:49-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-fda-acceptance-eylear-aflibercept-injection 2013-12-18T02:33:27-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/sanofi-and-regeneron-announce-collaboration-american-college 2013-12-18T20:00:15-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-amendment-investor-agreement-sanofi 2014-01-12T21:03:47-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-geisinger-health-system-announce-major-human 2014-01-13T03:07:24-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-launches-new-human-genetics-initiative 2014-01-13T03:07:26-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-bayer-develop-new-treatment-option-wet-age-related 2014-01-13T11:06:49-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-report-fourth-quarter-and-full-year-2013-financial-and 2014-01-21T04:34:02-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/two-year-results-phase-3-vista-trial-eylear-aflibercept 2014-02-10T02:33:30-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-fourth-quarter-and-full-year-2013-financial 2014-02-11T01:33:23-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-upcoming-2014-investor-conference 2014-02-14T04:30:24-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-fda-acceptance-eylear-aflibercept-0 2014-02-24T02:30:46-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/bayer-healthcare-and-regeneron-announce-regulatory-submission 2014-03-02T21:00:32-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/sanofi-and-regeneron-present-alirocumab-clinical-data-american 2014-03-26T22:03:16-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/sanofi-and-regeneron-report-positive-results-alirocumab-phase-2 2014-04-01T04:09:42-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-initiative-stem-education-hudson-valley 2014-04-03T12:00:22-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/robert-ingram-elected-regeneron-board-directors 2014-04-04T12:03:24-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-report-first-quarter-2014-financial-and-operating 2014-04-11T05:30:25-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-upcoming-2014-investor-conference-0 2014-05-02T05:30:35-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-avalanche-biotechnologies-announce-collaboration 2014-05-05T04:30:11-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-first-quarter-2014-financial-and-operating 2014-05-08T02:30:29-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-update-upcoming-2014-investor-conference 2014-05-30T12:06:37-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-winners-2014-regeneron-prize-creative 2014-06-02T13:06:11-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/eylear-aflibercept-injection-submitted-eu-marketing-0 2014-06-10T22:30:12-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/sanofi-and-regeneron-announce-new-detailed-data-positive 2014-06-11T21:00:18-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/eylear-aflibercept-injection-recommended-approval-treatment-0 2014-06-27T03:18:09-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-announce-positive-results-phase-2b-study 2014-07-09T13:00:52-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/two-year-results-phase-3-vivid-dme-trial-eylear-aflibercept 2014-07-18T02:00:23-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-report-second-quarter-2014-financial-and-operating 2014-07-18T12:03:21-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/eylear-aflibercept-injection-receives-fda-approval-treatment 2014-07-29T14:33:07-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-report-positive-top-line-results-nine-phase 2014-07-30T04:01:01-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-announce-plan-use-priority-review-voucher 2014-07-30T12:06:37-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-second-quarter-2014-financial-and-operating 2014-08-05T02:30:42-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/eylear-aflibercept-injection-receives-eu-approval-treatment 2014-08-10T22:33:09-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-upcoming-2014-investor-conference-1 2014-08-19T05:30:33-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-present-results-four-phase-3-alirocumab 2014-08-24T21:03:19-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-announce-presentation-detailed-positive 2014-08-30T23:03:26-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-submission-application-eylear-aflibercept 2014-09-03T23:03:23-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/eylear-aflibercept-injection-receives-fda-breakthrough-therapy 2014-09-16T06:38:31-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-eylear-aflibercept-injection-approved 2014-09-21T22:33:10-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-announce-positive-phase-2-top-line 2014-09-29T21:03:20-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/eylear-aflibercept-injection-receives-fda-approval-macular-edema 2014-10-06T13:00:11-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-report-third-quarter-2014-financial-and-operating 2014-10-15T12:05:32-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-genetics-center-fully-operational-announces-new 2014-10-16T04:31:33-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-ranked-number-one-biopharmaceutical-employer-science 2014-10-16T10:00:17-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/eylear-aflibercept-injection-demonstrates-significantly-greater 2014-10-17T03:00:43-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-announce-start-phase-3-study-dupilumab 2014-10-20T03:01:43-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-upcoming-2014-investor-conference-2 2014-11-03T11:08:33-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-third-quarter-2014-financial-and-operating 2014-11-04T01:30:36-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-announce-positive-results-phase-2b-study-0 2014-11-10T20:00:11-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-eylear-aflibercept-injection-approved-0 2014-11-17T22:06:15-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-announce-new-results-six-phase-3-trials 2014-11-19T03:15:18-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-announce-dupilumab-has-received-fda 2014-11-19T20:30:08-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/eylear-aflibercept-injection-accepted-priority-review-fda 2014-12-01T02:00:58-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/have-you-been-counted-regeneron-and-sanofi-us-join-forces 2014-12-15T03:05:06-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-and-panel-discussion-33rd 2014-12-19T04:30:38-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-announce-positive-topline-results-first 2015-01-08T20:03:16-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-report-fourth-quarter-and-full-year-2014-financial-and 2015-01-09T04:30:18-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-announce-praluenttm-alirocumab-marketing 2015-01-11T20:18:06-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/eylear-aflibercept-injection-recommended-approval-treatment-1 2015-01-23T02:33:13-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-announce-praluenttm-alirocumab-biologics 2015-01-25T20:18:14-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-fourth-quarter-and-full-year-2014-financial 2015-02-10T01:33:14-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-upcoming-2015-investor-conference 2015-02-13T04:30:28-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/new-results-cholesterol-counts-show-most-americans-polled-do-not 2015-02-18T03:04:04-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/nih-sponsored-comparative-effectiveness-trial-diabetic-macular 2015-02-18T12:00:53-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/eylear-aflibercept-injection-receives-eu-approval-treatment-0 2015-02-26T03:42:07-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-announce-18-month-results-odyssey-long-term 2015-03-15T07:00:15-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/eylear-aflibercept-injection-receives-fda-approval-treatment-0 2015-03-25T07:06:36-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-report-first-quarter-2015-financial-and-operating 2015-04-10T05:30:44-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-upcoming-2015-investor-conference-0 2015-04-29T05:33:35-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-first-quarter-2015-financial-and-operating 2015-05-07T02:30:48-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-announce-positive-pivotal-phase-2b 2018-12-13T12:38:15-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/trading-regeneron-common-stock-halted-0 2015-06-09T03:05:23-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/fda-advisory-committee-recommends-approval-regeneron-and-sanofis 2015-06-09T14:30:25-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-2015-winners-regeneron-prize-creative 2015-06-25T04:31:55-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/eylear-aflibercept-injection-receives-approval-japan-treatment 2015-06-25T23:00:16-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-rapid-response-platform-emerging-infectious-diseases 2015-06-29T11:00:42-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/new-film-documents-heart-felt-stories-people-living-high-ldl 2015-06-30T06:38:13-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-report-second-quarter-2015-financial-and-operating 2015-07-08T05:30:45-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-announce-phase-3-results-showing-ldl-c 2015-07-08T18:00:23-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-announce-positive-topline-results-phase-3 2015-07-14T07:34:48-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-announce-chmp-recommends-european-approval 2015-07-24T03:15:10-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-launch-major-new-immuno-oncology 2015-07-27T21:02:09-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-second-quarter-2015-financial-and-operating 2015-08-04T02:30:24-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-announce-fda-approval-praluentr-alirocumab 2015-08-21T06:54:42-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-upcoming-2015-investor-conference-1 2015-08-31T05:30:22-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-announce-new-positive-praluentr-alirocumab 2015-09-01T05:07:40-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-discovery-cause-rare-genetic-bone-disease-detailed 2015-09-01T12:28:34-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-hires-maya-bermingham-executive-director-public-policy 2015-09-10T04:51:57-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-agreement-barda-development-new-antibody 2015-09-21T04:00:49-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-icahn-school-medicine-mount-sinai-announce-new 2015-09-24T04:31:37-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-announce-approval-praluentr-alirocumab 2015-09-27T21:00:17-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-collaboration-mitsubishi-tanabe-pharma 2015-10-01T12:05:33-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-report-third-quarter-2015-financial-and-operating 2015-10-08T05:30:35-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-announce-publication-positive-phase-2b 2015-10-08T05:32:05-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-additional-350-million-investment-and-200 2015-10-18T12:30:10-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-24th-annual-credit-suisse 2015-10-23T05:32:21-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-named-among-top-two-global-biopharmaceutical-employers 2015-10-29T09:40:01-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-eu-approval-eylear-aflibercept-injection 2015-10-30T05:02:33-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-third-quarter-2015-financial-and-operating 2015-11-04T01:30:29-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-present-results-phase-3-praluentr 2015-11-05T12:36:44-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/new-survey-us-adults-diabetes-reveals-less-half-understand-their 2015-11-06T03:11:22-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-present-results-pivotal-phase-3-study 2019-01-21T18:18:57-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-announce-new-praluentr-alirocumab-injection 2015-11-10T13:00:13-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-celebrates-patient-innovation-and-growth-new-york 2015-11-12T08:47:33-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-announce-18000-patient-odyssey-outcomes 2015-11-23T20:00:06-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-announce-unitedhealth-group-selects 2015-12-10T20:01:59-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-mourns-passing-dr-alfred-g-gilman-board-member-and 2015-12-27T07:01:49-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-34th-annual-jp-morgan 2016-01-07T04:30:01-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-announce-sarilumab-biologics-license 2016-01-07T20:01:45-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-report-fourth-quarter-and-full-year-2015-financial-and 2016-01-26T04:31:36-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-upcoming-2016-investor-conference 2016-02-02T04:31:59-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-announce-publication-positive-phase-2 2016-02-02T07:56:44-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-fourth-quarter-and-full-year-2015-financial 2016-02-09T01:31:58-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-joins-human-vaccines-project-improve-global-disease 2016-02-09T11:55:25-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-upcoming-2016-investor-conference-0 2016-02-29T04:30:05-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-hires-david-weinreich-md-mba-senior-vice-president 2016-02-29T11:59:29-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-genetics-center-publication-new-england-journal 2016-03-02T12:00:05-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-announce-humana-provides-exclusive-or 2016-03-04T12:40:20-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-announce-topline-results-phase-3 2016-03-10T20:01:55-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-strongly-disagree-us-jury-verdict-ongoing 2016-03-16T08:31:52-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-announce-positive-topline-results-phase-3-0 2016-03-22T21:59:55-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-bayer-jointly-develop-novel-combination-therapy 2016-03-24T04:00:01-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-present-phase-3-praluentr-alirocumab 2016-03-29T16:59:46-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-announce-positive-dupilumab-topline-results 2016-04-01T07:38:20-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-medimmune-enter-licensing-agreement-development 2016-04-04T12:01:51-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-intellia-therapeutics-announce-collaboration 2016-04-11T12:05:58-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-hires-sally-paull-senior-vice-president-human 2016-04-11T12:13:33-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-report-first-quarter-2016-financial-and-operating 2016-04-15T05:30:01-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-upcoming-2016-investor-conference-1 2016-04-29T05:29:55-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-positive-topline-results-phase-23-fasinumab 2016-05-02T03:01:20-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-first-quarter-2016-financial-and-operating 2016-05-05T02:30:10-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-genzyme-present-additional-data-pivotal 2016-05-10T14:18:36-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-important-us-prescribing-information 2016-05-24T18:16:11-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-selected-society-science-public-new-sponsor-science 2016-05-26T04:31:52-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/words-support-public-figures-regeneron-sts-sponsorship 2016-05-26T04:33:01-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-presents-positive-interim-data-phase-2-proof-concept 2016-05-31T05:00:20-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-announce-dupilumab-used-topical 2016-06-05T21:02:00-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-announce-approval-praluentr-alirocumab-0 2016-07-04T21:01:46-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-report-second-quarter-2016-financial-and-operating 2016-07-08T05:31:45-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/award-winning-chef-elizabeth-falkner-reveals-her-struggle-atopic 2016-07-12T03:00:12-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-2016-winners-regeneron-prize-creative 2016-07-13T04:30:10-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-upcoming-2016-investor-conference-2 2016-07-18T05:31:56-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-adicet-bio-announce-strategic-collaboration 2016-08-02T04:30:11-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-second-quarter-2016-financial-and-operating 2016-08-04T02:30:34-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-agreement-barda-manufacturing-and-testing 2019-01-21T18:17:03-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-present-positive-phase-3-investigational 2016-08-28T22:02:00-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-upcoming-2016-investor-conference-3 2016-09-01T05:30:10-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-election-bonnie-bassler-phd-and-huda-zoghbi 2016-09-12T04:31:56-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-teva-announce-global-collaboration-develop-and 2016-09-20T03:01:52-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-announce-dupilumab-biologics-license 2016-09-25T21:02:00-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-announce-positive-dupixentr-dupilumab-phase 2016-09-30T22:02:01-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/new-survey-reveals-widespread-and-serious-impact-moderate-severe 2016-10-05T04:40:23-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-report-third-quarter-2016-financial-and-operating 2016-10-07T05:32:00-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-teva-provide-update-fasinumab-clinical-development 2019-01-21T18:13:17-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-25th-annual-credit-suisse 2016-10-21T05:30:05-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/science-magazine-once-again-names-regeneron-best-company-work 2016-10-27T11:13:12-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-receive-complete-response-letter-fda 2016-10-28T10:47:00-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-phase-2-study-aflibercept-co-formulated 2016-10-31T11:50:18-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-third-quarter-2016-financial-and-operating 2016-11-04T02:32:14-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-present-data-phase-3-praluentr-alirocumab 2016-11-11T04:00:08-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-present-results-phase-3-monarch-study 2016-11-16T03:00:12-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-announce-praluentr-alirocumab 2016-11-16T21:02:01-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-ceo-leonard-schleifer-and-cso-george-yancopoulos-named 2016-11-21T03:30:12-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-announce-marketing-authorization 2016-12-07T20:02:01-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-35th-annual-jp-morgan 2016-12-22T04:32:01-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/science-publication-highlights-precision-medicine-approach 2016-12-22T09:00:07-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-genetics-center-and-geisinger-study-finds-life 2016-12-22T09:00:07-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-hires-jay-markowitz-md-senior-vice-president-portfolio 2017-01-04T02:00:10-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-appeal-us-district-court-rulings-ongoing 2017-01-05T15:02:01-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/sanofi-and-regeneron-provide-update-ongoing-patent-litigation 2017-01-09T10:51:33-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/sanofi-and-regeneron-file-notice-appeal-and-motion-stay-suspend 2017-01-14T06:05:08-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/forty-nations-brightest-young-scientists-named-regeneron-science 2017-01-24T07:02:01-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/tony-coles-md-elected-regeneron-board-directors 2017-01-31T02:02:05-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-announce-first-approval-kevzaratm-sarilumab 2017-01-31T20:02:01-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-report-fourth-quarter-and-full-year-2016-financial-and 2017-02-07T01:32:02-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/amgen-inc-v-sanofi-court-order-granted-stay-pending-appeal 2017-02-08T11:58:58-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/appeals-court-grants-stay-permanent-injunction-praluentr 2019-01-21T18:06:49-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-fourth-quarter-and-full-year-2016-financial 2017-02-09T01:32:10-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-upcoming-2017-investor-conference 2017-02-13T04:30:06-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-present-new-data-dupixentr-dupilumab 2017-02-27T03:30:12-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-announce-presentation-positive-data-long 2019-01-21T18:03:01-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-present-new-phase-3-praluentr-alirocumab 2017-03-07T03:00:37-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/teen-scientist-researches-new-approach-neurological-damage-wins 2017-03-14T17:30:01-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/uk-biobank-regeneron-and-gsk-announce-largest-gene-sequencing 2017-03-22T16:02:00-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-announce-fda-approval-dupixentr-dupilumab 2017-03-28T07:42:00-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-host-investor-conference-call-discuss 2017-03-28T09:52:00-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-evinacumab-has-received-fda-breakthrough 2017-04-06T03:00:12-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-report-first-quarter-2017-financial-and-operating 2017-04-14T05:32:00-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-receive-positive-chmp-opinion-kevzarar 2017-04-23T21:02:01-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-announce-fda-approval-new-once-monthly 2017-04-25T04:00:33-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-announce-kevzarar-sarilumab-biologics 2017-04-27T21:02:00-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-first-quarter-2017-financial-and-operating 2017-05-04T02:32:09-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/survey-results-show-eighty-percent-rheumatoid-arthritis-patients 2017-05-04T03:01:50-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-upcoming-investor-conference-presentations-0 2017-05-05T05:32:00-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-inovio-enter-immuno-oncology-clinical-study 2017-05-08T03:30:18-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sillajen-announce-immuno-oncology-clinical-study 2017-05-09T05:56:35-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-upcoming-investor-conference-presentations-1 2017-05-18T05:30:11-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-announce-fda-approval-kevzarar-sarilumab 2017-05-22T13:46:00-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-angptl3evinacumab-publication-new-england 2017-05-24T13:00:11-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-present-positive-study-results 2017-06-04T06:02:00-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-announce-positive-results-first-dedicated 2017-06-11T07:02:07-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-recognized-civic-50-list-most-community-minded 2018-09-10T18:22:39-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-details-royalty-agreement-novartis-canakinumab-acz885 2017-06-22T05:02:07-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-announce-approval-kevzarar-sarilumab-treat 2019-01-21T17:59:27-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-2017-winners-regeneron-prize-creative 2017-07-13T04:30:25-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-report-second-quarter-2017-financial-and-operating 2017-07-13T05:30:07-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-receive-positive-chmp-opinion-dupixentr 2017-07-21T03:30:08-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-second-quarter-2017-financial-and-operating 2017-08-03T02:30:23-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/accessing-regeneron-second-quarter-2017-financial-and-operating 2017-08-03T04:38:32-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-discontinue-development-suptavumab-respiratory 2017-08-14T05:08:00-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-present-new-analyses-praluentr-alirocumab 2017-08-25T04:02:02-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-upcoming-investor-conference-presentations-2 2017-08-31T12:02:01-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-announce-cemiplimab-regn2810-has-received 2017-09-07T21:00:06-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-announce-positive-study-results-dupixentr 2017-09-15T22:16:00-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/important-note-regarding-september-11-2017-press-release 2018-09-10T18:19:41-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-announce-positive-dupilumab-topline-0 2019-01-21T17:51:09-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-announce-approval-dupixentr-dupilumab-treat 2019-01-21T17:45:34-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-new-collaborations-hhs-develop-antibodies 2017-10-02T03:00:18-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/appellate-court-orders-new-trial-and-vacates-permanent 2017-10-06T08:39:26-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/internationally-acclaimed-writer-and-executive-producer-hbos 2017-10-11T04:00:28-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-report-third-quarter-2017-financial-and-operating 2017-10-11T05:32:01-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-announce-positive-phase-2-study-results 2017-10-16T04:00:26-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/science-magazine-ranks-regeneron-1-biopharma-employer-fifth-time 2017-10-19T10:32:00-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-300-additional-jobs-limerick 2018-07-10T06:05:37-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regenerons-first-global-day-service-supports-over-100-non-profit 2017-10-27T03:00:17-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupilumab-significantly-reduced-steroid-use-asthma-attacks-and 2019-01-21T17:40:10-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-share-clinical-progress-regn1979-and-cemiplimab 2017-11-01T05:02:03-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-present-new-analyses-praluentr-alirocumab-0 2017-11-07T03:01:02-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-third-quarter-2017-financial-and-operating 2017-11-08T01:32:03-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-upcoming-investor-conference-presentation 2017-11-15T04:32:00-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-provides-update-eylear-aflibercept-injection-and 2017-11-26T21:02:01-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-decibel-therapeutics-announce-strategic 2017-11-29T02:00:08-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-fda-acceptance-sbla-filing-12-week-dosing 2017-12-11T02:00:14-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-announce-positive-topline-pivotal-results 2019-01-21T17:36:34-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-collaboration-programs-highlighted-during-sanofi 2017-12-12T20:32:00-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-isa-pharmaceuticals-announce-strategic-immuno 2017-12-17T20:00:06-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-36th-annual-jp-morgan 2017-12-27T04:32:00-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-forms-consortium-leading-life-sciences-companies 2018-01-08T02:00:13-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-accelerate-and-expand-investment-cemiplimab 2019-01-21T17:31:46-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-approval-dupixentr-dupilumab-japan-treatment 2018-01-22T02:00:12-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/forty-nations-most-promising-young-scientists-named-finalists 2018-01-23T07:09:23-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-report-fourth-quarter-and-full-year-2017-financial-and 2018-01-23T11:06:01-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-fourth-quarter-and-full-year-2017-financial 2018-02-08T01:32:50-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-appointment-marion-mccourt-senior-vice 2018-02-12T02:00:07-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/fda-review-dupixentr-dupilumab-potential-treatment-moderate 2018-03-01T20:04:25-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-announce-plans-make-praluentr-alirocumab 2018-03-10T04:02:11-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/praluentr-alirocumab-injection-significantly-reduced-risk 2018-03-10T04:36:00-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/teen-scientists-win-18-million-regeneron-science-talent-search 2018-03-13T17:30:00-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/eylear-aflibercept-injection-demonstrates-positive-topline 2018-03-19T03:00:19-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-genetics-centerr-publication-new-england-journal 2018-03-21T13:06:01-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-alnylam-pharmaceuticals-announce-collaboration 2018-03-21T13:06:07-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/ema-review-cemiplimab-potential-treatment-advanced-cutaneous 2018-04-02T21:02:01-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/ema-review-dupixentr-dupilumab-potential-treatment-inadequately 2018-04-02T21:02:01-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-report-first-quarter-2018-financial-and-operating 2018-04-09T05:32:01-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-upcoming-investor-conference-presentations-3 2018-04-23T05:30:12-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/fda-conduct-priority-review-cemiplimab-potential-treatment 2018-04-29T23:25:36-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-lower-net-price-praluentr-alirocumab 2018-05-01T03:00:02-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-first-quarter-2018-financial-and-operating 2018-05-03T02:32:03-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/positive-phase-3-trial-dupixentr-dupilumab-adolescents 2018-05-16T05:38:20-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-share-first-positive-clinical-data 2018-05-16T13:00:13-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-upcoming-investor-conference-presentation-0 2018-05-18T05:30:06-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/new-england-journal-medicine-publishes-two-positive-phase-3 2018-05-21T10:16:00-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regenerons-investigational-ebola-treatment-shipping-democratic 2018-05-31T12:06:04-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/new-england-journal-medicine-publishes-pivotal-cemiplimab-trials 2018-06-04T10:16:01-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-zoetis-announce-collaboration-research-antibody 2018-06-06T03:00:17-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-report-second-quarter-2018-financial-and-operating 2018-07-09T05:30:05-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-second-quarter-2018-financial-and-operating 2018-08-02T02:33:20-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-2018-winners-regeneron-prize-creative 2018-08-03T03:32:01-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-bluebird-bio-announce-collaboration-discover 2018-08-06T02:32:01-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-provides-regulatory-update-eylear-aflibercept 2018-08-13T03:00:23-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-teva-announce-positive-topline-phase-3-fasinumab 2018-08-16T03:00:17-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/fda-approves-eylear-aflibercept-injection-sbla-wet-age-related 2018-08-17T03:00:11-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-upcoming-investor-conference-presentation-1 2018-08-24T05:30:06-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/fda-review-supplemental-biologics-license-application-praluentr 2019-01-17T18:58:35-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/fda-review-eylea-aflibercept-injection-treatment-diabetic 2018-09-13T08:24:29-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/positive-phase-3-results-presented-dupixentr-dupilumab-show 2018-09-15T02:20:01-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/fda-approves-libtayor-cemiplimab-rwlc-first-and-only-treatment 2018-09-28T16:40:47-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-report-third-quarter-2018-financial-and-operating 2018-10-08T09:33:57-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/libtayor-cemiplimab-rwlc-data-esmo-2018-congress-provide-new 2018-10-08T18:09:02-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-showed-positive-topline-results-two-phase-3 2018-10-16T01:02:44-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/kevzarar-sarilumab-data-2018-acrarhp-annual-meeting-provide 2018-10-19T07:03:54-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/fda-approves-asthma-indication-dupixentr-dupilumab 2018-10-19T17:58:01-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/eylear-aflibercept-injection-improves-diabetic-retinopathy-and 2018-10-25T07:03:05-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-ranked-1-biopharma-employer-sixth-time-science 2018-10-26T07:02:22-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/fda-grants-priority-review-dupixentr-dupilumab-potential 2018-11-06T01:01:06-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-third-quarter-2018-financial-and-operating 2018-11-06T06:33:08-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/new-england-journal-medicine-publishes-positive-detailed-results 2018-11-07T17:19:39-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/odyssey-outcomes-investigators-highlight-aha-praluentr 2018-11-11T08:16:32-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-upcoming-investor-conference-presentation-2 2018-11-20T17:03:52-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-presents-positive-data-ash-regn1979-cd20xcd3 2018-12-01T12:02:45-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-37th-annual-jp-morgan 2018-12-18T16:04:57-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-restructure-immuno-oncology-collaboration 2019-01-07T02:32:07-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-provides-update-commercial-and-pipeline-progress-jp 2019-01-07T07:06:10-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-report-fourth-quarter-and-full-year-2018-financial-and 2019-01-18T16:04:20-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/forty-nations-most-brilliant-young-scientists-named-finalists 2019-01-23T12:05:11-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/chmp-recommends-approval-praluentr-alirocumab-injection-reduce 2019-02-04T16:26:32-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-fourth-quarter-and-full-year-2018-financial 2019-02-06T06:33:42-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/one-year-results-positive-phase-3-eylea-trial-diabetic 2019-02-09T16:32:31-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-offer-praluentr-alirocumab-new-reduced-us 2019-02-11T07:01:39-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-upcoming-investor-conference-presentation-3 2019-02-14T09:32:46-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/us-and-eu-patent-office-decisions-invalidate-amgen-subsidiary 2019-02-15T16:43:44-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/positive-results-presented-two-phase-3-trials-dupixentr 2019-02-25T12:45:02-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-strongly-disagree-verdict-upholding-three 2019-02-25T17:25:04-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/new-analyses-be-presented-aad-dupixentr-dupilumab-and-burden 2019-03-01T07:00:58-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/chmp-recommends-approval-dupixentr-dupilumab-asthma-indication 2019-03-01T08:37:03-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/fda-undertake-priority-review-dupixentr-dupilumab-adults 2019-03-08T01:00:17-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-upcoming-investor-conference-call 2019-03-08T16:03:35-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/new-genetic-data-regeneron-and-gsk-50000-uk-biobank-participants 2019-03-11T01:01:03-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/fda-approves-dupixentr-dupilumab-moderate-severe-atopic 2019-03-11T15:46:12-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/teen-scientists-win-18-million-regeneron-science-talent-search-0 2019-03-12T22:00:38-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-present-new-praluentr-alirocumab-data-acc19 2019-03-13T07:05:38-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/praluentr-alirocumab-now-approved-european-union-reduce-risk 2019-03-15T16:04:12-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-alnylam-announce-broad-collaboration-discover 2019-04-08T07:03:16-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-report-first-quarter-2019-financial-and-operating 2019-04-08T16:03:22-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/chmp-issues-positive-opinion-libtayor-cemiplimab-advanced 2019-04-26T11:16:53-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/fda-approves-praluentr-alirocumab-prevent-heart-attack-stroke 2019-04-26T19:20:57-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-upcoming-investor-conference-presentations-4 2019-05-07T17:45:04-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-first-quarter-2019-financial-and-operating-0 2019-05-07T21:48:22-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-approved-severe-asthma-european-commission 2019-05-07T08:59:30-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/fda-approves-eylear-aflibercept-injection-diabetic-retinopathy 2019-05-13T14:45:37-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/updated-libtayor-cemiplimab-rwlc-results-reinforce-durable-and 2019-05-16T07:00:47-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-upcoming-investor-conference-presentation-4 2019-05-23T09:30:46-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-cd20xcd3-bispecific-regn1979-shows-positive-results 2019-06-14T07:30:44-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-announce-positive-topline-phase-2-results 2019-06-21T00:59:41-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/fda-approves-dupixentr-dupilumab-chronic-rhinosinusitis-nasal 2019-06-26T13:29:42-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/chmp-recommends-approval-dupixentr-dupilumab-moderate-severe 2019-06-28T06:59:46-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/libtayor-cemiplimab-approved-advanced-cutaneous-squamous-cell 2019-07-01T10:00:54-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-report-second-quarter-2019-financial-and-operating 2019-07-08T09:30:33-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-2019-winners-regeneron-prize-creative 2019-07-18T07:30:41-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-approved-european-commission-adolescents 2019-08-06T00:59:40-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-showed-positive-topline-results-phase-3 2019-08-06T01:04:39-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-second-quarter-2019-financial-and-operating 2019-08-06T06:31:08-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/palm-ebola-clinical-trial-stopped-early-regenerons-regn-eb3 2019-08-12T10:02:09-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/fda-approves-eylear-aflibercept-injection-prefilled-syringe 2019-08-13T07:00:53-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-positive-topline-results-phase-3-trial 2019-08-14T07:00:49-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-upcoming-investor-conference-presentation-5 2019-08-15T09:30:41-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/us-district-court-invalidates-amgen-patent-claims-targeting 2019-08-28T16:58:36-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-debuts-prestigious-dow-jones-sustainability-world 2019-09-17T07:00:54-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/educational-campaign-helps-teens-and-their-caregivers-tackle 2019-09-18T06:59:45-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/chmp-recommends-approval-dupixentr-dupilumab-severe-chronic 2019-09-20T06:44:30-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/lancet-publishes-results-two-positive-phase-3-trials-dupixentr 2019-09-20T06:59:31-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-report-third-quarter-2019-financial-and-operating 2019-10-10T09:30:42-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-upcoming-investor-conference-presentations-5 2019-10-18T08:30:25-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-colleagues-support-150-community-organizations-during 2019-10-25T07:00:44-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-ranked-2-science-magazines-top-biopharma-companies 2019-10-25T07:05:45-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-now-approved-european-union-severe-chronic 2019-10-29T08:15:44-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-third-quarter-2019-financial-and-operating 2019-11-05T06:30:56-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-provides-updates-phase-3-libtayor-cemiplimab 2019-11-05T06:40:51-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-vyriad-announce-strategic-agreement-discovery-and 2019-11-06T07:01:00-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-report-results-cd20xcd3-and-bcmaxcd3-bispecifics-and 2019-11-06T09:01:46-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-upcoming-investor-conference-presentations-6 2019-11-12T07:30:45-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regenerons-yancopoulos-receives-columbia-colleges-alexander 2019-11-22T07:01:02-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/new-england-journal-medicine-publishes-results-ebola-clinical 2019-11-27T17:00:34-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-positive-topline-phase-2-data-anti-c5 2019-12-06T15:14:35-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/first-clinical-data-regn5458-bcmaxcd3-show-positive-preliminary 2019-12-08T09:00:27-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-announce-intent-restructure-antibody 2019-12-10T08:29:32-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-cold-spring-harbor-laboratory-unveil-new-dedicated 2019-12-12T07:00:46-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/society-science-public-announces-regeneron-new-title-sponsor 2019-12-12T10:15:37-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-38th-annual-jp-morgan 2019-12-20T07:00:36-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/publication-highlights-regenerons-costimulatory-bispecific 2020-01-08T14:03:10-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-encouraging-garetosmab-phase-2-results 2020-01-10T12:48:08-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-report-fourth-quarter-and-full-year-2019-financial-and 2020-01-10T07:00:36-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/forty-nations-brightest-young-scientists-named-finalists 2020-01-22T12:01:39-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/fda-accepts-priority-review-dupixentr-dupilumab-children-aged-6 2020-01-28T00:59:42-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-expanded-collaboration-hhs-develop-antibody 2020-03-04T14:25:09-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-fourth-quarter-and-full-year-2019-financial 2020-02-06T06:30:54-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/eylear-aflibercept-injection-reduced-risk-developing-vision 2020-02-10T17:19:59-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-upcoming-investor-conference-presentations-7 2020-02-12T16:01:54-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-upcoming-investor-conference-presentations-8 2020-03-03T16:06:29-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-begin-global-kevzarar-sarilumab-clinical 2020-03-16T09:36:20-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-important-advances-novel-covid-19-antibody 2020-03-17T07:00:54-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/first-patient-outside-us-treated-global-kevzarar-sarilumab 2020-03-30T07:03:28-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-american-college-cardiology-presentation 2020-03-30T11:46:36-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-phase-3-data-revolutionizing-atopic 2020-04-03T00:59:42-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-finalizes-praluentr-alirocumab-restructuring-and 2020-04-06T17:00:46-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-zai-lab-announce-regional-strategic-collaboration 2020-04-08T10:06:05-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/fda-accepts-priority-review-biologics-license-application-regn 2020-04-16T08:55:13-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-provide-update-us-phase-23-adaptive 2020-04-27T11:06:30-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/phase-3-trial-libtayor-cemiplimab-monotherapy-first-line 2020-04-27T06:59:41-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-upcoming-investor-conference-presentations-9 2020-04-29T07:00:55-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/libtayor-cemiplimab-shows-clinically-meaningful-and-durable 2020-05-05T00:59:21-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-first-quarter-2020-financial-and-operating 2020-05-05T06:31:21-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-colorado-center-personalized-medicine-announce 2020-05-11T07:01:51-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-presentations-asco-2020-showcase-diverse-clinical 2020-05-14T07:15:52-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-eosinophilic-esophagitis-trial-meets-both-co 2020-05-22T18:48:10-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-secondary-offering-its-common-stock-held 2020-05-25T12:40:33-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/fda-approves-dupixentr-dupilumab-first-biologic-medicine 2020-05-26T11:39:34-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-pricing-secondary-offering-its-common-stock 2020-05-26T19:55:43-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/libtayor-cemiplimab-rwlc-longer-term-results-advanced-cutaneous 2020-05-29T08:01:47-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-completes-secondary-offering-common-stock-held-sanofi 2020-05-29T16:01:44-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-intellia-therapeutics-expand-collaboration-develop 2020-06-01T07:01:47-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-upcoming-investor-conference-10 2020-06-05T07:00:54-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-virtual-only-format-2020-annual-meeting 2020-06-08T09:01:39-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-recognized-healthcare-sector-leader-civic-50-list-most 2020-06-10T09:02:17-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-collaborations-dupixentr-dupilumab-highlighted-during 2020-06-11T00:59:35-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-begins-first-clinical-trials-anti-viral-antibody 2020-06-11T07:53:46-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/two-science-publications-highlight-potential-regn-cov2-anti 2020-07-02T11:12:03-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-approved-china-adults-moderate-severe-atopic 2020-06-19T07:30:46-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/fda-approves-new-dupixentr-dupilumab-pre-filled-pen-designed 2020-06-19T13:44:27-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-2020-winners-regeneron-prize-creative 2020-06-22T07:01:29-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/new-publication-highlights-preclinical-research-showing 2020-06-24T14:00:49-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-vigorously-defend-allegations-related-contributions 2020-06-24T15:23:42-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-provide-update-kevzarar-sarilumab-phase-3 2020-07-02T16:29:48-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-start-regn-cov2-phase-3-covid-19-prevention 2020-07-06T07:01:09-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-manufacturing-and-supply-agreement-barda-and 2020-07-07T07:01:53-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-report-second-quarter-2020-financial-and-operating 2020-07-08T16:30:43-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/barda-procures-regenerons-regn-eb3-investigational-ebola 2020-07-29T07:01:10-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/teen-scientists-win-18-million-virtual-regeneron-science-talent 2020-07-29T21:00:57-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-second-quarter-2020-financial-and-operating 2020-08-05T06:31:30-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-pricing-public-offering-senior-unsecured 2020-08-07T16:05:40-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/fda-accepts-evinacumab-biologics-license-application-priority 2020-08-12T07:01:26-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-roche-collaborate-significantly-increase-global 2020-08-19T01:00:33-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/new-england-journal-medicine-publishes-positive-phase-3 2020-08-19T20:26:10-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-investor-conference-presentations 2020-08-26T07:01:07-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-400-new-jobs-limerick 2020-08-27T09:25:04-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/late-breaking-libtayor-cemiplimab-pivotal-data-advanced-non 2020-09-03T07:12:49-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-long-term-data-show-sustained-improvement 2020-09-08T00:59:40-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/fda-grants-dupixentr-dupilumab-breakthrough-therapy-designation 2020-09-14T00:59:42-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/recovery-covid-19-phase-3-trial-evaluate-regenerons-regn-cov2 2020-09-21T09:02:08-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/positive-pivotal-data-libtayor-cemiplimab-monotherapy-locally 2020-09-18T03:06:10-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/late-breaking-esmo-presentation-shows-libtayor-cemiplimab 2020-09-21T08:25:47-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regenerons-regn-cov2-antibody-cocktail-reduced-viral-levels-and 2020-09-29T16:01:49-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-report-third-quarter-2020-financial-and-operating 2020-10-06T16:05:49-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-significantly-reduced-severe-asthma-attacks 2020-10-13T00:59:47-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regenerons-antibody-cocktail-regn-eb3-inmazebr-first-fda 2020-10-14T19:27:39-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/chmp-recommends-approval-dupixentr-dupilumab-children-aged-6-11 2020-10-16T07:59:44-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-late-breaking-pivotal-data-showing 2020-10-26T07:59:44-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-investor-conference-presentations-0 2020-10-27T16:30:49-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regenerons-covid-19-outpatient-trial-prospectively-demonstrates 2020-10-28T17:01:04-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-efficacy-and-safety-patients-young-six-years 2020-10-29T02:00:00-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/fda-accepts-priority-review-libtayor-cemiplimab-rwlc-advanced 2020-10-29T07:02:44-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-once-again-earns-1-ranking-science-magazines-top 2020-10-29T14:33:38-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regn-cov2-independent-data-monitoring-committee-recommends 2020-10-30T09:13:13-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-third-quarter-2020-financial-and-operating 2020-11-05T06:32:05-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/recovery-trial-data-monitoring-committee-recommends-continuing 2020-11-05T15:22:10-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-investor-conference-presentations-1 2020-11-13T16:15:44-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-included-dow-jones-sustainability-world-index-second 2020-11-16T07:01:25-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regenerons-regen-cov2-first-antibody-cocktail-covid-19-receive 2020-11-22T20:40:16-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-approved-european-commission-first-and-only 2020-11-30T00:59:31-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-investor-webcast-american-society-hematology 2020-11-30T07:01:42-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regenerons-bcmaxcd3-bispecific-antibody-regn5458-shows-deep-and 2020-12-05T17:00:44-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-39th-annual-jp-morgan 2020-12-16T07:02:01-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/new-england-journal-medicine-publishes-positive-initial 2020-12-17T17:22:27-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-encouraging-initial-data-covid-19-antibody 2020-12-29T16:30:42-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-us-government-agreement-purchase-additional 2021-01-12T17:45:55-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-report-fourth-quarter-and-full-year-2020-financial-and 2021-01-19T16:15:54-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/forty-nations-most-talented-young-scientists-named-finalists 2021-01-21T12:43:52-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-positive-interim-data-regen-covtm-antibody 2021-01-26T07:02:27-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regen-covtm-antibody-cocktail-active-against-sars-cov-2-variants 2021-01-27T11:53:28-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/new-dupixentr-dupilumab-data-showcasing-improvements-across-four 2021-02-01T09:59:47-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-fourth-quarter-and-full-year-2020-financial 2021-02-05T06:31:57-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/fda-approves-libtayor-cemiplimab-rwlc-first-immunotherapy 2021-02-09T17:24:57-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/fda-approves-first-class-evkeezatm-evinacumab-dgnb-patients 2021-02-11T14:01:30-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/us-federal-circuit-court-appeals-rules-favor-regeneron-and 2021-02-11T17:06:41-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/lancet-publishes-libtayor-cemiplimab-data-showing-extended 2021-02-12T01:01:39-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-investor-conference-presentations-2 2021-02-12T16:16:26-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/fda-approves-libtayor-cemiplimab-rwlc-monotherapy-patients-first 2021-02-22T13:01:23-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/independent-data-monitoring-committee-finds-clear-efficacy-regen 2021-02-25T07:04:50-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/ema-issues-advice-regenerons-antibody-cocktail-casirivimab 2021-02-26T06:48:12-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-positive-phase-2-data-evaluating-fel-d-1 2021-02-27T18:26:15-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/fda-accepts-dupixentr-dupilumab-review-children-moderate-severe 2021-03-04T01:00:11-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/phase-3-trial-libtayor-cemiplimab-monotherapy-advanced-cervical 2021-03-15T02:01:10-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/teen-scientists-win-18-million-virtual-regeneron-science-0 2021-03-17T20:58:39-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/phase-3-trial-shows-regen-covtm-casirivimab-imdevimab-antibody 2021-03-23T02:01:13-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/nih-sponsored-trial-finds-eylear-aflibercept-injection-reduced 2021-03-30T19:06:25-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-report-first-quarter-2021-financial-and-operating 2021-04-06T16:07:23-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/nih-covid-19-treatment-guidelines-strongly-recommend-use-regen 2021-04-09T08:16:19-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/phase-3-prevention-trial-showed-81-reduced-risk-symptomatic-sars 2021-04-12T01:01:15-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/phase-3-treatment-trial-recently-infected-asymptomatic-patients 2021-04-12T01:16:25-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/new-dupixentr-dupilumab-analyses-two-upcoming-dermatology 2021-04-23T09:59:49-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-investor-conference-presentations-3 2021-04-23T16:06:01-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/ats-2021-breaking-news-session-feature-pivotal-data-regen-covtm 2021-05-03T08:05:40-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-first-quarter-2021-financial-and-operating 2021-05-06T06:32:37-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/positive-phase-3-libtayor-cemiplimab-results-advanced-cervical 2021-05-12T13:31:06-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/pivotal-data-ats-2021-show-dupixentr-dupilumab-significantly 2021-05-17T09:59:37-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/phase-3-data-presented-ats-2021-show-regen-covtm-casirivimab 2021-05-17T10:01:57-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/libtayor-cemiplimab-rwlc-presentations-asco-highlight-expanding 2021-05-19T17:02:12-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/teen-scientists-and-engineers-win-5-million-largest-global-high 2021-05-21T11:45:54-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/libtayor-cemiplimab-receives-positive-chmp-opinion-treatment 2021-05-24T01:02:46-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-investor-conference-presentations-4 2021-05-25T16:16:46-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/fda-authorizes-lower-1200-mg-intravenous-and-subcutaneous-dose 2021-06-04T07:01:48-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regen-covtm-casirivimab-and-imdevimab-phase-3-recovery-trial 2021-08-25T09:00:26-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-participate-guggenheim-biopharma-strategy-series 2021-06-22T16:15:59-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/libtayor-cemiplimab-approved-european-commission-first-line 2021-06-25T01:00:43-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/libtayor-cemiplimab-approved-european-commission-first 2021-06-25T01:15:44-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/intellia-and-regeneron-announce-landmark-clinical-data-showing 2021-06-26T11:16:45-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-smpc-updated-long-term-data-reinforcing-well 2021-06-28T00:59:57-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-genetics-center-discovers-gpr75-gene-mutations-protect 2021-07-01T14:05:54-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-report-second-quarter-2021-financial-and-operating 2021-07-07T16:16:54-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/japan-becomes-first-country-approve-regeneron-antibody-cocktail 2021-07-20T01:00:58-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-astrazeneca-research-develop-and-commercialize-new 2021-07-27T07:02:36-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-significantly-improved-itch-and-hives 2021-07-29T13:55:20-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/fda-expands-authorized-use-regen-covtm-casirivimab-and-imdevimab 2021-07-30T13:45:55-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-2021-winners-regeneron-prize-creative 2021-08-03T07:05:37-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/new-england-journal-medicine-publishes-positive-phase-3-trial 2021-08-04T17:06:45-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/phase-3-trial-libtayor-cemiplimab-rwlc-combined-chemotherapy 2021-08-26T12:00:43-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-second-quarter-2021-financial-and-operating 2021-08-05T07:20:55-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/uk-authorizes-regeneron-antibody-cocktail-prevent-and-treat 2021-08-20T07:01:20-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-encouraging-topline-phase-2-data-high-dose 2021-08-24T07:01:42-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-pivotal-trial-meets-all-primary-and 2021-08-30T00:59:52-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-investor-conference-presentations-5 2021-09-08T16:07:14-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-new-us-government-agreement-purchase 2021-09-14T20:06:00-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/esmo-late-breaking-data-show-libtayor-cemiplimab-and 2021-09-19T11:30:55-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/new-dupixentr-dupilumab-data-patients-young-six-years-old 2021-09-21T00:59:55-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/fda-accepts-libtayor-cemiplimab-rwlc-priority-review-advanced 2021-09-28T07:03:19-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/new-england-journal-medicine-publishes-positive-phase-3-trial-0 2021-09-29T17:01:26-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/new-regen-covtm-casirivimab-and-imdevimab-data-show-supportive 2021-09-30T01:02:04-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-report-third-quarter-2021-financial-and-operating 2021-10-11T16:16:02-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/fda-accepts-regen-covr-casirivimab-and-imdevimab-priority-review 2021-10-14T07:22:08-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/fda-expands-approval-dupixentr-dupilumab-include-children-aged-6 2021-10-20T17:30:12-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-first-biologic-significantly-reduce-itch-and 2021-10-22T00:59:51-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/second-dupixentr-dupilumab-phase-3-eosinophilic-esophagitis 2021-10-25T01:00:10-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-third-quarter-2021-financial-and-operating 2021-11-04T06:32:24-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-presentations-ash-highlight-expanding-clinical 2021-11-04T10:00:56-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/new-phase-3-analyses-show-single-dose-regen-covr-casirivimab-and 2021-11-08T07:04:15-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/chmp-recommends-eu-approval-regeneron-antibody-cocktail-treat 2021-11-11T11:03:58-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-antibody-cocktail-approved-european-commission-treat 2021-11-12T10:20:49-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-3-billion-share-repurchase-program 2021-11-12T16:12:30-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-listed-dow-jones-sustainability-world-index-third 2021-11-15T07:05:21-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-investor-conference-presentations-6 2021-11-16T16:16:55-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-participate-hc-wainwright-co-virtual-event 2021-12-03T10:00:58-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/new-england-journal-medicine-publishes-positive-phase-3-0 2021-12-08T17:30:28-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/new-regn5458-bcmaxcd3-phase-1-data-show-75-response-rate-highest 2021-12-13T08:39:09-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/positive-phase-3-dupixentr-dupilumab-data-children-6-months-5 2021-12-13T00:59:55-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-40th-annual-jp-morgan 2021-12-22T16:16:01-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-ultragenyx-collaborate-commercialize-evkeezar 2022-01-07T07:02:12-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-report-fourth-quarter-and-full-year-2021-financial-and 2022-01-13T16:06:42-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/second-positive-phase-3-dupixentr-dupilumab-trial-confirms 2022-01-19T00:59:52-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/fda-accepts-review-libtayor-cemiplimab-rwlc-combination 2022-01-19T07:02:13-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/forty-accomplished-young-scientists-named-finalists-2022 2022-01-20T12:00:54-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-provide-regulatory-update-libtayor 2022-01-28T07:02:08-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/chmp-recommends-approval-dupixentr-dupilumab-children-aged-6-0 2022-01-31T01:00:17-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/positive-dupixentr-dupilumab-data-across-five-diseases 2022-02-01T16:30:40-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-fourth-quarter-and-full-year-2021-financial 2022-02-04T06:31:17-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/fda-accepts-dupixentr-dupilumab-priority-review-children-aged-6 2022-02-10T01:00:40-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-presents-encouraging-phase-2-results-high-dose 2022-02-11T07:50:59-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-investor-conference-presentations-7 2022-02-17T16:10:04-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-provide-update-ongoing-dupixentr-dupilumab 2022-02-18T01:00:36-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/late-breaking-phase-3-data-2022-aaaai-annual-meeting-show 2022-02-26T12:00:12-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/late-breaking-data-2022-aaaai-annual-meeting-show-dupixentr 2022-02-26T12:05:12-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/intellia-and-regeneron-announce-updated-phase-1-data 2022-02-28T16:05:46-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/students-win-18-million-regeneron-science-talent-search-2022 2022-03-15T21:19:14-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/late-breaking-phase-3-data-aad-2022-show-dupixentr-dupilumab 2022-03-26T10:00:07-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/fda-accepts-dupixentr-dupilumab-priority-review-patients-aged-12 2022-04-04T01:00:13-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-report-first-quarter-2022-financial-and-operating 2022-04-05T16:07:38-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-approved-european-commission-children-aged-6 2022-04-07T01:00:58-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/us-fda-extends-review-biologics-license-application-regen-covr 2022-04-14T07:00:25-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-acquire-checkmate-pharmaceuticals-and-its 2022-04-19T07:01:02-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-investor-conference-presentations-8 2022-05-02T16:15:52-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-first-quarter-2022-financial-and-operating 2022-05-04T06:30:42-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/high-school-scientists-around-world-win-nearly-8m-awards 2022-05-13T12:53:35-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/fda-approves-dupixentr-dupilumab-first-treatment-adults-and 2022-05-20T15:15:24-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/evkeezar-evinacumab-phase-3-trial-demonstrates-48-ldl-c 2022-05-21T07:26:56-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/fda-accepts-dupixentr-dupilumab-priority-review-adults-prurigo 2022-05-31T00:59:24-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-completes-acquisition-checkmate-pharmaceuticals 2022-05-31T08:32:14-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-strengthens-commitment-oncology-through-purchase 2022-06-02T07:30:39-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/fda-approves-dupixentr-dupilumab-first-biologic-medicine-0 2022-06-07T17:00:30-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/intellia-and-regeneron-present-updated-interim-data-phase-1 2022-06-24T07:31:27-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/eylear-aflibercept-injection-sbla-every-16-week-dosing-regimen 2022-06-29T07:30:37-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-completes-purchase-sanofis-stake-libtayor-cemiplimab 2022-07-01T07:00:26-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-report-second-quarter-2022-financial-and-operating 2022-07-06T16:01:27-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-phase-3-trial-shows-positive-results 2022-07-14T00:59:27-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-2022-winners-regeneron-prize-creative 2022-07-26T07:01:44-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-genetics-center-discovers-rare-mutations-cideb-gene 2022-07-27T17:15:33-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/novel-costimulatory-bispecific-antibody-shows-encouraging-anti 2022-08-03T09:18:14-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-second-quarter-2022-financial-and-operating 2022-08-03T06:30:41-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-investor-conference-presentations-9 2022-08-25T16:05:29-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/esmo-presentations-libtayor-cemiplimab-fianlimab-and-novel 2022-09-04T18:05:23-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/late-breaking-dupixentr-dupilumab-data-ers-2022-show-consistent 2022-09-05T07:29:14-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/aflibercept-8-mg-meets-primary-endpoints-two-global-pivotal 2022-09-08T09:01:25-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-late-breaking-phase-3-data-eadv-2022 2022-09-08T11:29:21-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-investor-call-and-webcast-esmo-2022 2022-09-09T10:00:24-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/novel-regeneron-bispecific-antibodies-show-encouraging-anti 2022-09-10T02:30:24-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/fianlimab-lag-3-inhibitor-combined-libtayor-cemiplimab 2022-09-12T02:30:25-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/positive-neoadjuvant-libtayor-cemiplimab-monotherapy-data 2022-09-12T04:30:17-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-alnylam-report-promising-data-ongoing-phase-1 2022-09-15T07:01:14-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/positive-dupixentr-dupilumab-phase-3-data-children-aged-6-months 2022-09-15T18:39:49-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/intellia-and-regeneron-announce-initial-data-cardiomyopathy-arm 2022-09-16T07:15:19-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-approved-fda-first-and-only-treatment 2022-09-28T17:44:23-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/aflibercept-8-mg-positive-pivotal-results-diabetic-macular-edema 2022-09-30T17:04:16-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-elects-dr-craig-b-thompson-board-directors 2022-10-03T07:00:47-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-report-third-quarter-2022-financial-and-operating 2022-10-04T16:00:24-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-late-breaking-phase-3-data-presented-ueg 2022-10-11T00:59:29-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/eylear-aflibercept-injection-sbla-treatment-retinopathy 2022-10-12T07:00:41-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/libtayor-cemiplimab-receives-positive-chmp-opinion-recommending 2022-10-14T07:06:53-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-receives-six-months-us-pediatric-exclusivity-eylear 2022-10-21T07:00:30-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/inmazebtm-atoltivimab-maftivimab-and-odesivimab-ebgn-wins 2022-10-28T16:32:28-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-third-quarter-2022-financial-and-operating 2022-11-03T06:30:48-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-presents-new-data-ash-advancing-hematology-pipeline 2022-11-03T09:01:30-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-investor-conference-presentations-10 2022-11-03T16:06:06-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/aflibercept-8-mg-late-breaking-data-presented-retina-society 2022-11-04T19:30:18-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/libtayor-cemiplimab-rwlc-combination-chemotherapy-approved-fda 2022-11-08T18:33:40-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-recommended-eu-approval-chmp-treatment 2022-11-11T06:59:26-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-cytomx-announce-strategic-research-collaboration 2022-11-17T07:00:45-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/libtayor-cemiplimab-approved-european-commission-first-0 2022-11-22T13:25:44-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/evkeezar-evinacumab-dgnb-sbla-children-ultra-rare-inherited-form 2022-11-30T08:05:55-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-esmo-io-presentations-highlight-potential-fianlimab 2022-12-01T07:00:52-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/pivotal-odronextamab-cd20xcd3-phase-2-data-patients 2022-12-11T12:14:55-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-named-dow-jones-sustainability-world-index-fourth 2022-12-12T07:30:46-05:00 0.5 https://investor.regeneron.com/node/27321 2022-12-22T08:48:17-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/odronextamab-cd20xcd3-demonstrates-high-and-durable-complete 2022-12-12T17:30:34-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-approved-european-commission-first-and-0 2022-12-15T00:59:33-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-recommended-eu-approval-chmp-treatment-0 2022-12-16T07:29:18-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-41st-annual-jp-morgan 2022-12-19T16:01:26-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/positive-dupixentr-dupilumab-phase-3-results-adults-and 2022-12-21T17:29:24-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/libtayor-cemiplimab-approved-japan-advanced-or-recurrent 2022-12-23T08:30:32-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-report-fourth-quarter-and-full-year-2022-financial-and 2023-01-03T16:01:20-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/top-40-high-school-scientists-selected-finalists-regeneron 2023-01-24T14:23:57-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-recommended-expanded-eu-approval-chmp-treat 2023-01-27T00:59:31-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-approved-european-commission-first-and-1 2023-01-30T01:00:41-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-investor-conference-presentations-11 2023-01-31T16:01:20-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-fourth-quarter-and-full-year-2022-financial 2023-02-03T06:30:32-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/eylear-aflibercept-injection-approved-first-pharmacologic 2023-02-08T18:45:14-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/pozelimab-c5-antibody-bla-treatment-children-and-adults-ultra 2023-02-21T07:00:33-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/aflibercept-8-mg-bla-treatment-wet-age-related-macular 2023-02-23T07:01:06-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/libtayor-cemiplimab-combination-chemotherapy-receives-positive 2023-02-24T08:44:59-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/kevzarar-sarilumab-approved-fda-first-and-only-biologic 2023-02-28T20:00:24-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-application-treatment-chronic-spontaneous 2023-03-07T01:00:33-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/students-win-more-18-million-2023-regeneron-science-talent 2023-03-14T22:41:49-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-late-breaking-data-aad-show-significant 2023-03-18T10:00:28-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-approved-european-commission-first-and-2 2023-03-21T01:59:21-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/fda-approves-first-class-evkeezar-evinacumab-dgnb-young-children 2023-03-22T07:00:44-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-demonstrates-potential-become-first-biologic 2023-03-23T02:00:30-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sonoma-biotherapeutics-announce-collaboration 2023-03-28T07:30:23-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/libtayor-cemiplimab-combination-chemotherapy-approved-european 2023-03-29T07:00:47-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-report-first-quarter-2023-financial-and-operating 2023-04-03T16:02:14-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-investor-conference-presentations-12 2023-04-11T16:00:20-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/aflibercept-8-mg-and-eylear-aflibercept-injection-presentations 2023-04-17T07:00:59-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-retirement-board-chair-dr-p-roy-vagelos 2023-04-17T07:30:32-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-alnylam-report-positive-interim-phase-1-clinical 2023-04-26T16:05:52-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-highlight-new-and-updated-clinical-data-asco 2023-05-02T12:50:48-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-first-quarter-2023-financial-and-operating 2023-05-04T06:31:03-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-applauds-supreme-courts-unanimous-opinion-striking 2023-05-18T12:11:00-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-investor-conference-presentations-13 2023-05-18T16:01:27-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/high-school-scientists-and-engineers-win-nearly-9-million 2023-05-19T13:32:36-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-late-breaking-phase-3-copd-results-presented 2023-05-21T14:19:07-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/fianlimab-lag-3-inhibitor-combined-libtayor-cemiplimab-shows 2023-05-25T17:00:31-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/updated-linvoseltamab-bcmaxcd3-data-pivotal-trial-demonstrates 2023-05-25T17:05:42-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/fda-issues-complete-response-letter-crl-aflibercept-8-mg 2023-06-27T14:45:19-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/two-year-results-aflibercept-8-mg-pivotal-photon-trial 2023-06-27T14:46:14-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-report-second-quarter-2023-financial-and-operating 2023-06-29T16:01:12-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/aflibercept-8-mg-two-year-results-pivotal-photon-trial-diabetic 2023-07-29T14:25:18-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-2023-winners-regeneron-prize-creative 2023-08-01T07:00:49-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-second-quarter-2023-financial-and-operating 2023-08-03T06:30:58-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-acquire-decibel-therapeutics-strengthening-gene 2023-08-09T07:31:07-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/two-year-pulsar-trial-results-aflibercept-8-mg-demonstrate 2023-08-10T07:01:02-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/odronextamab-receives-ema-filing-acceptance-treatment 2023-08-17T08:30:47-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/veopoztm-pozelimab-bbfg-receives-fda-approval-first-treatment 2023-08-18T13:43:42-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/eylea-hd-aflibercept-injection-8-mg-approved-fda-treatment-wet 2023-08-18T18:35:34-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-agreement-barda-supporting-development-next 2023-08-22T14:16:10-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-investor-conference-presentations-14 2023-08-23T16:05:24-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-updates-board-directors 2023-09-08T16:45:12-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-provides-update-planned-chief-financial-officer 2023-09-08T16:46:22-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-completes-acquisition-decibel-therapeutics-adding 2023-09-25T08:37:02-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-sbla-treatment-eosinophilic-esophagitis-eoe 2023-09-26T01:29:20-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-report-third-quarter-2023-financial-and-operating 2023-09-28T16:05:23-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/odronextamab-bla-treatment-relapsedrefractory-follicular 2023-09-29T08:30:31-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-intellia-announce-expanded-research-collaboration 2023-10-03T07:00:51-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/eylear-hd-aflibercept-injection-8-mg-two-year-results-pivotal 2023-10-05T09:45:29-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-showcase-progress-innovative-oncology-portfolio 2023-10-15T18:05:37-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/together-change-genomics-and-equity-initiative-launched 2023-10-18T09:01:12-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-builds-together-changetm-initiative-five-year-5 2023-10-18T09:30:20-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-provide-update-dupixentr-dupilumab-sbla 2023-10-20T17:00:55-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/libtayor-cemiplimab-neoadjuvant-treatment-demonstrates 2023-10-21T08:50:35-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-phase-3-results-show-sustained-efficacy-one 2023-10-24T09:47:30-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-investor-conference-presentations-15 2023-10-25T16:05:23-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-shares-preliminary-results-showing-gene-therapy 2023-10-26T16:00:32-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/eylear-hd-aflibercept-injection-8-mg-data-presentations-aao 2023-11-01T16:00:28-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-third-quarter-2023-financial-and-operating 2023-11-02T06:31:05-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-highlight-scientific-advancements-across-diversified 2023-11-03T07:01:29-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-commits-34-million-over-five-years-continue-sponsor 2023-11-13T09:01:39-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-investor-conference-presentation 2023-11-15T16:05:30-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-significantly-reduced-copd-exacerbations 2023-11-27T01:30:30-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-host-investor-call-and-webcast-december-14-2023 2023-11-30T16:07:21-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-share-progress-novel-combination-therapies-oncology 2023-12-07T02:31:24-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/updated-linvoseltamab-pivotal-data-demonstrated-strong-rates-and 2023-12-11T09:56:50-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/updated-odronextamab-data-relapsedrefractory-diffuse-large-b 2023-12-10T12:30:29-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/latest-odronextamab-data-relapsedrefractory-follicular-lymphoma 2023-12-10T19:30:30-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-named-dow-jones-sustainability-world-index-fifth 2023-12-11T07:30:32-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-42nd-annual-jp-morgan 2023-12-18T16:05:28-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-report-fourth-quarter-and-full-year-2023-financial-and 2024-01-05T16:05:39-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-us-label-updated-data-further-supporting-use 2024-01-16T07:00:45-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/top-40-high-school-scientists-prestigious-regeneron-science 2024-01-24T14:56:44-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-fda-approved-first-and-only-treatment 2024-01-25T15:50:25-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-formation-regeneron-cell-medicines 2024-01-30T07:07:30-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/linvoseltamab-receives-ema-filing-acceptance-treatment 2024-02-02T06:00:22-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-fourth-quarter-and-full-year-2023-financial 2024-02-02T06:30:35-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-investor-conference-presentations-16 2024-02-06T16:06:05-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/japan-first-world-approve-dupixentr-dupilumab-chronic 2024-02-16T00:59:20-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/linvoseltamab-bla-treatment-relapsedrefractory-multiple-myeloma 2024-02-21T07:01:41-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-sbla-accepted-fda-priority-review-treatment 2024-02-23T01:00:29-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/eylear-hd-aflibercept-injection-8-mg-pivotal-data-wet-age 2024-03-08T07:00:46-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/praluentr-alirocumab-injection-receives-fda-approval-treat 2024-03-11T07:00:57-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/high-school-seniors-win-18-million-regeneron-science-talent 2024-03-12T21:55:33-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-provides-update-biologics-license-application 2024-03-25T07:00:35-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-report-first-quarter-2024-financial-and-operating 2024-04-01T16:05:35-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/linvoseltamab-pivotal-data-presented-aacr-reinforce-high 2024-04-07T16:00:39-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-highlight-advances-genetic-medicine-research-american 2024-04-22T17:54:38-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-showcase-progress-advancing-novel-investigational 2024-04-24T10:05:35-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-mammoth-biosciences-collaborate-pursue-next 2024-04-25T07:00:40-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/eylear-hd-aflibercept-injection-8-mg-presentations-arvo 2024-04-29T07:00:56-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-first-quarter-2024-financial-and-operating 2024-05-02T06:30:30-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-investor-conference-presentations-17 2024-05-06T16:06:20-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/latest-db-oto-results-show-dramatically-improved-hearing-normal 2024-05-08T06:01:18-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-sbla-accepted-fda-priority-review-0 2024-05-13T01:00:33-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/more-9-million-awarded-high-school-scientists-and-engineers 2024-05-24T15:06:30-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-late-breaking-data-notus-confirmatory-phase 2024-05-20T14:15:34-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/promising-anti-tumor-activity-novel-costimulatory-bispecific 2024-05-23T17:03:42-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/update-fda-priority-review-dupixentr-dupilumab-treatment-copd 2024-05-31T01:00:36-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-recommended-eu-approval-chmp-treat-patients 2024-05-31T01:05:26-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/kevzarar-sarilumab-approved-fda-treatment-active-polyarticular 2024-06-11T07:00:45-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/updated-linvoseltamab-data-showcase-continued-deepening 2024-06-16T06:10:26-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-positive-phase-3-data-children-1-11-years 2024-06-26T17:30:26-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-report-second-quarter-2024-financial-and-operating 2024-06-27T16:06:09-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/odronextamab-recommended-eu-approval-chmp-treat 2024-06-28T07:16:59-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-approved-european-union-first-ever-targeted 2024-07-03T01:00:25-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-2024-winners-regeneron-prize-creative 2024-07-31T07:32:12-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-second-quarter-2024-financial-and-operating 2024-08-01T06:30:48-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-investor-conference-presentations-and 2024-08-07T16:05:34-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-provides-update-biologics-license-application-0 2024-08-20T18:45:24-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/latest-dupixentr-dupilumab-and-itepekimab-data-ers-highlight 2024-08-26T01:00:26-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/ordsponotm-odronextamab-approved-european-union-treatment 2024-08-26T09:27:18-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-highlight-progress-across-its-differentiated-oncology 2024-09-09T07:00:59-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/libtayor-cemiplimab-demonstrates-durable-survival-benefit-five 2024-09-09T17:00:38-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-first-and-only-biologic-achieve-significant 2024-09-11T00:59:20-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-phase-3-trial-confirms-significant 2024-09-18T13:57:34-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/eylea-hdr-aflibercept-injection-8-mg-data-euretina-reinforce 2024-09-11T07:01:04-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-approved-us-first-and-only-treatment 2024-09-13T12:15:57-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-recommended-eu-approval-chmp-treat 2024-09-20T07:45:35-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-report-third-quarter-2024-financial-and-operating 2024-09-26T16:08:19-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-approved-china-first-ever-biologic-medicine 2024-09-27T07:00:55-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-approved-us-first-ever-biologic-medicine 2024-09-27T09:36:00-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/three-year-results-eylea-hdr-aflibercept-injection-8-mg 2024-10-18T17:07:40-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-late-breaking-positive-phase-3-data-chronic 2024-10-24T08:02:40-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-third-quarter-2024-financial-and-operating 2024-10-31T06:31:00-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-approved-european-union-first-and-only 2024-11-06T01:00:34-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-investor-conference-presentations-18 2024-11-11T16:05:45-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-highlight-pioneering-pipeline-progress-across-multiple 2024-11-13T07:01:33-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-sbla-accepted-fda-review-treatment-chronic 2024-11-15T01:01:09-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/novel-combination-pozelimab-and-cemdisiran-poze-cemdi-achieved 2024-12-07T19:01:27-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/odronextamab-ash-presentations-underscore-impressive-potential 2024-12-09T17:46:47-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-named-dow-jones-sustainability-world-index-sixth 2024-12-16T16:31:21-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/eylea-hdr-aflibercept-injection-8-mg-phase-3-trial-meets-primary 2024-12-17T07:00:45-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-43rd-annual-jp-morgan 2024-12-17T16:06:31-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-advance-two-factor-xi-antibodies-broad-phase-3-program 2024-12-19T07:01:39-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-report-fourth-quarter-and-full-year-2024-financial-and 2025-01-07T16:05:25-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-collaborates-truveta-and-leading-american-health 2025-01-13T06:05:23-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/adjuvant-libtayor-cemiplimab-significantly-improves-disease-free 2025-01-13T06:16:09-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-provides-business-updates-and-highlights-broad 2025-02-26T11:28:13-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/americas-top-40-high-school-scientists-compete-18-million-awards 2025-02-26T11:07:00-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-fourth-quarter-and-full-year-2024-financial 2025-02-04T06:30:37-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/three-year-results-eylea-hdr-aflibercept-injection-8-mg-patients 2025-02-08T15:55:38-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/eylea-hdr-aflibercept-injection-8-mg-positive-phase-3-results 2025-02-26T10:53:41-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/linvoseltamab-bla-accepted-fda-review-treatment 2025-02-11T07:01:19-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-investor-conference-presentations-19 2025-02-11T16:05:28-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-sbla-accepted-fda-priority-review-targeted 2025-02-18T00:59:31-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/latest-db-oto-results-demonstrate-clinically-meaningful-hearing 2025-02-24T15:00:29-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/odronextamab-bla-accepted-fda-review-treatment 2025-03-07T12:47:29-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/linvoseltamab-recommended-eu-approval-chmp-treat 2025-02-28T07:00:48-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-late-breaking-positive-pivotal-data-bullous 2025-03-08T13:00:28-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-science-talent-search-2025-awards-more-18-million-high 2025-03-11T22:17:04-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-report-first-quarter-2025-financial-and-operating 2025-03-25T16:05:34-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-approved-first-ever-biologic-medicine-japan 2025-03-28T02:00:43-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/eylea-hdr-aflibercept-injection-8-mg-sbla-accepted-fda-priority 2025-04-17T07:00:59-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-approved-us-first-new-targeted-therapy-over 2025-04-18T11:16:39-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-provides-update-eylea-hdr-aflibercept-injection-8-mg 2025-04-18T15:01:13-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-investor-conference-presentations-20 2025-04-21T16:06:03-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-new-investment-manufacturing-its-industry 2025-04-22T06:01:01-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/eylea-hdr-aflibercept-injection-8-mg-presentations-arvo 2025-04-28T07:01:28-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/lynozyfictm-linvoseltamab-approved-european-union-treatment 2025-04-28T07:02:32-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-first-quarter-2025-financial-and-operating 2025-04-29T09:35:31-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-data-presented-ats-reinforce-impact 2025-05-01T09:01:23-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-highlight-advances-asco-phase-3-adjuvant-libtayor 2025-05-01T09:50:29-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-prevails-over-amgen-antitrust-pcsk9-lawsuit-protecting 2025-05-15T14:03:09-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/75th-annual-regeneron-international-science-and-engineering-fair 2025-05-18T21:47:59-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-enters-asset-purchase-agreement-acquire-23andmer-256 2025-07-16T12:04:33-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/linvoseltamab-combination-carfilzomib-or-bortezomib-shows 2025-05-22T17:00:46-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/itepekimab-met-primary-endpoint-one-two-chronic-obstructive 2025-05-30T01:00:27-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/libtayor-cemiplimab-phase-3-data-adjuvant-treatment-post 2025-05-31T08:04:52-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/interim-results-ongoing-phase-2-courage-trial-confirm-potential 2025-06-02T07:00:54-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-expands-clinical-stage-obesity-portfolio-strategic 2025-06-02T07:05:50-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-data-revolutionizing-atopic-dermatitis-rad 2025-06-17T13:36:24-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-demonstrated-superiority-over-xolairr 2025-06-15T11:21:23-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-approved-us-only-targeted-medicine-treat 2025-06-20T01:01:23-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-first-its-kind-donation-matching-program 2025-06-24T07:30:53-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-report-second-quarter-2025-financial-and-operating 2025-06-27T14:25:41-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/lynozyfictm-linvoseltamab-gcpt-receives-fda-accelerated-approval 2025-07-02T11:45:05-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-2025-winners-regeneron-prize-creative 2025-07-24T07:30:26-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-second-quarter-2025-financial-and-operating 2025-08-01T06:30:30-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-investor-conference-presentations-21 2025-08-07T16:06:18-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/eylea-hdr-aflibercept-injection-8-mg-applications-expanded-us 2025-08-20T11:20:12-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-positive-results-phase-3-trial-generalized 2025-08-26T07:01:15-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-updated-presentation-time-upcoming-investor 2025-09-04T16:05:20-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-advances-allergy-pipeline-two-positive-phase-3-trials 2025-09-08T06:30:24-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/libtayor-cemiplimab-plus-chemotherapy-results-five-years 2025-09-09T07:01:09-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-positive-phase-3-trial-adults-ultra-rare 2025-09-17T07:01:06-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/results-phase-2-courage-trial-demonstrating-potential-improve 2025-09-17T09:30:25-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-donates-ebola-treatment-use-countries-most-risk 2025-09-19T07:00:38-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-treat-chronic-spontaneous-urticaria-csu 2025-09-22T00:29:24-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/evkeezar-evinacumab-dgnb-angptl3-antibody-approved-us-children 2025-09-26T07:01:09-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-report-third-quarter-2025-financial-and-operating 2025-09-30T16:05:24-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/libtayor-cemiplimab-rwlc-approved-us-first-and-only 2025-10-08T14:32:20-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/db-oto-results-new-england-journal-medicine-showcase-dramatic 2025-10-12T10:18:47-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-showcases-advances-across-oncology-portfolio-and 2025-10-15T11:16:59-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/libtayor-cemiplimab-recommended-eu-approval-chmp-adjuvant 2025-10-17T08:44:25-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-third-quarter-2025-financial-and-operating 2025-10-28T06:30:39-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-wins-prestigious-2025-prix-galien-usa-best 2025-10-31T07:00:32-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-investor-conference-presentations-22 2025-11-03T16:05:32-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-pivotal-trial-met-all-primary-and-secondary 2025-11-07T08:00:44-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/phase-2-trials-demonstrating-antithrombotic-effect-two-novel 2025-11-08T10:47:08-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-highlights-progress-american-society-hematology-ash 2025-11-13T10:17:42-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/libtayor-cemiplimab-approved-european-union-first-and-only 2025-11-19T07:00:49-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/eylea-hdr-aflibercept-injection-8-mg-approved-fda-treatment 2025-11-19T16:10:18-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-approved-first-targeted-medicine-european 2025-11-25T01:00:26-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-tessera-therapeutics-jointly-develop-tsra-196 2025-12-01T07:00:45-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/lynozyfictm-linvoseltamab-monotherapy-newly-diagnosed-multiple 2025-12-07T16:30:35-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-presentation-44th-annual-jp-morgan 2025-12-22T16:05:21-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-approved-japan-children-aged-6-11-years 2025-12-23T01:00:41-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-report-fourth-quarter-and-full-year-2025-financial-and 2026-01-02T16:05:21-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/nations-top-40-high-school-scientists-compete-18-million-awards 2026-01-21T12:00:27-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-fourth-quarter-and-full-year-2025-financial 2026-01-30T06:30:37-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/eylea-hdr-aflibercept-injection-8-mg-presentations-angiogenesis 2026-02-02T07:01:03-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-highlights-expanding-immunology-portfolio-and-pipeline 2026-02-10T07:00:51-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-investor-conference-presentations-23 2026-02-11T16:05:28-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/garetosmab-biologics-license-application-accepted-fda-priority 2026-02-19T07:01:10-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-approved-us-first-and-only-medicine-allergic 2026-02-24T09:30:47-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-renews-sponsorship-regeneron-science-talent-search 2026-02-26T12:01:02-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-recommended-eu-approval-treat-chronic 2026-02-27T07:00:20-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-investor-conference-presentation-0 2026-03-05T16:05:31-05:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/olatorepatide-obesity-treatment-licensed-regeneron-demonstrates 2026-03-09T07:00:38-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-science-talent-search-2026-recognizes-americas-top 2026-03-10T21:30:14-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-approved-japan-first-targeted-medicine-treat 2026-03-24T02:00:42-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-report-first-quarter-2026-financial-and-operating 2026-04-01T08:53:32-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/eylea-hdr-aflibercept-approved-fda-first-and-only-injectable 2026-04-02T12:02:12-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-collaborates-trinetx-access-de-identified-electronic 2026-04-02T16:30:16-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-approved-eu-first-targeted-medicine-treat 2026-04-13T01:00:43-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-telix-announce-strategic-radiopharma-collaboration 2026-04-13T06:30:32-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-investor-conference-presentations-24 2026-04-20T16:05:37-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/cemdisiran-dosed-subcutaneously-every-12-weeks-demonstrates 2026-04-21T10:30:26-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-approved-us-first-biologic-medicine-young 2026-04-22T17:30:15-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/otarmenitm-lunsotogene-parvec-cwha-approved-fda-first-and-only 2026-04-23T12:40:30-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-agreement-us-government-help-lower-drug 2026-04-23T15:46:36-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-first-quarter-2026-financial-and-operating 2026-04-29T06:30:50-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/dupixentr-dupilumab-demonstrates-improved-esophageal-function 2026-05-05T07:00:44-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-named-dow-jones-best-class-world-index-global 2026-05-08T07:00:19-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/next-generation-scientific-leaders-awarded-more-7-million-2026 2026-05-15T19:25:36-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-provides-update-phase-3-trial-fianlimab-lag-3 2026-05-15T20:20:13-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-strategic-collaboration-parabilis-medicines 2026-05-18T07:01:00-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/lynozyficr-linvoseltamab-monotherapy-demonstrates-deep-and-rapid 2026-05-21T18:41:58-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/otarmenitm-lunsotogene-parvec-receives-ema-filing-acceptance 2026-05-22T07:00:40-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regenerons-ebola-antibody-recommended-world-health-organization 2026-05-28T16:16:41-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-highlight-progress-across-its-metabolic-disease 2026-06-04T07:01:15-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/cemdisiran-regulatory-submissions-accepted-review-fda-and-ema 2026-06-22T07:00:21-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-report-second-quarter-2026-financial-and-operating 2026-06-25T16:05:42-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-reports-second-quarter-2026-financial-and-operating 2026-07-30T06:30:59-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-awards-150000-winners-2026-regeneron-prize-creative 2026-07-31T07:00:37-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/pasatrutm-garetosmab-grts-first-and-only-fda-approved-treatment 2026-08-19T13:58:22-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-investor-conference-presentations-25 2026-09-10T11:09:57-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-report-third-quarter-2026-financial-and-operating 2026-09-24T16:05:33-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-and-sanofi-expand-global-alliance-multiple-next 2026-10-01T01:00:25-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/phase-2-courage-trial-confirms-trevogrumab-prevents-lean-mass 2026-10-01T11:30:28-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/ubamatamab-muc16xcd3-shows-high-rate-durable-responses-initial 2026-10-01T11:35:28-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/regeneron-showcases-advances-care-across-several-cancers-and 2026-10-06T14:26:42-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/pasatrutm-garetosmab-grts-demonstrates-zero-new-heterotopic 2026-10-12T12:06:25-04:00 0.5 https://investor.regeneron.com/news-releases/news-release-details/libtayor-cemiplimab-recommended-eu-approval-chmp-updated-dosing 2026-10-16T07:00:23-04:00 0.5 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001532176-18-000010 2021-03-11T20:00:20-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000902219-18-000183 2021-03-11T20:00:20-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/5/0001104659-18-007629 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-k/0001532176-18-000013 2018-07-06T08:47:59-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13g/0000932471-18-003748 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/3/0001104659-18-008557 2021-03-11T20:00:27-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-18-000010 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000315066-18-001539 2021-03-11T20:00:27-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-18-000011 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0001422849-18-000102 2021-03-11T20:00:27-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-18-000012 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-18-000013 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/def-14a/0001047469-18-003073 2021-03-11T20:00:27-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/defa14a/0001104659-18-025866 2021-03-11T20:00:27-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/defa14a/0001104659-18-025868 2021-03-11T20:00:27-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001532176-18-000018 2021-03-11T20:00:27-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0001532176-18-000020 2018-07-06T08:57:49-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-18-000006 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-18-000007 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001140361-18-028055 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000891836-03-000581 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-03-011181 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-03-000026 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-03-011974 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0000950123-03-012534 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-03-000028 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-03-000029 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-03-000030 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-03-000031 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-03-000032 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-03-000033 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-03-000034 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-03-000038 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-03-000040 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-03-000041 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-04-000001 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/5/0001237899-04-000002 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-04-000003 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/5/0001237899-04-000004 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-04-000005 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-04-000006 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-04-000007 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-04-000008 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-04-000009 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-04-000010 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-04-000011 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-04-000012 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-04-000013 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-04-000014 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-04-000017 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13da/0000895345-04-000059 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000902219-04-000921 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0001015402-04-000492 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000315066-04-000968 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000950123-04-002024 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-04-002235 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-04-002555 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-04-000019 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-04-000020 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-04-000021 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-k/0000950123-04-003254 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-04-000023 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-ka/0000950123-04-003550 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4a/0001237899-04-000025 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-04-000027 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/424b3/0000950123-04-005015 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/def-14a/0001206774-04-000384 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-04-005202 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-04-005322 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/424b3/0000950123-04-005343 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001254560-04-000004 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001254560-04-000005 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0001193125-04-079147 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-04-000029 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0000950123-04-005871 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-04-000031 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-04-000032 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-04-000035 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-04-000037 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-04-000039 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-04-008811 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0000950123-04-009281 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/s-8/0000950123-04-011352 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-04-000041 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-04-000042 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-04-000043 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-04-000044 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-04-012639 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0000950123-04-013173 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-04-013538 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001206774-04-001652 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001206774-04-001653 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/pre-14a/0001206774-04-001651 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-c/0001206774-04-001654 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/defa14a/0001206774-04-001655 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-c/0001145443-04-001897 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/def-14a/0001206774-04-001683 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-i/0000950123-04-014407 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-ia/0000950123-04-014459 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-04-014716 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-ka/0000950123-04-014749 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/s-3/0000950123-04-014750 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-04-000046 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-04-000047 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-04-000048 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-04-000049 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-04-000050 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-04-000051 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-04-000052 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-04-000053 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950172-04-003022 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-ia/0000950172-04-003023 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-ia/0000950172-05-000011 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-05-000002 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-05-000003 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-05-000004 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-05-000005 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-05-000006 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-05-000007 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-05-000008 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-05-000009 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-ia/0000950172-05-000053 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950172-05-000071 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-ia/0000950172-05-000074 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-05-000011 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-05-000012 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-05-000013 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-05-000014 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-05-000015 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-05-000016 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-05-000248 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/5/0001237899-05-000017 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-05-000018 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-05-000019 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-05-000020 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950172-05-000381 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-05-000021 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-05-000022 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0001104659-05-004894 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0001193125-05-023401 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/s-3a/0000950123-05-001401 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0001193125-05-024957 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000315066-05-001065 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-05-000023 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13g/0000902219-05-001037 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13g/0000913414-05-000407 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-05-000024 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-05-000025 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-05-002144 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-05-000026 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-k/0000950123-05-002979 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13g/0000950123-05-004013 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000950123-05-004016 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950172-05-001189 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950172-05-001375 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/def-14a/0001206774-05-000747 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0000950123-05-005904 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-05-000029 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-05-006417 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13d/0000912057-95-005657 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13da/0000912057-95-010780 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13da/0000950150-95-000590 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0000889812-96-001067 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0000889812-96-001653 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13da/0000912057-96-003913 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13da/0000912057-96-006661 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/defn14a/0000940180-96-000082 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-a12g/0000950172-96-000641 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13d/0000080424-97-000040 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13da/0000080424-97-000048 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000889812-97-000079 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-k/0000889812-97-000791 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0000889812-97-001109 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000889812-97-001152 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/def-14a/0000889812-97-001264 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-ka/0000889812-97-001283 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0000889812-97-001703 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0000889812-97-002443 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13g/0000899140-97-000081 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/s-8/0000950172-97-000778 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-k/0000889812-98-000733 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0000889812-98-001229 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0000889812-98-001991 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0000889812-98-002587 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13g/0000950123-98-001058 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/def-14a/0001024739-98-000464 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13g/0000354204-99-000597 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-k/0000889812-99-000997 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/def-14a/0000889812-99-001353 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/defa14a/0000889812-99-001411 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0000889812-99-001510 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0000889812-99-002314 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0000889812-99-003259 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000899140-99-000257 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/s-8/0000950172-99-000760 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13g/0000354204-00-001046 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-k/0000889812-00-001090 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/s-3/0000889812-00-001092 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/s-3a/0000889812-00-001158 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/424b1/0000889812-00-001434 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000889812-00-001619 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/def-14a/0000889812-00-002043 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13da/0000898430-00-000675 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13da/0000898430-00-001166 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950172-00-000647 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0000889812-00-002227 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13da/0000895345-00-000320 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0000889812-00-003433 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13da/0000080424-00-000031 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0001125282-00-000582 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-01-000606 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/s-3/0000950123-01-000607 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-ka/0000950123-01-000634 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13g/0000354204-01-001130 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-k/0000950123-01-500091 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/s-3a/0000950123-01-500092 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13da/0000080424-01-000013 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/s-3a/0000950123-01-500194 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13da/0000898430-01-000923 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/s-3a/0000950123-01-002397 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13g/0000891836-01-000086 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/424b4/0000950123-01-002421 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/pos-ex/0000950123-01-500272 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/424b1/0000950123-01-002432 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13da/0000898430-01-000993 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13g/0001015402-01-500576 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13g/0000902219-01-500002 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/def-14a/0000950123-01-501439 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0000950123-01-502280 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/s-8/0000950123-01-502703 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0000950123-01-505460 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-01-507177 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-01-507186 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/pres14a/0000950123-01-508078 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0000950123-01-508241 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/defs14a/0000950123-01-508707 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13da/0000895345-01-500668 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/s-3/0000950123-01-508977 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000891836-01-500378 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/s-3a/0000950123-01-509508 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/s-3a/0000950123-02-000546 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/s-3a/0000950123-02-000590 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/424b3/0000950123-02-000616 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/424b3/0000950172-02-000172 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13g/0001021408-02-001289 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/424b3/0000950123-02-001029 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000902219-02-000997 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/424b3/0000950123-02-001454 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-05-000031 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-05-000033 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-05-008119 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-05-000034 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-05-000038 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-05-009421 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-05-000040 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/424b3/0000950123-05-009494 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0000950123-05-009557 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-05-011496 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-05-013047 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0000950123-05-013081 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0000950127-05-000798 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000950127-05-000799 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-05-014882 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-05-000043 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-05-000044 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-05-000045 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-05-000046 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-05-000047 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-05-000048 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-05-000049 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-05-000050 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-05-015057 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-05-015141 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001209191-05-065747 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-05-000058 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-05-000059 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-05-000060 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-06-000002 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-06-000003 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-06-000004 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-06-000005 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-06-000006 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-06-000007 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-06-000009 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-06-000008 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/5/0001237899-06-000010 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-06-000012 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-06-000013 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-06-000014 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-06-000015 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-06-000016 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-06-000017 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-06-000018 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-06-000019 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-06-000020 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-06-000678 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13g/0000913414-06-001444 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-06-000924 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-06-001068 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-06-000024 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-06-000025 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-06-000026 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13g/0000312069-06-001762 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0001140361-06-002279 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000902219-06-000953 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000950123-06-001686 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000950123-06-001687 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000315066-06-002706 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-06-002192 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-06-002213 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-k/0000950123-06-002365 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-06-000028 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-06-000029 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-06-000031 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-06-000033 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-06-004826 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/def-14a/0001206774-06-000842 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-06-005554 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-06-005771 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0000950123-06-005880 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-06-007245 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-06-000035 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-06-007528 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-06-000037 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-06-000038 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-06-009822 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0000950123-06-010084 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-06-000042 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-06-000044 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-06-011408 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001209191-06-050323 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/3/0001237899-06-000047 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-06-000048 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001209191-06-055147 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4a/0001209191-06-055148 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-06-012721 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-06-000050 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/15-12g/0001341004-06-002821 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-06-013247 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001336665-06-000002 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001336665-06-000004 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001336665-06-000006 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0000950123-06-013527 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-06-013595 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-06-000052 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001209191-06-058447 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-06-000055 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-06-000056 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/424b5/0000950123-06-014209 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-06-014213 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-06-014319 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-06-000059 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-06-000060 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001336665-06-000008 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001336665-06-000009 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001336665-06-000010 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001336665-06-000011 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001336665-06-000012 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001336665-06-000013 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001336665-06-000014 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001336665-06-000015 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001336665-06-000016 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-06-015550 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-07-000002 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-07-000004 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-07-000003 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-07-000005 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-07-000006 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-07-000007 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-07-000008 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-07-000009 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13g/0000913414-07-002093 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-07-000011 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-07-001413 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/5/0001209191-07-007979 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000950123-07-001484 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0001104659-07-010175 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000950123-07-001972 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000902219-07-000978 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13g/0000312348-07-000029 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-07-000015 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-07-000014 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/3/0001237899-07-000017 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-07-000018 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-07-000020 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-07-000021 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-07-003120 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-k/0000950123-07-003627 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-07-004963 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-07-000023 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-07-000024 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-07-000025 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-07-000026 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-07-000027 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-07-000029 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-07-000030 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/def-14a/0001206774-07-001113 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-07-000031 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-07-006700 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0000950123-07-006735 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-k/0000950123-02-002817 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13g/0000315066-02-001525 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/424b3/0000950123-02-004260 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/def-14a/0000950123-02-004815 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0000950123-02-004899 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/424b3/0000950123-02-005298 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-02-006802 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-02-006929 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-02-007231 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/s-8-pos/0000950123-02-007336 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/s-8/0000950123-02-007337 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0000950123-02-007796 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0001015402-02-003064 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0000950123-02-010532 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/424b3/0000950123-02-011130 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-03-000476 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-03-000974 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000902219-03-000922 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000891836-03-000079 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000950123-03-001386 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000315066-03-001919 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000902219-03-001081 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001181431-03-004353 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-k/0000950123-03-003582 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-03-003749 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000891836-03-000217 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13g/0001005477-03-000122 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/424b3/0000950123-03-004015 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-03-004333 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/def-14a/0000950123-03-005127 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-03-005307 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000315066-03-002302 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0000950123-03-006048 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/3/0001005477-03-001497 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0001005477-03-001507 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-03-000004 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-03-000005 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-03-000006 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-03-000007 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000315066-03-002515 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-03-008861 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0000950123-03-009451 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-03-000010 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-03-010206 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13g/0001104659-03-020606 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-03-000011 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-03-000012 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-03-000013 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-03-000014 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-03-000015 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-03-000016 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-03-000021 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-03-000022 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-03-000023 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-03-000024 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-03-000025 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-07-008443 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/3/0001237899-07-000035 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-07-000037 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-07-000038 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-07-010633 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0000950123-07-010794 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-07-011404 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/3/0001237899-07-000040 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-07-000041 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-07-013232 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-07-000043 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-07-014391 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-07-014793 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001209191-07-062009 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-07-014956 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-07-000045 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-07-000046 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-07-000048 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-07-000047 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0000950123-07-015042 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-07-015387 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-07-016134 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001209191-07-070980 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-07-000050 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-07-000051 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-07-000052 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-07-000054 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-07-000055 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-07-000056 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-07-000057 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-07-000058 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-07-000059 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-07-000060 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/3/0001181431-07-077061 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13g/0001193125-07-269851 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001209191-07-071440 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-07-016972 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-08-000002 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-08-000003 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-08-000004 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-08-000005 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-08-000006 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-08-000007 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-08-000008 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000902219-08-000011 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-08-000009 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-08-000010 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13g/0000728889-08-000259 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13g/0000913414-08-004308 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000312348-08-000025 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000315066-08-002036 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-08-000012 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-08-000014 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-k/0000950123-08-002191 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-08-000015 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-08-002251 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-08-002319 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-08-003946 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0001140361-08-009406 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/def-14a/0001206774-08-000874 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0000950123-08-005043 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-08-005050 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-08-005993 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/ct-order/9999999997-08-026388 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001431092-08-000007 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-08-006564 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13g/0001193125-08-130017 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-08-006981 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/s-8/0000950123-08-007267 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-08-007572 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/ct-order/9999999997-08-033879 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-08-008608 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0000950123-08-008675 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-08-000017 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-08-000019 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/ct-order/9999999997-08-037235 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-08-010597 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-08-000021 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-08-000023 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-08-000025 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-08-000026 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-08-000028 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001209191-08-054077 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001431092-08-000009 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-08-000029 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-08-000031 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-08-000032 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-08-000033 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-08-000034 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-08-014344 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0000950123-08-014408 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-08-015831 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-08-000036 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-08-000038 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-08-000040 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-08-000041 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-08-000042 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-08-000043 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-08-000044 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-08-000049 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-08-000050 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-08-000051 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-08-000052 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-08-000053 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-08-000054 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-08-000056 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-09-000001 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-09-000002 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-09-000003 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-09-000004 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-09-000005 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-09-000006 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-09-000007 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-09-000008 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-09-000448 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-09-000009 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000728889-09-000271 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0001193125-09-018680 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13g/0000913414-09-003906 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000312348-09-000034 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000902219-09-000912 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000315066-09-002068 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-09-000010 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-09-000011 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-k/0001206774-09-000338 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001206774-09-000352 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/3/0001237899-09-000013 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/def-14a/0001206774-09-000860 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-09-000014 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0001206774-09-000907 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001206774-09-000928 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001206774-09-001178 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001206774-09-001183 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-09-000016 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-09-000018 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001206774-09-001497 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0001206774-09-001498 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001431092-09-000001 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-09-000020 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001206774-09-001753 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/ct-order/9999999997-09-024828 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-09-000022 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-09-000024 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0001206774-09-002017 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001206774-09-002042 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000315066-09-003864 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001206774-09-002097 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-09-000026 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-09-000028 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001206774-09-002305 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-09-000030 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-09-000032 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-09-000033 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-09-000034 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-09-000035 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-09-000036 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-09-000037 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-09-000038 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-09-000039 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-09-000040 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-09-000041 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-09-000042 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-09-000043 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-09-000044 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-09-000046 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-10-000001 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-10-000002 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-10-000003 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-10-000004 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-10-000005 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-10-000006 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-10-000008 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-10-000009 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-10-000010 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-10-000011 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13g/0001086364-10-007801 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-10-000012 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-10-000013 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-10-000014 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-10-000015 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-10-000016 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-10-000017 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13g/0000080255-10-000093 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000902219-10-000813 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13g/0000315066-10-002056 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001206774-10-000283 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-k/0001206774-10-000298 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001206774-10-000319 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001431092-10-000002 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/3/0001237899-10-000019 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-10-000020 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-10-000021 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/def-14a/0001206774-10-001040 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/defa14a/0001206774-10-001041 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0001206774-10-001072 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001206774-10-001084 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001206774-10-001275 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-10-000022 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-10-000023 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-10-000024 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-10-000025 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-10-000026 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/defa14a/0001206774-11-001181 2021-03-11T19:53:13-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/defa14a/0001206774-11-001317 2021-03-11T19:53:13-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/s-8/0001206774-11-001374 2021-03-11T19:53:13-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001206774-11-001383 2021-03-11T19:53:13-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001206774-11-001412 2021-03-11T19:53:13-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000034 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001206774-11-001439 2021-03-11T19:53:39-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000035 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000036 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000037 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13g/0001422849-11-000342 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000038 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000039 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000040 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000041 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000042 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0001206774-11-001639 2021-03-11T19:53:39-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001206774-11-001641 2021-03-11T19:53:39-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000043 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000044 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000045 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000046 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001206774-11-001884 2021-03-11T19:53:39-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000047 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001206774-11-001912 2021-03-11T19:53:39-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/3/0001237899-11-000048 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000049 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000050 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000052 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001209191-11-047115 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000053 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000054 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000055 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000056 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000057 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000058 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-ka/0001206774-11-002065 2021-03-11T19:53:39-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000059 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000060 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000062 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000061 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001206774-11-002117 2021-03-11T19:53:39-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000063 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000064 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000065 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001193125-11-273012 2021-03-11T19:52:53-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001193125-11-274038 2021-03-11T19:52:53-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001193125-11-278786 2021-03-11T19:52:53-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0001206774-11-002300 2021-03-11T19:53:39-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001206774-11-002304 2021-03-11T19:53:39-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001206774-11-002392 2021-03-11T19:53:39-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001206774-11-002523 2021-03-11T19:53:39-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000066 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001206774-11-002628 2021-03-11T19:53:39-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-ka/0001206774-11-002642 2021-03-11T19:53:39-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001206774-11-002647 2021-03-11T19:53:39-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000069 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/3/0001237899-11-000068 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000070 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000071 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001206774-11-002780 2021-03-11T19:53:39-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000072 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000073 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000074 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000075 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000076 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000078 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000077 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000079 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000080 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000081 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000082 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000083 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000084 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000085 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000086 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001206774-11-002936 2021-03-11T19:53:39-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001206774-12-000034 2021-03-11T19:53:39-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000001 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000002 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000003 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000004 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000005 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000006 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000007 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000008 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000009 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000010 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001206774-12-000074 2021-03-11T19:53:39-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000011 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000012 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000013 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000014 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000015 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000016 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-ka/0001206774-12-000199 2021-03-11T19:53:39-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000017 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000018 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13g/0001193125-12-042488 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000020 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0001086364-12-000233 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0001422849-12-000295 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001206774-12-000566 2021-03-11T19:53:39-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000080255-12-000403 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/5/0001237899-12-000023 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000902219-12-000377 2021-03-11T19:51:47-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000315066-12-002976 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000024 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000025 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000026 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000027 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000028 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000029 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-k/0001206774-12-000709 2021-03-11T19:53:39-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000030 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000031 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000032 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000034 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000035 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000036 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/ct-order/9999999997-12-007597 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000047 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/def-14a/0001206774-12-001697 2021-03-11T19:53:39-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/defa14a/0001206774-12-001698 2021-03-11T19:53:39-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0001206774-12-001689 2021-03-11T19:53:39-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001206774-12-001690 2021-03-11T19:53:39-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000050 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000051 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000052 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001209191-12-025352 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000054 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001193125-12-216794 2021-03-11T19:52:53-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000056 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000057 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000058 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000059 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001193125-12-271011 2021-03-11T19:52:53-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000060 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000062 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001193125-12-313310 2021-03-11T19:52:53-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0001206774-12-003062 2021-03-11T19:54:09-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000063 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000064 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000065 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000066 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000067 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000068 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000069 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000070 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001556247-12-000001 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000071 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000072 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000073 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000074 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000075 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001556247-12-000002 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/ct-order/9999999997-12-013781 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001193125-12-432296 2021-03-11T19:52:53-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0001532176-12-000004 2021-03-11T19:56:28-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000076 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000077 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000078 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001556247-12-000003 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000079 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000080 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000081 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000082 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001209191-12-053828 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000083 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000084 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000085 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000086 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000087 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000088 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000089 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000090 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000091 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000092 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000093 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-10-000027 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-ka/0001206774-10-001385 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-10-000028 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-10-000029 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-10-000030 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001206774-10-001430 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000315066-10-002904 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-10-000031 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001206774-10-001439 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-10-000032 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/ct-order/9999999997-10-013144 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-10-000033 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-10-000034 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000902219-10-000987 2021-03-11T19:51:47-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0001206774-10-001689 2021-03-11T19:53:13-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001206774-10-001715 2021-03-11T19:53:13-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0001140361-10-037934 2021-03-11T19:52:48-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/s-8/0001206774-10-002055 2021-03-11T19:53:13-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/s-8-pos/0001206774-10-002056 2021-03-11T19:53:13-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-10-000038 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/s-3asr/0000950123-10-091753 2021-03-11T19:52:40-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/424b5/0000950123-10-091917 2021-03-11T19:52:40-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-10-000039 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/424b5/0000950123-10-092368 2021-03-11T19:52:40-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001206774-10-002150 2021-03-11T19:53:13-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001181431-10-050881 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0001206774-10-002228 2021-03-11T19:53:13-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001206774-10-002230 2021-03-11T19:53:13-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/3/0001237899-10-000041 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-10-000042 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001206774-10-002373 2021-03-11T19:53:13-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950123-10-107620 2021-03-11T19:52:40-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-10-000043 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-10-000044 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-10-000045 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/ct-order/9999999997-10-020071 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001206774-10-002628 2021-03-11T19:53:13-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-10-000046 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-10-000048 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-10-000049 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-10-000047 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-10-000050 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-10-000051 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-10-000052 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-10-000053 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-10-000055 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-10-000054 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-10-000056 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-10-000058 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-10-000057 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-10-000059 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-10-000060 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-10-000061 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4a/0001237899-10-000062 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4a/0001237899-10-000063 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4a/0001237899-10-000064 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-10-000065 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000950172-10-000048 2021-03-11T19:52:40-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000001 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000002 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000003 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000004 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000005 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000006 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000007 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000008 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000009 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000010 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000011 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000080255-11-000007 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000012 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000013 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000014 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000015 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000016 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000017 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000018 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0001086364-11-003655 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000902219-11-000812 2021-03-11T19:51:47-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000315066-11-002886 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000019 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000020 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000021 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-k/0001206774-11-000263 2021-03-11T19:53:13-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001206774-11-000267 2021-03-11T19:53:13-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000022 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000023 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001206774-11-000353 2021-03-11T19:53:13-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000024 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001206774-11-000473 2021-03-11T19:53:13-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001431092-11-000002 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001431092-11-000003 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001431092-11-000004 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001431092-11-000005 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000025 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000026 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000027 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000028 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000029 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000030 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001206774-11-000939 2021-03-11T19:53:13-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000031 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001206774-11-001013 2021-03-11T19:53:13-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001206774-11-001022 2021-03-11T19:53:13-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/def-14a/0001206774-11-001031 2021-03-11T19:53:13-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/defa14a/0001206774-11-001035 2021-03-11T19:53:13-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000032 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0001206774-11-001105 2021-03-11T19:53:13-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001206774-11-001111 2021-03-11T19:53:13-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-11-000033 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000094 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000095 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000097 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000096 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000100 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000101 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000098 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000099 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000102 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000103 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000105 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000104 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000106 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000107 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000108 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000109 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000110 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000111 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-12-000112 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000001 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000002 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000005 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000004 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000003 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000006 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000007 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000008 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000009 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000010 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000011 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001193125-13-006146 2021-03-11T19:56:49-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000012 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000013 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001556247-13-000001 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0001086364-13-002393 2021-03-11T19:56:49-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000080255-13-000067 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/5/0001237899-13-000014 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0001193125-13-044761 2021-03-11T19:56:49-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0001422849-13-000277 2021-03-11T19:56:49-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001193125-13-057470 2021-03-11T19:56:49-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000902219-13-000388 2021-03-11T19:56:49-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000315066-13-002752 2021-03-11T19:56:49-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-k/0001532176-13-000004 2021-03-11T19:56:49-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000015 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000017 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000018 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000019 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000020 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/ars/9999999997-11-009913 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/ars/9999999997-10-011936 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/ars/9999999997-09-019251 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/ars/9999999997-08-024815 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/regdex/9999999997-03-036110 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/ars/9999999997-07-025761 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/ars/9999999997-06-020290 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/9999999997-02-010987 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/ars/9999999997-05-024000 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000021 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001193125-13-138077 2021-03-11T19:57:03-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001193125-13-147701 2021-03-11T19:57:03-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000022 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/defa14a/0001193125-13-178404 2021-03-11T19:57:03-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/def-14a/0001193125-13-178388 2021-03-11T19:57:03-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001193125-13-197533 2021-03-11T19:57:03-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0001532176-13-000008 2021-03-11T19:57:03-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000024 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000023 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001193125-13-201761 2021-03-11T19:57:03-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000026 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000025 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000029 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000028 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000027 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000030 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000031 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000032 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000033 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000034 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000035 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000036 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001193125-13-228009 2021-03-11T19:57:13-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4a/0001237899-13-000037 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000038 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000040 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000039 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000041 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000042 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000043 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000044 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001193125-13-264466 2021-03-11T19:57:13-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001556247-13-000002 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001532176-13-000020 2021-03-11T19:57:13-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0001532176-13-000022 2021-03-11T19:57:13-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000045 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000046 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001556247-13-000003 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000315066-13-003898 2021-03-11T19:57:27-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001209191-13-043847 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/3/0001237899-13-000048 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000049 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001193125-13-365438 2021-03-11T19:57:27-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/ct-order/9999999997-13-013990 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001556247-13-000004 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000051 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000050 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000053 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000054 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000055 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001193125-13-388997 2021-03-11T19:57:27-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000056 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001532176-13-000029 2021-03-11T19:57:27-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0001532176-13-000030 2021-03-11T19:57:27-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/s-3asr/0001193125-13-426539 2021-03-11T19:57:27-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000057 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000058 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000059 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000060 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000061 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000065 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000068 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000064 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000063 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000062 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000066 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000067 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000071 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000070 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000069 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000072 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000076 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000073 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000074 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000075 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000077 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000078 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-13-000079 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000002 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000001 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000003 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000005 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000004 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000006 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000008 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000007 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000009 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000010 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001193125-14-008775 2021-03-11T19:57:45-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001193125-14-010330 2021-03-11T19:57:45-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13d/0000909518-14-000012 2021-03-11T19:57:45-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000012 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000011 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001193125-14-013132 2021-03-11T19:57:45-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13da/0000909518-14-000016 2021-03-11T19:57:45-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001140361-14-003496 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0001086364-14-001449 2021-03-11T19:57:45-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001140361-14-004578 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001193125-14-036031 2021-03-11T19:57:45-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/5/0001237899-14-000013 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001140361-14-005151 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001140361-14-005654 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001532176-14-000005 2021-03-11T19:57:45-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000014 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000015 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000016 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000080255-14-000490 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000017 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000018 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-k/0001532176-14-000008 2021-03-11T19:57:45-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0001422849-14-000247 2021-03-11T19:57:45-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000019 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000020 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000315066-14-002465 2021-03-11T19:57:56-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000021 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000022 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000023 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000025 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000024 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000027 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000026 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000028 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000029 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000030 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000031 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000032 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001193125-14-082705 2021-03-11T19:57:56-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13da/0000909518-14-000115 2021-03-11T19:57:56-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001140361-14-011339 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000033 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001140361-14-012027 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001140361-14-012028 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001140361-14-012431 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13da/0000909518-14-000120 2021-03-11T19:57:56-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001140361-14-012800 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000034 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001140361-14-013393 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001140361-14-013863 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001140361-14-014134 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001140361-14-014135 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000035 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000036 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13da/0000909518-14-000129 2021-03-11T19:58:03-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001140361-14-014862 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001140361-14-014863 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000046 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/3/0001237899-14-000045 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13da/0000909518-14-000145 2021-03-11T19:58:03-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13da/0000909518-14-000147 2021-03-11T19:58:03-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001193125-14-137223 2021-03-11T19:58:03-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/def-14a/0001193125-14-157198 2021-03-11T19:58:03-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/defa14a/0001193125-14-157221 2021-03-11T19:58:03-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001532176-14-000021 2021-03-11T19:58:03-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0001532176-14-000022 2018-07-10T07:23:07-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001193125-14-204760 2021-03-11T19:58:03-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001140361-14-022505 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000048 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000049 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-ka/0001193125-14-211502 2021-03-11T19:58:03-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/ct-order/9999999997-14-011157 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/s-8/0001193125-14-237593 2021-03-11T19:58:03-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/s-8-pos/0001193125-14-237597 2021-03-11T19:58:03-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001193125-14-240075 2021-03-11T19:58:03-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13da/0001140361-14-027105 2021-03-11T19:58:14-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001140361-14-027278 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001140361-14-027751 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001140361-14-027754 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001140361-14-027965 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13da/0001140361-14-028082 2021-03-11T19:58:14-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001140361-14-028181 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001140361-14-028423 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001140361-14-028501 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001140361-14-028705 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/3/0001209191-14-049584 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000050 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13da/0000909518-14-000233 2021-03-11T19:58:14-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001532176-14-000034 2021-03-11T19:58:14-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0001532176-14-000035 2021-03-11T19:58:14-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001209191-14-050677 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000051 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13g/0001193125-14-300679 2021-03-11T19:58:14-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000052 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000053 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000054 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000055 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000056 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000057 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000058 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000059 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000060 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000061 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000063 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000062 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000064 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000065 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000066 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000068 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001140361-14-035768 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/s-8-pos/0001193125-14-343973 2021-03-11T19:58:26-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/s-8/0001193125-14-343976 2021-03-11T19:58:26-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001140361-14-036015 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13da/0000909518-14-000295 2021-03-11T19:58:26-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001140361-14-038472 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001140361-14-038571 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000069 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000070 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000071 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001532176-14-000045 2021-03-11T19:58:26-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0001532176-14-000046 2018-07-10T07:19:49-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000072 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000073 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000074 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000075 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000076 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000077 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001193125-14-421896 2021-03-11T19:58:36-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000078 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000079 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000080 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001193125-14-427199 2021-03-11T19:58:36-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000081 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000086 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000083 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000082 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000084 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000085 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000093 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000087 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000092 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000090 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000091 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000089 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000088 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000094 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-14-000095 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001193125-14-450726 2021-03-11T19:58:36-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001140361-14-046592 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-15-000002 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-15-000003 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-15-000004 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-15-000005 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-15-000006 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-15-000009 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-15-000010 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-15-000011 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-15-000012 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001209191-15-001080 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-15-000013 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001193125-15-009141 2021-03-11T19:58:47-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000215457-15-000278 2021-03-11T19:58:47-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001532176-15-000004 2021-03-11T19:58:47-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13g/0000902219-15-000380 2021-03-11T19:58:47-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000080255-15-000318 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-k/0001532176-15-000008 2018-07-10T07:03:52-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13g/0001020066-15-000008 2021-03-11T19:58:47-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000315066-15-002296 2021-03-11T19:58:47-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0001422849-15-000286 2021-03-11T19:58:47-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-15-000014 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-15-000015 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-15-000017 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-15-000016 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-15-000019 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-15-000018 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-15-000020 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-15-000021 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-15-014708 2021-03-11T19:58:57-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-15-000022 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-15-000023 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-15-016877 2021-03-11T19:58:57-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-15-019719 2021-03-11T19:58:57-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/pre-14a/0001047469-15-002291 2021-03-11T19:58:57-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/ct-order/9999999997-15-004845 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-15-000024 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-15-000025 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-15-000026 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-15-021521 2021-03-11T19:58:57-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-15-000027 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-15-000028 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-15-000029 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-15-000030 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/def-14a/0001047469-15-003736 2021-03-11T19:58:57-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/defa14a/0001104659-15-029060 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001532176-15-000018 2021-03-11T19:58:57-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0001532176-15-000020 2018-07-10T07:00:36-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-15-000031 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/px14a6g/0001140361-15-020862 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-15-000032 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-15-000033 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-15-000034 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-15-000035 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-15-000036 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-15-000037 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/ct-order/9999999997-15-010681 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-15-045962 2021-03-11T19:59:07-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-15-000038 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001532176-15-000021 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001140361-15-029012 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-15-054976 2021-03-11T19:59:07-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-15-000039 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001532176-15-000028 2021-03-11T19:59:07-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0001532176-15-000029 2018-07-10T06:59:04-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-15-000040 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-15-000041 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-15-000042 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-15-056808 2021-03-11T19:59:07-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-15-000043 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-15-000046 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-15-000045 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-15-000044 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-15-000047 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-15-000049 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-15-000050 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-15-000051 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-15-000052 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001652917-15-000002 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001140361-15-035954 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-15-068747 2021-03-11T19:59:14-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001140361-15-037232 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001140361-15-037233 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001652917-15-000006 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001532176-15-000036 2021-03-11T19:59:14-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0001532176-15-000037 2018-07-10T06:55:27-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-15-000053 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001652917-15-000007 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001652917-15-000008 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-15-078776 2021-03-11T19:59:14-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-15-079098 2021-03-11T19:59:14-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-15-080234 2021-03-11T19:59:14-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-15-000054 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-15-000055 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/ct-order/9999999997-15-014847 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001652917-15-000009 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-15-000056 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-15-000058 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-15-000060 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-15-000057 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-15-000059 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-15-000064 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-15-000067 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-15-000062 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-15-000065 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-15-000066 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-15-000063 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-15-000061 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13da/0001140361-15-045831 2021-03-11T19:59:21-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-15-000068 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-16-000069 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-16-000073 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-16-000072 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-16-000071 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-16-000070 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-16-000075 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-16-000074 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-16-089230 2021-03-11T19:59:21-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001140361-16-047842 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-16-093255 2021-03-11T19:59:21-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/ct-order/9999999997-16-016570 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001532176-16-000041 2021-03-11T19:59:21-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000215457-16-005736 2021-03-11T19:59:21-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000902219-16-000995 2021-03-11T19:59:21-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-k/0001532176-16-000045 2018-07-10T06:52:19-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000315066-16-005398 2021-03-11T19:59:21-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0001140361-16-052449 2021-03-11T19:59:21-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0001422849-16-000665 2021-03-11T19:59:28-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001140361-16-053976 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-16-098217 2021-03-11T19:59:28-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-16-099426 2021-03-11T19:59:28-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-16-000076 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-16-108062 2021-03-11T19:59:28-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-16-000077 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001652917-16-000010 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/def-14a/0001047469-16-012560 2021-03-11T19:59:28-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/defa14a/0001104659-16-114231 2021-03-11T19:59:28-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/defa14a/0001104659-16-114229 2021-03-11T19:59:28-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001532176-16-000053 2021-03-11T19:59:28-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0001532176-16-000055 2018-07-10T06:49:13-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13g/0001104659-16-120084 2021-03-11T19:59:28-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-16-000078 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001652917-16-000011 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-16-000079 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-16-127197 2021-03-11T19:59:28-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001140361-16-070116 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/ct-order/9999999997-16-024248 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-16-000080 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001532176-16-000066 2021-03-11T19:59:28-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0001532176-16-000067 2018-07-10T06:47:21-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-16-000081 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/3/0001104659-16-144224 2021-03-11T19:59:28-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/3/0001104659-16-144225 2021-03-11T19:59:39-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001104659-16-144226 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001104659-16-144227 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-16-144644 2021-03-11T19:59:39-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-16-145589 2021-03-11T19:59:39-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/ct-order/9999999997-16-026542 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-16-152699 2021-03-11T19:59:39-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001532176-16-000080 2021-03-11T19:59:39-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0001532176-16-000082 2018-07-10T06:44:50-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-16-000082 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-16-156420 2021-03-11T19:59:39-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-16-000083 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-16-000084 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-16-157915 2021-03-11T19:59:39-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-16-159026 2021-03-11T19:59:39-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/ct-order/9999999997-16-027632 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-16-000085 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-16-000086 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-16-000087 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-16-000088 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-16-000091 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-16-000089 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-16-000090 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-16-000092 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-16-000093 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-16-000094 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-16-000095 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-16-163216 2021-03-11T19:59:46-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-16-164541 2021-03-11T19:59:46-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-17-000001 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-17-000004 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-17-000002 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-17-000003 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-17-000005 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-17-000007 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-17-000008 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-17-000009 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-17-000010 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-17-001558 2021-03-11T19:59:46-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001140361-17-001832 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000353480-17-001631 2021-03-11T19:59:46-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-17-005123 2021-03-11T19:59:46-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13da/0001140361-17-003771 2021-03-11T19:59:46-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/3/0001104659-17-005397 2021-03-11T19:59:46-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001104659-17-005427 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-17-006777 2021-03-11T19:59:46-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001532176-17-000006 2021-03-11T19:59:46-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13g/0000902219-17-000341 2021-03-11T19:59:46-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-k/0001532176-17-000008 2021-03-11T19:59:46-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/5/0001237899-17-000014 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0001422849-17-000106 2021-03-11T20:00:00-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000315066-17-002000 2021-03-11T20:00:00-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/ct-order/9999999997-17-000790 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/3/0001104659-17-013471 2021-03-11T20:00:00-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-17-015313 2021-03-11T20:00:00-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-17-000015 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/ct-order/9999999997-17-005432 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/defa14a/0001104659-17-025610 2021-03-11T20:00:00-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/def-14a/0001104659-17-025609 2021-03-11T20:00:00-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/defa14a/0001104659-17-025611 2021-03-11T20:00:00-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001532176-17-000015 2021-03-11T20:00:00-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0001532176-17-000017 2018-07-06T08:54:21-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/ct-order/9999999997-17-006015 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-17-000016 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-17-000017 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-17-000002 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001140361-17-023988 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/s-8/0001104659-17-038718 2021-03-11T20:00:00-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-17-000018 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-17-039157 2021-03-11T20:00:00-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-17-000003 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-17-000005 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-17-000007 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-17-000008 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-17-000009 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-17-000011 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-17-000010 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001532176-17-000025 2021-03-11T20:00:08-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0001532176-17-000027 2018-07-06T08:52:43-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-17-000019 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-17-000013 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-17-000015 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-17-000017 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-17-000019 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001140361-17-033310 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001140361-17-033562 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-17-000021 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-17-000021 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-ka/0001104659-17-056955 2021-03-11T20:00:08-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-17-000023 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-17-000024 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001532176-17-000033 2021-03-11T20:00:08-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0001532176-17-000034 2021-03-11T20:00:08-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/ct-order/9999999997-17-010412 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-17-000026 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-17-000027 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-17-000025 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-17-000031 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-17-000028 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-17-000029 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-17-000030 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-17-000032 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-17-000033 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-17-000034 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-18-000220 2021-03-11T20:00:20-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-18-000002 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-18-000002 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-18-000001 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-18-000001 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-18-000003 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-18-000004 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-18-000004 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-18-000005 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-18-000003 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-18-000006 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-18-001100 2021-03-11T20:00:20-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/ct-order/9999999997-18-000301 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13da/0001140361-18-001480 2021-03-11T20:00:20-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-18-000007 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-18-002858 2021-03-11T20:00:20-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000215457-18-003599 2021-03-11T20:00:20-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/5/0001237899-18-000008 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-18-039843 2021-03-11T20:00:27-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-18-000009 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-18-000011 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-18-000013 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/ct-order/9999999997-18-007040 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001532176-18-000025 2021-03-11T20:00:27-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0001532176-18-000028 2021-03-11T20:00:27-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-18-000015 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-18-000014 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-18-000017 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-18-000019 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001140361-18-038175 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-18-000021 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-18-000022 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-18-000016 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-18-000024 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-18-061697 2021-03-11T20:00:40-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001532176-18-000034 2021-03-11T20:00:40-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0001532176-18-000036 2021-03-11T20:00:40-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/s-3asr/0001104659-18-067924 2021-03-11T20:00:40-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-18-000028 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-18-000029 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-18-000030 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-18-000019 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-18-000020 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-18-000021 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001104659-18-073103 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-18-000022 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-18-000023 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-18-000024 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-18-073328 2021-03-11T20:00:40-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-18-000026 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-19-000001 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-19-000004 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-19-000003 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-19-000002 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-19-000006 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-19-000005 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-19-000004 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-19-000006 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-19-000005 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-19-000977 2021-03-11T20:00:49-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-19-000007 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-19-000008 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001532176-19-000005 2021-03-11T20:00:49-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000215457-19-005675 2021-03-11T20:00:49-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-k/0001532176-19-000009 2021-03-11T20:00:49-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000932471-19-005508 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000315066-19-001261 2021-03-11T20:00:49-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13g/0001422849-19-000108 2021-03-11T20:00:49-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001140361-19-004808 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-19-000008 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000930413-19-001187 2021-03-11T20:00:49-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-19-000011 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/def-14a/0000930413-19-001350 2021-03-11T20:00:49-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/defa14a/0000930413-19-001351 2021-03-11T20:00:49-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/defa14a/0000930413-19-001352 2021-03-11T20:00:49-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000930413-19-001557 2021-03-11T20:00:49-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001532176-19-000015 2021-03-11T20:01:05-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0001532176-19-000017 2021-03-11T20:01:05-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/ct-order/9999999997-19-003999 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-ka/0000930413-19-001590 2019-05-09T10:27:34-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/ct-order/9999999997-19-004163 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/ct-order/9999999997-19-004343 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-19-000012 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-19-000013 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-19-000016 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000930413-19-001896 2021-03-11T20:01:05-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001532176-19-000024 2021-03-11T20:01:05-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0001532176-19-000026 2021-03-11T20:01:05-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001140361-19-016600 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/ct-order/9999999997-19-007250 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001532176-19-000032 2021-03-11T20:01:05-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0001532176-19-000034 2021-03-11T20:01:05-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-19-000018 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-19-000010 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-19-000012 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-19-000020 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-19-000024 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-19-000025 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-19-000027 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13da/0001140361-19-022193 2021-03-11T20:01:05-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-19-000033 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-19-000032 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-19-000030 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-19-000029 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-19-000035 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-19-000031 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-19-000034 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/3/0000930413-19-003027 2021-03-11T20:01:28-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-19-000036 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0000930413-19-003028 2021-03-11T20:01:28-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-19-000037 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-19-000038 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-19-000039 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-19-000014 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-20-000002 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-20-000006 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-20-000002 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-20-000001 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-20-000004 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-20-000003 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-20-000010 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-20-000004 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-20-000008 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000930413-20-000068 2021-03-11T20:01:28-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-20-000005 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-20-000006 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001532176-20-000005 2021-03-11T20:01:41-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000834237-20-006686 2021-03-11T20:01:41-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-k/0001532176-20-000008 2021-03-11T20:01:41-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000315066-20-001144 2021-03-11T20:01:41-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-20-000007 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0001104659-20-018803 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0001422849-20-000101 2021-03-11T20:01:41-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-20-000009 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-20-000010 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-20-000008 2021-07-09T20:00:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-20-000011 2021-03-11T20:01:41-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-20-000012 2021-03-11T20:01:41-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-20-000012 2021-03-11T20:01:41-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-20-000014 2021-03-11T20:01:41-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-20-000013 2021-03-11T20:01:41-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-20-000018 2021-03-11T20:01:41-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-20-000017 2021-03-11T20:01:41-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-20-000014 2021-03-11T20:01:41-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-20-000022 2021-03-11T20:01:41-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-20-000021 2021-03-11T20:01:41-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001140361-20-005506 2021-03-11T20:01:41-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-20-000024 2021-03-11T20:01:41-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-20-000015 2021-03-11T20:01:41-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-20-000026 2021-03-11T20:01:41-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-20-000029 2021-03-11T20:01:41-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-20-000030 2021-03-11T20:01:59-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000930413-20-000983 2021-03-11T20:01:59-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-20-000032 2021-03-11T20:01:59-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-20-000016 2021-03-11T20:01:59-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-20-000034 2021-03-11T20:01:59-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-20-000038 2021-03-11T20:01:59-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-20-000037 2021-03-11T20:01:59-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-20-000042 2021-03-11T20:01:59-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-20-000043 2021-03-11T20:01:59-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-20-000044 2021-03-11T20:01:59-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/def-14a/0000930413-20-001198 2021-03-11T20:01:59-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/defa14a/0000930413-20-001199 2021-03-11T20:01:59-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/defa14a/0000930413-20-001200 2021-03-11T20:01:59-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-20-000046 2021-03-11T20:01:59-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001804220-20-000009 2021-03-11T20:01:59-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0001804220-20-000011 2021-03-11T20:01:59-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-20-000017 2021-03-11T20:01:59-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-20-000018 2021-03-11T20:01:59-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-20-000019 2021-03-11T20:01:59-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-20-000051 2021-03-11T20:01:59-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-20-000050 2021-03-11T20:01:59-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-20-000052 2021-03-11T20:01:59-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-20-000054 2021-03-11T20:01:59-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-20-000058 2021-03-11T20:01:59-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-20-000057 2021-03-11T20:01:59-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-20-000020 2021-03-11T20:02:09-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-20-000061 2021-03-11T20:02:09-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-20-000062 2021-03-11T20:02:09-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/fwp/0001104659-20-065591 2021-03-11T20:02:09-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/fwp/0001104659-20-065593 2021-03-11T20:02:09-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/424b3/0001047469-20-003194 2021-03-11T20:02:09-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/424b3/0001047469-20-003238 2021-03-11T20:02:09-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-20-067752 2021-03-11T20:02:09-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001140361-20-012718 2021-03-11T20:02:09-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13da/0001140361-20-012717 2021-03-11T20:02:09-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-20-000064 2021-03-11T20:02:09-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-20-000021 2021-03-11T20:02:09-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-20-000066 2021-03-11T20:02:09-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-20-000022 2021-03-11T20:02:09-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/defa14a/0001104659-20-070667 2021-03-11T20:02:09-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-20-000023 2021-03-11T20:02:09-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13g/0000315066-20-001593 2021-03-11T20:02:09-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-20-000068 2021-03-11T20:02:09-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001140361-20-013625 2021-03-11T20:02:09-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-20-000072 2021-03-11T20:02:09-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-20-000071 2021-03-11T20:02:09-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/s-8/0001104659-20-073764 2021-03-11T20:02:09-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-20-073794 2021-03-11T20:02:09-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-20-000074 2021-03-11T20:02:09-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13da/0001140361-20-014084 2021-03-11T20:02:09-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-20-000025 2021-03-11T20:02:22-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-20-000076 2021-03-11T20:02:22-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-20-000027 2021-03-11T20:02:22-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-20-000078 2021-03-11T20:02:22-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-20-000082 2021-03-11T20:02:22-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-20-000081 2021-03-11T20:02:22-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-20-081559 2021-03-11T20:02:22-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-20-000029 2021-03-11T20:02:22-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-20-000028 2021-03-11T20:02:22-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-20-000084 2021-03-11T20:02:22-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-20-000030 2021-03-11T20:02:22-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-20-000031 2021-03-11T20:02:22-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/ct-order/9999999997-20-004105 2021-03-11T20:02:22-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-20-000087 2021-03-11T20:02:22-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-20-000088 2021-03-11T20:02:22-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-20-000034 2021-03-11T20:02:22-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-20-000035 2021-03-11T20:02:22-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001804220-20-000020 2021-03-11T20:02:22-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0001804220-20-000022 2021-03-11T20:02:22-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-20-000091 2021-03-11T20:02:22-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-20-000092 2021-03-11T20:02:22-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/424b3/0001047469-20-004435 2021-03-11T20:02:22-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/fwp/0001104659-20-092011 2021-03-11T20:02:22-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/424b5/0001047469-20-004486 2021-03-11T20:02:22-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-20-093924 2021-03-11T20:02:22-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-20-000094 2021-03-11T20:02:38-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-20-096661 2021-03-11T20:02:38-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001104659-20-098009 2021-03-11T20:02:38-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-20-000036 2021-03-11T20:02:38-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-20-000098 2021-03-11T20:02:38-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-20-000097 2021-03-11T20:02:38-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-20-000101 2021-03-11T20:02:38-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-20-000102 2021-03-11T20:02:38-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-20-000037 2021-03-11T20:02:38-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-20-000038 2021-03-11T20:02:38-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-20-000039 2021-03-11T20:02:38-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-20-000040 2021-03-11T20:02:38-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-20-000106 2021-03-11T20:02:38-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-20-000105 2021-03-11T20:02:38-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-20-000041 2021-03-11T20:02:38-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-20-000042 2021-03-11T20:02:38-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-20-000043 2021-03-11T20:02:38-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-20-000044 2021-03-11T20:02:38-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-20-000046 2021-03-11T20:02:38-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001804220-20-000028 2021-03-11T20:02:38-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0001804220-20-000030 2021-03-11T20:02:38-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-20-000048 2021-03-11T20:02:38-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-20-000108 2021-03-11T20:02:38-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-20-000049 2021-03-11T20:02:38-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-20-000113 2021-03-11T20:02:38-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-20-000115 2021-03-11T20:02:50-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-20-000051 2021-03-11T20:02:50-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-20-000050 2021-03-11T20:02:50-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-20-000052 2021-03-11T20:02:50-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-20-000114 2021-03-11T20:02:50-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-20-000053 2021-03-11T20:02:50-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-20-000116 2021-03-11T20:02:50-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-20-000118 2021-03-11T20:02:50-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-21-000538 2021-03-11T20:02:50-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001104659-21-000904 2021-03-11T20:02:50-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001104659-21-000901 2021-03-11T20:02:50-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-21-000001 2021-03-11T20:02:50-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-21-000006 2021-03-11T20:02:50-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-21-000007 2021-03-11T20:02:50-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-21-000002 2021-03-11T20:02:50-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-21-000009 2021-03-11T20:02:50-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-21-000008 2021-03-11T20:02:50-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-21-000010 2021-03-11T20:02:50-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-21-000003 2021-03-11T20:02:50-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-21-000004 2021-03-11T20:02:50-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-21-002614 2021-03-11T20:02:50-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-21-004699 2021-03-11T20:02:50-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-21-000012 2021-03-11T20:02:50-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000834237-21-005506 2021-03-11T20:02:50-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-21-000014 2021-03-11T20:02:50-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/upload/0000000000-21-000006 2021-03-11T20:03:04-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001804220-21-000006 2021-03-11T20:03:04-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-k/0001804220-21-000008 2021-03-11T20:03:04-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000315066-21-001204 2021-03-11T20:03:04-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0001104659-21-018970 2021-03-11T20:03:04-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/3/0001104659-21-020783 2021-03-11T20:03:04-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0001422849-21-000062 2021-03-11T20:03:04-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001104659-21-025193 2021-03-11T20:03:04-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-21-000016 2021-03-11T20:03:04-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/def-14a/0000930413-21-000869 2021-04-23T16:14:41-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/defa14a/0000930413-21-000870 2021-04-23T16:19:48-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/defa14a/0000930413-21-000871 2021-04-23T16:24:23-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/defa14a/0000930413-21-001020 2021-05-03T16:44:14-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001804220-21-000015 2021-05-06T07:14:15-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0001804220-21-000017 2021-05-06T07:24:53-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-21-000018 2021-05-10T16:09:07-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-21-000020 2021-05-18T16:06:15-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-21-000008 2021-06-08T16:05:50-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-21-000007 2021-06-08T16:06:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-21-000023 2021-06-16T16:04:59-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-21-000024 2021-06-16T16:05:55-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-21-082035 2021-06-16T16:38:45-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-21-000026 2021-06-23T16:06:34-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-21-000028 2021-06-28T16:04:01-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-21-000034 2021-07-02T16:05:33-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-21-000033 2021-07-02T16:05:38-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-21-000032 2021-07-02T16:05:58-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-21-000036 2021-07-07T16:03:49-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-21-000039 2021-08-04T16:06:13-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-21-000040 2021-08-04T16:12:05-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001804220-21-000023 2021-08-05T07:01:38-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0001804220-21-000025 2021-08-05T07:14:03-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-21-000043 2021-08-06T16:05:31-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-21-000044 2021-08-06T16:06:11-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-21-000011 2021-08-10T17:03:40-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-21-000012 2021-08-10T17:04:16-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-21-000048 2021-08-10T17:09:06-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-21-000049 2021-08-10T17:56:53-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-21-000050 2021-08-10T17:58:04-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-21-000014 2021-08-13T17:22:47-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/corresp/0001804220-20-000032 2021-08-15T22:35:21-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/upload/0000000000-20-011132 2021-08-15T22:37:57-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-21-000052 2021-08-16T16:11:11-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-21-000055 2021-08-17T16:16:42-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-21-000056 2021-08-17T16:19:19-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-21-000016 2021-08-17T16:24:20-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-21-000058 2021-08-17T16:46:40-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-21-000061 2021-08-19T16:07:21-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-21-000062 2021-08-19T16:08:06-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-21-000064 2021-08-20T16:04:24-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-21-000018 2021-08-24T16:08:11-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-21-000017 2021-08-24T16:08:13-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4a/0001104659-21-109328 2021-08-25T16:10:34-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-21-000066 2021-08-27T16:15:54-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-21-000020 2021-08-30T16:27:44-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-21-000068 2021-08-31T16:05:53-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-21-000070 2021-09-01T16:08:10-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-21-000073 2021-09-03T16:04:24-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-21-000074 2021-09-03T16:06:23-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-21-000076 2021-09-13T16:02:54-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-21-000080 2021-09-15T16:04:04-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-21-000081 2021-09-15T16:04:39-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-21-000082 2021-09-15T16:05:51-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-21-116352 2021-09-16T16:04:36-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-21-000022 2021-09-17T16:03:14-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/corresp/0001532176-16-000069 2021-10-02T09:59:20-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/upload/0000000000-07-024397 2021-10-02T10:20:17-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/upload/0000000000-16-074618 2021-10-02T11:45:15-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/corresp/0001532176-16-000049 2021-10-02T12:03:54-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/corresp/0001206774-09-001581 2021-10-02T13:00:28-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/corresp/0001532176-16-000071 2021-10-02T13:13:12-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/upload/0000000000-15-017174 2021-10-02T13:35:46-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/corresp/0001532176-16-000058 2021-10-02T14:40:14-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/corresp/0001532176-16-000060 2021-10-02T14:43:44-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/corresp/0001206774-09-001434 2021-10-02T15:16:01-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/upload/0000000000-15-018741 2021-10-02T15:54:52-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/upload/0000000000-09-046659 2021-10-02T16:08:53-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/upload/0000000000-13-038074 2021-10-02T16:50:02-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/corresp/0001341004-07-001671 2021-10-02T16:52:17-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/upload/0000000000-16-086409 2021-10-02T17:00:27-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/upload/0000000000-16-081753 2021-10-02T17:07:15-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/upload/0000000000-09-043226 2021-10-02T17:57:08-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/corresp/0001532176-14-000028 2021-10-02T18:33:03-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/corresp/0001341004-07-001713 2021-10-02T18:50:59-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/corresp/0001532176-15-000010 2021-10-02T19:05:39-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/corresp/0001532176-16-000073 2021-10-02T19:08:27-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/upload/0000000000-14-019576 2021-10-02T19:55:17-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/corresp/0001532176-13-000011 2021-10-02T20:10:02-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/upload/0000000000-16-095045 2021-10-02T20:33:35-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/corresp/0001532176-14-000024 2021-10-02T20:45:09-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/upload/0000000000-16-097532 2021-10-02T22:22:23-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/corresp/0001532176-14-000013 2021-10-02T23:53:54-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/upload/0000000000-09-037555 2021-10-03T00:57:22-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/upload/0000000000-07-035627 2021-10-03T01:01:39-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/upload/0000000000-13-046941 2021-10-03T01:13:53-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/upload/0000000000-14-036733 2021-10-03T01:39:46-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-21-000003 2021-10-04T16:10:29-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-21-000004 2021-10-04T16:11:51-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-21-000007 2021-11-03T16:13:29-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-21-000006 2021-11-03T16:13:54-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001804220-21-000031 2021-11-04T07:15:21-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0001804220-21-000033 2021-11-04T07:23:22-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/s-3asr/0001104659-21-134393 2021-11-04T16:23:19-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-21-000085 2021-11-17T16:04:28-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-21-000086 2021-11-17T16:07:09-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-21-000024 2021-11-18T16:11:59-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-21-000088 2021-11-18T16:24:36-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-21-000009 2021-11-19T17:52:36-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-21-000012 2021-11-23T16:31:15-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-21-000014 2021-12-02T16:08:58-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-21-000016 2021-12-02T16:09:26-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-21-000018 2021-12-06T16:12:38-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-21-000022 2021-12-10T17:31:08-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-21-000023 2021-12-10T17:32:51-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-21-000024 2021-12-10T17:32:51-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-21-000093 2021-12-10T17:36:46-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-21-000094 2021-12-10T17:38:24-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-21-000095 2021-12-10T17:39:32-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-21-000096 2021-12-10T17:39:32-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001237899-21-000027 2021-12-10T17:44:19-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-21-000098 2021-12-10T18:43:41-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-21-000029 2021-12-14T16:05:57-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-21-000028 2021-12-14T16:05:59-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-21-000030 2021-12-14T16:07:20-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-21-000103 2021-12-14T16:08:47-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-21-000104 2021-12-14T16:09:27-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-21-000105 2021-12-14T16:11:37-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-21-000106 2021-12-14T16:12:13-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-21-000032 2021-12-20T16:14:50-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-21-000034 2021-12-23T16:32:10-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-22-000005 2022-01-05T16:21:08-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-22-000006 2022-01-05T16:22:20-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-22-000007 2022-01-05T16:22:32-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-22-000008 2022-01-05T16:23:55-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000006 2022-01-05T16:24:09-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000008 2022-01-05T16:24:56-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000007 2022-01-05T16:24:57-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000009 2022-01-05T16:25:36-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000010 2022-01-05T16:26:46-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000012 2022-01-05T16:46:51-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-22-002403 2022-01-10T06:06:14-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000834237-22-004576 2022-02-01T17:14:34-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-22-000010 2022-02-02T16:15:48-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-22-000012 2022-02-02T16:18:37-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001804220-22-000004 2022-02-04T07:32:38-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-k/0001804220-22-000007 2022-02-07T09:30:09-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000315066-22-001353 2022-02-09T10:28:33-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0001104659-22-018438 2022-02-10T08:48:36-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0001422849-22-000078 2022-02-11T14:54:37-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0001104659-22-020472 2022-02-11T16:10:39-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0001104659-22-020475 2022-02-11T16:12:46-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13g/0001104659-22-020463 2022-02-11T16:17:09-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-22-000014 2022-02-16T16:19:16-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-22-000017 2022-02-24T16:10:58-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-22-000018 2022-02-24T16:25:56-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000014 2022-03-01T16:20:14-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000016 2022-03-03T16:11:13-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000018 2022-03-03T16:24:43-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-22-031232 2022-03-08T06:18:27-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000020 2022-03-15T16:04:33-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-22-000020 2022-03-18T16:08:09-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-22-000022 2022-03-18T16:10:38-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-22-000024 2022-03-18T16:15:54-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-22-000027 2022-03-23T16:02:43-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-22-000028 2022-03-23T16:05:08-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000022 2022-03-30T16:44:23-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-22-000030 2022-03-31T16:12:23-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000028 2022-04-01T16:09:39-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000030 2022-04-01T16:10:15-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000029 2022-04-01T16:10:19-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000032 2022-04-01T16:11:48-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000031 2022-04-01T16:12:30-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000035 2022-04-04T16:04:35-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000036 2022-04-04T16:05:13-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-22-000033 2022-04-04T16:05:18-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-22-000034 2022-04-04T16:06:34-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000038 2022-04-07T16:05:56-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-22-000038 2022-04-11T16:40:19-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-22-000039 2022-04-11T16:42:06-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-22-000040 2022-04-11T16:42:47-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000040 2022-04-11T18:03:03-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-c/0001104659-22-047376 2022-04-19T16:52:31-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/def-14a/0000930413-22-000787 2022-04-21T16:13:40-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/defa14a/0000930413-22-000789 2022-04-21T16:17:12-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/defa14a/0000930413-22-000790 2022-04-21T16:24:01-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-t/0001104659-22-054147 2022-05-02T07:50:27-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000043 2022-05-03T17:11:09-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000044 2022-05-03T17:11:41-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001804220-22-000013 2022-05-04T07:10:56-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0001804220-22-000015 2022-05-04T07:20:29-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-ta/0001104659-22-058856 2022-05-11T17:04:32-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000046 2022-05-18T16:07:41-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-ta/0001104659-22-063410 2022-05-20T16:39:31-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-ta/0001104659-22-066277 2022-05-31T09:04:31-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-22-067375 2022-06-02T07:39:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001708138-22-000042 2022-06-03T16:03:33-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-22-071446 2022-06-15T16:13:08-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000048 2022-07-05T16:05:31-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000050 2022-08-02T16:31:10-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001804220-22-000020 2022-08-03T07:11:19-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0001804220-22-000023 2022-08-03T07:25:16-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000053 2022-08-08T16:15:26-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000054 2022-08-08T16:15:30-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000056 2022-08-11T16:15:25-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000058 2022-08-17T16:08:02-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000060 2022-09-02T16:09:53-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000064 2022-09-08T16:10:40-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000063 2022-09-08T16:11:17-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000068 2022-09-12T16:39:06-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000067 2022-09-12T16:39:24-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000070 2022-09-13T16:07:35-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-22-104901 2022-10-03T07:20:02-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000072 2022-10-03T16:08:47-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/3/0001104659-22-106300 2022-10-05T16:07:32-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000076 2022-10-05T16:13:59-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000077 2022-10-05T16:14:07-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000078 2022-10-05T16:14:50-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001104659-22-106311 2022-10-05T16:15:48-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000080 2022-10-07T16:06:32-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000315066-22-001787 2022-10-11T09:06:19-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000082 2022-10-18T16:10:16-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000085 2022-11-02T16:06:14-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000086 2022-11-02T16:08:07-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001804220-22-000029 2022-11-03T07:22:15-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0001804220-22-000031 2022-11-03T07:28:38-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000088 2022-11-03T16:09:36-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000090 2022-11-07T16:09:21-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000092 2022-11-08T16:04:01-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000094 2022-11-10T16:03:44-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000096 2022-11-16T16:04:01-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000098 2022-11-25T13:10:04-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000102 2022-12-02T16:10:46-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000104 2022-12-02T16:10:46-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000103 2022-12-02T16:10:48-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/upload/0000000000-22-012109 2022-12-08T00:10:27-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/corresp/0001104659-22-107078 2022-12-08T00:10:28-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/upload/0000000000-22-010371 2022-12-12T05:12:50-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000107 2022-12-12T16:37:21-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000108 2022-12-12T16:37:26-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000117 2022-12-13T16:13:37-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000120 2022-12-13T16:13:37-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000119 2022-12-13T16:13:42-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000118 2022-12-13T16:13:43-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000121 2022-12-13T16:16:15-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000122 2022-12-13T16:16:15-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000123 2022-12-13T16:16:16-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-22-128613 2022-12-20T16:04:18-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000132 2022-12-20T16:08:32-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000131 2022-12-20T16:08:54-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000135 2022-12-20T16:11:08-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000136 2022-12-20T16:11:09-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000134 2022-12-20T16:11:16-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000133 2022-12-20T16:11:21-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000137 2022-12-20T16:12:57-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000139 2022-12-20T17:48:11-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000141 2022-12-21T17:50:08-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-22-000143 2022-12-30T16:14:03-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-23-000014 2023-01-05T16:18:13-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-23-000012 2023-01-05T16:18:18-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-23-000013 2023-01-05T16:18:31-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-23-000011 2023-01-05T16:18:36-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-23-000015 2023-01-05T16:20:52-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-23-000017 2023-01-05T16:23:02-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-23-000016 2023-01-05T16:23:09-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-23-000018 2023-01-05T16:24:28-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-23-000020 2023-01-05T16:26:12-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-23-000021 2023-01-05T16:26:16-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-23-000019 2023-01-05T16:26:17-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-23-000023 2023-01-05T16:39:26-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-23-002091 2023-01-09T08:51:46-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-23-000025 2023-01-10T16:06:56-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13g/0000019617-23-000061 2023-01-11T12:11:29-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-23-000027 2023-01-30T16:15:11-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001804220-23-000005 2023-02-03T07:10:25-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-23-000029 2023-02-03T16:16:00-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-23-000031 2023-02-03T16:18:09-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0001306550-23-007818 2023-02-03T16:35:34-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-k/0001804220-23-000008 2023-02-06T09:29:19-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-23-000035 2023-02-07T16:12:33-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-23-000036 2023-02-07T16:13:57-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-23-000037 2023-02-07T16:14:09-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-23-000044 2023-02-08T16:18:02-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-23-000043 2023-02-08T16:18:42-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-23-000045 2023-02-08T16:18:54-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-23-000046 2023-02-08T16:18:54-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0001104659-23-016829 2023-02-09T11:44:56-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000315066-23-002022 2023-02-09T12:36:53-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0001422849-23-000075 2023-02-13T14:51:18-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-23-000048 2023-02-14T16:34:11-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-23-000050 2023-02-24T16:12:46-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-23-000054 2023-03-03T16:06:59-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-23-000053 2023-03-03T16:08:08-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-23-000002 2023-03-14T16:12:21-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-23-000060 2023-03-27T16:41:27-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-23-000061 2023-03-27T16:42:15-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-23-000063 2023-03-27T16:44:59-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-23-000062 2023-03-27T16:45:38-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-23-000064 2023-03-27T16:45:51-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-23-038299 2023-03-29T16:06:34-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-23-000004 2023-03-29T16:13:05-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-23-000006 2023-04-05T16:05:11-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-23-000005 2023-04-05T16:05:11-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-23-000007 2023-04-05T16:05:15-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-23-043287 2023-04-10T07:04:35-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-23-045897 2023-04-17T07:39:41-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/defa14a/0001308179-23-000729 2023-04-21T16:08:24-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/def-14a/0001308179-23-000728 2023-04-21T16:09:29-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/ars/0001104659-23-048387 2023-04-21T16:11:55-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001950047-23-000205 2023-04-21T16:28:05-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-23-000009 2023-04-24T16:08:57-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-23-000011 2023-05-03T16:04:28-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001804220-23-000015 2023-05-04T07:13:37-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0001804220-23-000016 2023-05-17T09:37:36-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-23-000013 2023-05-10T16:12:46-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/defa14a/0001104659-23-061817 2023-05-17T16:08:40-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-23-000069 2023-05-17T16:13:04-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/px14a6g/0001214659-23-007448 2023-05-18T16:51:41-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001950047-23-001129 2023-06-01T16:24:29-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-23-000072 2023-06-02T16:15:05-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-23-000073 2023-06-02T16:18:46-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-23-071187 2023-06-14T16:09:05-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001968582-23-000294 2023-07-03T12:10:23-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001950047-23-002090 2023-07-03T14:17:56-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-23-000016 2023-07-06T16:05:46-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-23-000017 2023-07-06T16:05:53-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001950047-23-002671 2023-08-01T16:19:05-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001804220-23-000021 2023-08-03T06:50:49-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0001804220-23-000023 2024-02-08T12:24:17-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-23-000019 2023-08-03T16:06:27-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-23-000075 2023-08-03T16:28:15-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-c/0001104659-23-089313 2023-08-09T16:17:06-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001000275-23-000036 2023-08-10T14:04:05-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-23-000077 2023-08-11T16:15:54-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13d/0001104659-23-093555 2023-08-18T17:18:56-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001000275-23-000037 2023-08-21T12:36:03-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001969223-23-000315 2023-08-22T15:58:10-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-23-000022 2023-08-23T16:06:54-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-23-000023 2023-08-23T16:06:54-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001958244-23-001731 2023-08-23T16:59:51-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001969223-23-000321 2023-08-23T17:08:20-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001958244-23-001732 2023-08-24T16:28:58-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-t/0001104659-23-095116 2023-08-25T08:00:43-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-23-000030 2023-08-25T16:04:18-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-23-000028 2023-08-25T16:04:26-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-23-000029 2023-08-25T16:04:29-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-23-000031 2023-08-25T16:06:37-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001950047-23-003620 2023-09-01T16:15:15-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-23-000033 2023-09-06T16:07:38-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-ta/0001104659-23-099290 2023-09-08T16:09:20-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-23-099345 2023-09-08T16:54:14-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-ka/0001104659-23-099351 2023-09-08T17:08:14-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/3/0001104659-23-099983 2023-09-12T16:05:09-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/3/0001104659-23-099984 2023-09-12T16:05:10-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001104659-23-099988 2023-09-12T16:06:42-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001104659-23-099992 2023-09-12T16:07:37-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-ta/0001104659-23-100041 2023-09-12T16:39:23-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-ta/0001104659-23-103362 2023-09-25T08:55:47-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13da/0001104659-23-104277 2023-09-27T16:06:59-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001950047-23-004359 2023-10-02T16:19:53-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001969223-23-000395 2023-10-03T15:51:10-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-23-000035 2023-10-03T16:07:38-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-23-107161 2023-10-05T16:08:59-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001973141-23-000242 2023-10-13T16:06:35-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-23-000037 2023-10-17T16:08:42-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001950047-23-004676 2023-11-01T16:50:06-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001804220-23-000029 2023-11-02T07:12:21-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0001804220-23-000031 2024-02-08T11:49:10-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-23-000079 2023-11-02T16:09:08-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001968582-23-000623 2023-11-07T16:47:16-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-23-000039 2023-11-08T16:12:43-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001973141-23-000294 2023-11-14T16:26:41-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-23-000040 2023-11-14T17:26:56-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-23-000042 2023-11-15T16:05:45-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-23-000044 2023-12-04T16:04:31-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001973141-23-000328 2023-12-05T16:04:25-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-23-000046 2023-12-06T16:05:39-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001950047-23-005844 2023-12-11T16:14:48-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-23-000050 2023-12-12T16:04:16-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-23-000052 2023-12-12T16:04:16-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-23-000051 2023-12-12T16:06:13-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-23-000090 2023-12-12T16:07:54-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-23-000091 2023-12-12T16:07:58-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-23-000088 2023-12-12T16:08:37-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-23-000089 2023-12-12T16:09:30-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001000275-23-000068 2023-12-13T11:45:03-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-23-000094 2023-12-13T16:08:19-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-23-000095 2023-12-13T16:08:19-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-23-000101 2023-12-14T16:11:04-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-23-000100 2023-12-14T16:11:05-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-23-000099 2023-12-14T16:11:05-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-23-000055 2023-12-14T16:14:03-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-23-000056 2023-12-14T16:14:04-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001973141-23-000365 2023-12-21T16:24:20-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-23-000103 2023-12-26T16:11:26-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001950047-23-006490 2023-12-27T16:24:24-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-23-000107 2023-12-29T16:08:46-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-23-000108 2023-12-29T16:08:50-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-23-000109 2023-12-29T16:09:36-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001973141-24-000007 2024-01-02T16:08:57-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001973141-24-000011 2024-01-02T16:12:55-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001950047-24-000019 2024-01-02T16:30:16-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001000275-24-000001 2024-01-03T11:36:33-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000023 2024-01-04T16:08:54-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000022 2024-01-04T16:08:55-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000024 2024-01-04T16:10:41-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000025 2024-01-04T16:12:14-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000027 2024-01-04T16:13:40-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000029 2024-01-04T16:13:40-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000026 2024-01-04T16:13:47-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000028 2024-01-04T16:13:52-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-24-000001 2024-01-04T16:18:25-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-24-000003 2024-01-04T16:19:29-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-24-000002 2024-01-04T16:19:30-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-24-000005 2024-01-04T16:20:58-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-24-000004 2024-01-04T16:21:05-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-24-000007 2024-01-04T16:24:00-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-24-000006 2024-01-04T16:24:01-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-24-000008 2024-01-04T16:25:28-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-24-002037 2024-01-08T06:41:31-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000031 2024-01-08T16:04:01-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000034 2024-01-17T16:06:56-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000036 2024-01-18T16:07:58-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001950047-24-000420 2024-01-23T16:18:59-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000019617-24-000154 2024-01-25T11:12:48-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000019617-24-000143 2024-01-25T11:12:48-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000042 2024-01-25T16:23:13-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000040 2024-01-25T16:24:47-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000041 2024-01-25T16:25:32-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0001086364-24-003704 2024-01-25T17:03:18-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001000275-24-000005 2024-01-30T17:08:03-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-24-008807 2024-01-31T16:20:44-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-24-000010 2024-01-31T16:56:55-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001950047-24-000554 2024-02-01T16:11:41-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001968582-24-000073 2024-02-01T16:48:09-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001804220-24-000006 2024-02-02T07:17:51-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000045 2024-02-02T16:05:13-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000046 2024-02-02T16:05:25-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-k/0001804220-24-000009 2024-02-05T09:19:19-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000048 2024-02-05T16:07:36-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001972362-24-000074 2024-02-05T17:07:52-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000053 2024-02-06T16:11:54-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000052 2024-02-06T16:11:54-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000054 2024-02-06T16:11:54-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001969223-24-000045 2024-02-07T16:38:28-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001969223-24-000047 2024-02-07T17:08:19-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001969223-24-000050 2024-02-07T18:03:51-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/3/0001104659-24-012275 2024-02-08T16:08:33-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000056 2024-02-08T16:10:34-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001950047-24-000766 2024-02-08T16:27:07-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001973141-24-000090 2024-02-08T16:57:56-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0000315066-24-001496 2024-02-09T09:52:10-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001969223-24-000075 2024-02-09T12:24:36-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001950047-24-000780 2024-02-09T16:05:58-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000058 2024-02-09T16:17:05-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0001422848-24-000245 2024-02-09T18:22:04-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000062 2024-02-12T16:05:49-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000061 2024-02-12T16:08:09-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000064 2024-02-13T16:08:41-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/sc-13ga/0001104659-24-021814 2024-02-13T17:21:28-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001958244-24-000537 2024-02-14T17:09:12-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000066 2024-02-16T16:18:57-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000068 2024-02-20T16:05:50-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001950047-24-001267 2024-02-22T16:07:24-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001969223-24-000135 2024-02-22T17:17:27-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001950047-24-001328 2024-02-23T16:07:05-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001000275-24-000007 2024-02-26T15:26:43-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001950047-24-001381 2024-02-26T16:11:16-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000072 2024-02-26T16:11:16-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000073 2024-02-26T16:11:16-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000074 2024-02-26T16:13:54-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001969223-24-000151 2024-02-26T16:35:58-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000079 2024-02-28T16:09:11-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000078 2024-02-28T16:09:12-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000080 2024-02-28T16:09:12-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001950047-24-001629 2024-03-01T16:17:57-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000084 2024-03-05T16:05:45-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000083 2024-03-05T16:06:29-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001973141-24-000178 2024-03-14T16:32:29-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000086 2024-03-15T16:07:29-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001950047-24-002789 2024-04-01T16:36:26-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000090 2024-04-03T16:08:24-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000089 2024-04-03T16:08:31-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/defa14a/0001308179-24-000578 2024-04-25T16:07:46-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/def-14a/0001308179-24-000577 2024-04-25T16:10:09-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/ars/0001104659-24-051965 2024-04-25T16:12:33-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-24-000012 2024-05-01T16:06:27-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-24-000013 2024-05-01T16:06:32-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001950047-24-003300 2024-05-01T17:04:56-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001968582-24-000345 2024-05-01T17:34:35-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001804220-24-000015 2024-05-02T07:08:54-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0001804220-24-000017 2024-05-02T07:24:52-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-24-000018 2024-05-03T16:07:07-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-24-000017 2024-05-03T16:07:50-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-24-000020 2024-05-06T16:23:21-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001973141-24-000254 2024-05-14T16:24:27-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001973141-24-000258 2024-05-15T16:25:21-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-24-000022 2024-05-15T18:15:35-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000094 2024-05-17T16:09:10-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000093 2024-05-17T16:09:11-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-24-000025 2024-05-17T18:00:07-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001973141-24-000264 2024-05-21T16:15:57-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000096 2024-05-22T16:06:18-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001950047-24-004179 2024-05-28T16:34:28-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001104659-24-066045 2024-05-29T16:03:56-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001950047-24-004314 2024-06-03T16:37:47-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001000275-24-000043 2024-06-05T14:25:56-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000099 2024-06-05T16:08:39-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000100 2024-06-05T16:08:45-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001973141-24-000300 2024-06-06T16:13:34-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-24-000027 2024-06-07T16:09:18-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-24-000029 2024-06-10T16:05:32-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-24-000032 2024-06-12T16:12:42-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-24-000033 2024-06-12T16:14:40-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001973141-24-000310 2024-06-12T17:06:18-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001104659-24-071247 2024-06-13T16:05:18-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001950047-24-004775 2024-06-14T16:32:03-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000102 2024-06-17T16:04:24-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-24-073372 2024-06-20T16:03:19-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001000275-24-000047 2024-06-24T14:49:58-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-24-000037 2024-06-25T16:44:10-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-24-000036 2024-06-25T16:44:10-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001950047-24-005174 2024-07-01T17:28:18-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000106 2024-07-02T16:05:48-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000105 2024-07-02T16:05:48-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-24-078172 2024-07-08T07:03:17-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000107 2024-07-12T16:03:43-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001804220-24-000026 2024-08-01T07:10:52-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0001804220-24-000028 2024-08-01T07:21:56-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001968582-24-000646 2024-08-01T16:07:37-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001950047-24-005730 2024-08-01T16:19:35-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001000275-24-000055 2024-08-02T10:47:21-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000111 2024-08-05T16:03:56-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000110 2024-08-05T16:04:03-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-24-000041 2024-08-05T16:07:57-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-24-000040 2024-08-05T16:08:06-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000113 2024-08-06T16:09:06-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001969223-24-000573 2024-08-07T16:38:04-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-24-000043 2024-08-07T16:47:50-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001969223-24-000580 2024-08-08T16:54:44-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000115 2024-08-12T16:07:19-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000117 2024-08-14T16:09:45-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001973141-24-000411 2024-08-14T16:11:52-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001000275-24-000058 2024-08-15T11:47:45-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000119 2024-08-15T16:03:28-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001958244-24-003929 2024-08-15T17:57:04-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000122 2024-08-19T16:03:19-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000123 2024-08-19T16:04:29-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001969223-24-000655 2024-08-28T16:36:49-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-24-000045 2024-08-29T16:29:59-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001950047-24-006679 2024-09-03T16:05:05-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000124 2024-09-05T16:04:54-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000125 2024-09-05T16:05:02-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000126 2024-09-05T16:05:24-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001950047-24-007484 2024-10-01T16:14:17-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000129 2024-10-03T16:08:22-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000130 2024-10-03T16:08:31-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-24-106432 2024-10-07T07:02:51-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/corresp/0001804220-24-000020 2024-10-10T00:08:06-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/upload/0000000000-24-005254 2024-10-10T00:08:06-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/corresp/0001804220-24-000031 2024-10-10T00:08:15-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/upload/0000000000-24-008276 2024-10-10T00:09:31-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/upload/0000000000-24-010260 2024-10-10T00:09:31-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001804220-24-000038 2024-10-31T07:12:32-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0001804220-24-000040 2024-10-31T07:28:44-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/s-3asr/0001104659-24-113087 2024-10-31T16:36:09-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001950047-24-007992 2024-11-01T16:39:14-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000132 2024-11-05T16:27:37-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000134 2024-11-12T16:10:27-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000138 2024-12-10T16:05:51-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000137 2024-12-10T16:05:52-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-24-000049 2024-12-10T16:05:52-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-24-000050 2024-12-10T16:05:52-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000136 2024-12-10T16:05:52-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000135 2024-12-10T16:06:00-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-24-000051 2024-12-10T16:06:17-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-24-000061 2024-12-18T16:04:19-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000141 2024-12-18T16:07:07-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-24-000063 2024-12-18T16:07:07-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001883850-24-000062 2024-12-18T16:07:22-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000142 2024-12-18T16:08:38-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000140 2024-12-18T16:08:39-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-24-000139 2024-12-18T16:08:39-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-25-000001 2025-01-03T16:07:57-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-25-000002 2025-01-06T16:08:06-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-25-000003 2025-01-06T16:08:37-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-25-000004 2025-01-06T16:08:56-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-25-000006 2025-01-06T16:10:18-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-25-000005 2025-01-06T16:10:47-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-25-000007 2025-01-06T16:11:26-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-25-000011 2025-01-06T16:18:45-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-25-000010 2025-01-06T16:18:45-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-25-000009 2025-01-06T16:18:45-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001968202-25-000012 2025-01-06T17:45:19-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-25-002826 2025-01-13T07:29:14-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001804220-25-000007 2025-02-04T07:12:43-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-k/0001804220-25-000011 2025-02-05T09:24:26-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/13f-hr/0001104659-25-010583 2025-02-07T16:37:17-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/0000315066-25-000878 2025-02-12T09:33:01-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/pre-14a/0001308179-25-000406 2025-04-07T16:19:05-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/schedule-13ga/0000019617-25-000384 2025-04-22T12:02:41-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/defa14a/0001308179-25-000519 2025-04-29T06:07:56-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/def-14a/0001308179-25-000518 2025-04-29T06:11:16-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/ars/0001104659-25-040524 2025-04-29T06:14:35-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001804220-25-000020 2025-04-29T06:41:59-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0001804220-25-000022 2025-04-29T07:06:00-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/13f-hr/0001104659-25-044118 2025-05-02T16:16:14-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/schedule-13ga/0000019617-25-000496 2025-06-05T11:16:05-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-25-060637 2025-06-18T16:14:05-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/upload/0000000000-25-003068 2025-07-04T00:09:22-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/corresp/0001804220-25-000014 2025-07-04T00:09:22-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/upload/0000000000-25-004066 2025-07-04T00:09:48-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000872589-25-000017 2025-08-01T06:51:57-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0000872589-25-000019 2025-08-01T07:01:37-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/13f-hr/0001104659-25-073115 2025-08-01T16:10:18-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/schedule-13ga/0000315066-25-002076 2025-08-06T12:13:11-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-25-096921 2025-10-06T07:04:50-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000872589-25-000026 2025-10-28T06:53:14-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0000872589-25-000028 2025-10-28T07:02:33-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001958244-25-004419 2025-10-29T16:37:52-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001796226-25-000005 2025-10-31T18:50:07-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001189014-25-000005 2025-10-31T18:50:42-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/13f-hr/0001104659-25-108546 2025-11-07T16:57:31-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001969223-25-000926 2025-11-07T17:07:55-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0002009236-25-000006 2025-11-10T16:40:06-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001000275-25-000166 2025-11-20T14:33:32-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001683607-25-000006 2025-11-24T16:07:44-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001238303-25-000005 2025-11-24T16:09:49-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001697422-25-000004 2025-12-09T16:09:28-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001238303-25-000007 2025-12-09T16:11:50-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001663758-25-000007 2025-12-09T16:13:52-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001796226-25-000007 2025-12-09T16:19:13-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001411984-25-000005 2025-12-09T16:33:54-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0002009236-25-000008 2025-12-09T17:42:07-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001218629-25-000006 2025-12-11T16:25:28-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001226690-25-000005 2025-12-11T16:30:08-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001663758-25-000009 2025-12-11T16:33:12-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001796226-25-000009 2025-12-11T16:34:22-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001411984-25-000007 2025-12-11T16:37:23-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001225471-25-000006 2025-12-31T17:12:14-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001226690-26-000002 2026-01-05T17:57:52-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001218629-26-000002 2026-01-05T17:59:39-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001189014-26-000003 2026-01-06T16:09:51-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001683607-26-000004 2026-01-06T16:10:47-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001174475-26-000002 2026-01-06T16:13:59-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001187443-26-000002 2026-01-06T16:15:15-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001197018-26-000002 2026-01-06T16:16:20-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001225474-26-000002 2026-01-06T16:16:30-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001578200-26-000002 2026-01-06T16:17:08-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001225471-26-000002 2026-01-06T16:17:18-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001992352-26-000003 2026-01-06T16:17:18-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001423419-26-000001 2026-01-06T16:20:49-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001681643-26-000002 2026-01-06T16:27:33-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001000275-26-000001 2026-01-07T12:04:39-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001683607-26-000008 2026-01-08T16:05:24-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-26-002691 2026-01-12T06:58:14-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000872589-26-000004 2026-01-30T07:24:59-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-k/0000872589-26-000008 2026-02-04T09:15:19-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/13f-hr/0001104659-26-011601 2026-02-06T17:11:15-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001969223-26-000127 2026-02-09T16:07:52-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001968582-26-000093 2026-02-09T17:04:56-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001187443-26-000004 2026-02-11T16:06:37-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0002009236-26-000001 2026-02-11T16:08:34-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001969223-26-000203 2026-02-19T16:07:36-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001681643-26-000004 2026-02-23T16:58:30-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001187443-26-000006 2026-03-03T16:05:05-05:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/schedule-13ga/0000102909-26-002187 2026-03-27T11:38:14-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001104659-26-039613 2026-04-03T16:02:45-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-26-040661 2026-04-08T07:08:35-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/defa14a/0001308179-26-000341 2026-04-24T16:05:53-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/def-14a/0001308179-26-000340 2026-04-24T16:12:06-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/ars/0001104659-26-048580 2026-04-24T16:15:33-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000872589-26-000014 2026-04-29T06:51:20-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0000872589-26-000016 2026-04-29T06:57:25-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/schedule-13g/0002100119-26-001017 2026-04-30T13:04:23-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001187443-26-000008 2026-05-04T16:18:55-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/13f-hr/0001104659-26-057922 2026-05-08T16:12:32-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-26-075127 2026-06-17T16:09:23-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001968582-26-000693 2026-07-02T17:47:41-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-26-080562 2026-07-06T07:03:11-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001187443-26-000010 2026-07-07T16:07:13-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0000872589-26-000023 2026-07-30T06:50:09-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/10-q/0000872589-26-000025 2026-07-30T06:54:46-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/13f-hr/0001104659-26-092709 2026-08-07T16:12:29-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001969223-26-000870 2026-08-10T16:13:32-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001969223-26-000871 2026-08-10T16:15:08-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001681643-26-000006 2026-08-12T16:17:07-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001992352-26-000005 2026-08-12T16:20:26-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001697422-26-000002 2026-08-20T16:04:39-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/n-px/0001104659-26-099230 2026-08-20T16:13:22-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001238303-26-000002 2026-08-21T16:04:28-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001969223-26-000987 2026-09-02T16:11:11-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001969223-26-000988 2026-09-02T16:13:13-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001969223-26-000991 2026-09-03T16:10:01-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001992352-26-000007 2026-09-03T16:51:31-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001663758-26-000002 2026-09-03T16:55:51-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-26-112340 2026-09-30T16:15:33-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/8-k/0001104659-26-113895 2026-10-06T07:53:52-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/144/0001969223-26-001073 2026-10-14T16:05:43-04:00 0.4 https://investor.regeneron.com/sec-filings/sec-filing/4/0001796226-26-000002 2026-10-15T16:05:39-04:00 0.4 https://investor.regeneron.com/board-directors-management/leonard-schleifer 2024-12-04T18:52:21-05:00 0.5 https://investor.regeneron.com/board-directors/huda-zoghbi 2024-11-13T18:55:05-05:00 0.5 https://investor.regeneron.com/board-directors/bonnie-bassler 2025-12-02T12:03:09-05:00 0.5 https://investor.regeneron.com/analyst/joe-pantginis 2018-06-12T03:14:04-04:00 0.5 https://investor.regeneron.com/analyst/edward-tenthoff 2018-06-12T03:14:04-04:00 0.5 https://investor.regeneron.com/analyst/brian-skorney 2018-06-12T03:14:04-04:00 0.5 https://investor.regeneron.com/analyst/ying-huang 2018-06-12T03:14:04-04:00 0.5 https://investor.regeneron.com/analyst/biren-amin 2018-06-12T03:14:04-04:00 0.5 https://investor.regeneron.com/analyst/jonathan-aschoff 2018-06-12T03:14:04-04:00 0.5 https://investor.regeneron.com/analyst/robyn-karnauskas 2018-06-12T03:14:04-04:00 0.5 https://investor.regeneron.com/analyst/phil-nadeau 2018-06-12T03:14:04-04:00 0.5 https://investor.regeneron.com/analyst/cory-kasimov 2018-06-12T03:14:04-04:00 0.5 https://investor.regeneron.com/analyst/geoff-meacham 2018-06-12T03:14:04-04:00 0.5 https://investor.regeneron.com/analyst/terence-flynn 2018-06-12T03:14:04-04:00 0.5 https://investor.regeneron.com/analyst/adnan-butt 2018-06-12T03:14:04-04:00 0.5 https://investor.regeneron.com/analyst/joe-schwartz 2018-06-12T03:14:04-04:00 0.5 https://investor.regeneron.com/analyst/matthew-roden 2018-06-12T03:14:04-04:00 0.5 https://investor.regeneron.com/analyst/john-newman 2018-06-12T03:14:04-04:00 0.5 https://investor.regeneron.com/analyst/matthew-harrison 2018-06-12T03:14:04-04:00 0.5 https://investor.regeneron.com/analyst/gbola-amusa 2018-06-12T03:14:04-04:00 0.5 https://investor.regeneron.com/analyst/tony-butler-phd 2018-06-12T03:14:04-04:00 0.5 https://investor.regeneron.com/analyst/mark-schoenebaum 2018-06-12T03:14:04-04:00 0.5 https://investor.regeneron.com/analyst/christopher-raymond 2018-06-12T03:14:04-04:00 0.5 https://investor.regeneron.com/board-directors-management/george-yancopoulos 2024-12-04T18:54:46-05:00 0.5 https://investor.regeneron.com/board-directors/michael-brown 2024-12-04T18:55:54-05:00 0.5 https://investor.regeneron.com/board-directors/joseph-goldstein 2024-12-04T18:56:37-05:00 0.5 https://investor.regeneron.com/board-directors/george-sing 2024-12-04T18:58:27-05:00 0.5 https://investor.regeneron.com/management/peter-powchik 2024-11-13T18:57:40-05:00 0.5 https://investor.regeneron.com/management/neil-stahl 2024-11-13T18:58:09-05:00 0.5 https://investor.regeneron.com/management/robert-terifay 2018-06-11T23:14:04-04:00 0.5 https://investor.regeneron.com/management/daniel-van-plew 2018-06-11T23:14:04-04:00 0.5 https://investor.regeneron.com/board-directors/christine-poon 2024-12-04T18:59:11-05:00 0.5 https://investor.regeneron.com/board-directors/tony-coles 2024-12-04T19:01:13-05:00 0.5 https://investor.regeneron.com/board-directors/craig-b-thompson-md 2024-12-04T19:00:10-05:00 0.5 https://investor.regeneron.com/board-directors/kathryn-guarini-phd 2024-12-04T19:00:42-05:00 0.5 https://investor.regeneron.com/board-directors/david-p-schenkein-md 2024-12-04T18:59:42-05:00 0.5